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Abbreviations 
αfs   Fraction of cross-bridges in the force generating state  
[Ca2+]i   Intracellular calcium concentration 
ACh  Acetylcholine 
CK   Creatine kinase  
COPD  Chronic obstructive pulmonary disease 
CSA  Cross sectional area 
DHPR   Dihydropyridine receptor 
DTT  Dithiotreitol 
EH   Emphysematous hamster 
eNOS  endothelial type of nitric oxide synthase 
fapp  Apparent rate constant for cross-bridge attachment 
FEV1   Forced expiratory volume in one second 
Fmax  Maximal force 
FR  Free radical 
gapp  Apparent rate constant for cross-bridge detachment 
GPX  Glutathione peroxidase 
GR   Glutathione reductase 
GSH  Reduced glutathione 
GSSG   Oxidized glutathione 
H2O2  Hydrogen peroxide 
HOCl  Hypochlorous acid 
iNOS  Inducible type of nitric oxide synthase 
IRB   Inspiratory resistive breathing 
ktr   Rate constant for force redevelopment 
MDA   Malondialdehyde 
NAC   N-Acetylcysteine 
NH  Normal hamster 
(n)NOS  (neuronal type of) nitric oxide synthase 
ONOO   Peroxynitrate  
GR  Glutathione reductase 
pCa  -log calcium concentration 
PImax  Maximal inspiratory pressure 
Po   Maximal tetanic tension 
Pt   Twitch tension 
ROS  Reactive oxygen species 
RyR  Ryanodine receptor 
SNAP   S-nitroso-N-acetylpenicillamine  
SNK  Student-Newman-Keuls post hoc test 
S-NP  Sodium nitroprusside 
SOD  Superoxide dismutase 
SR  Sarcoplasmic reticulum 
TNF  Tumor necrosis factor 
VE   Minute ventilation  
Vo   Maximum shortening velocity 
Vo2   Oxygen consumption at maximal exercise 
Wmax  Maximal workload 
XD  Xanthine dehydrogenase 
XeD   Xestospongin-D 
XO  Xanthine oxidase 
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INTRODUCTION AND OUTLINE OF THE THESIS 
It is now well recognized that COPD is a multi-organ system disease (1). In particular, 
skeletal muscle dysfunction in these patients is gaining interest of different groups of basic 
and clinical investigators around the world. Skeletal muscle dysfunction frequently occurs in 
patients with severe COPD (2,5,8). Dysfunction of peripheral and respiratory muscles is 
associated with impaired exercise capacity, increased medical consumption, and mortality (3). 
Causative factors include disturbances in electrolytes, hypercapnia, forward failure, prolonged 
use of oral corticosteroids and possibly malnutrition. In addition, the altered geometry of the 
thorax may place the diaphragm at a suboptimal position of the Frank-Starling curve. 
 Little is known about the underlying mechanisms of muscle dysfunction in severe 
COPD. It has been shown that a shift in fiber type occurs in both respiratory and peripheral 
muscle of these patients. In the diaphragm a shift from type IIb to type IIA and type I fibers 
occurs (6). Since type I fibers generate less force per CSA compared to type II fibers, this may 
contribute to the impaired force generation of the respiratory muscles in COPD. Instead, in 
peripheral skeletal muscle of these patients a reduction in the proportion of type I fibers and 
an increase in the proportion of type IIb fibers occurs (9). Besides the shift in fiber types, 
other mechanisms may be involved in muscle dysfunction. Pro-inflammatory cytokines, such 
as TNF-α have been shown to induce skeletal muscle protein loss in vitro (7). Interestingly, 
circulating TNF-α levels are increased in a subgroup of COPD patients (4).  
 This thesis will focus on exercise-induced free radical generation in COPD and the 
effects of free radicals on skeletal muscle function. Resting skeletal muscles generate free 
radicals and generation is enhanced during contractile activity. Several sources for free 
radicals in skeletal muscle have been identified. The mitochondrial electron transport chain is 
considered a prominent source for free radicals in skeletal muscle. One to two percent of 
mitochondrial electron flow leaks of onto oxygen to form superoxide anion. Superoxide anion 
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may also be generated by the cytosolic enzyme xanthine oxidase (XO). Other possible sources 
include NADPH oxidase, prostanoid metabolism and nitric oxide synthase (NOS). A number 
of possible targets for free radicals have been identified in skeletal muscle, including 
contractile proteins, sarcoplasmic Ca2+ release channel and Ca2+ ATPases. However, both the 
contribution of each of these different sources and the most relevant intracellular targets are a 
point of ongoing discussion. In the present studies, we aimed to investigate the effect of redox 
modulation of specific intracellular targets on skeletal muscle function in vitro. In addition, in 
an animal model the contribution of free radicals generated by XO on rat diaphragm 
contractility was assessed under hypoxic and hyperoxic conditions. Furthermore, the role of 
xanthine oxidase in exercise-induced free radical generation in patients with COPD was 
studied.  
 The studies presented in this these are divided into three parts. In part one the effects 
of nitric oxide (NO) on muscle function are studied at single fiber level, using permeabilized 
rabbit psoas fibers and mouse skeletal myotubes. In part two studies are presented using 
diaphragm muscle bundles. Finally, part three contains the studies in patients with COPD.  
 
Part One  
Chapter 3 describes the effects of the nitric oxide donor DEA-NO on Ca2+ release in C2C12 
skeletal myotubes. Cytoplasmic free Ca2+ concentration was determined by fluo-3 
fluorescence using confocal laser microscopy. Myotubes were activated using acetylcholine 
and caffeine. 
 In chapter 4, the effects of the NO donor spermine-NO on cross-bridge recruitment 
and cross-bridge cycling kinetics in permeabilized rabbit psoas muscle fibers were studied. 
Single fibers were activated at varying Ca2+ concentrations. Maximal force, 50% maximal 
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force, fiber stiffness and the rate of force redevelopment after quick release at maximal and 
submaximal force were determined.  
 
Part Two 
In chapter 5 the role of free radicals on in vitro isometric and isotonic contractile properties of 
the rat diaphragm are studied under hyperoxic and hypoxic conditions. In addition, the role of 
free radicals generated by XO was studied on isometric and isotonic contractile properties of 
the rat diaphragm during hyperoxia and hypoxia.  
 Chapter 6 describes the effects of 12-week lasting endurance training on in vitro 
contractile properties and glutathione content of the normal and emphysematous hamster 
diaphragm.  
 
Part Three 
In chapter 7, the effect of the XO inhibitor allopurinol was studied on exercise-induced free 
radical generation in patients with severe COPD. Patients performed incremental cycle 
ergometry until maximal load (Wmax). Half of the patients were pretreated with allopurinol 
300 mg once a day for 2 days. Free radical generation was assessed by measuring blood 
reduced (GSH) and oxidized glutathione (GSSG) and plasma lipid-peroxidation before and 
after exercise.  
 Chapter 8 describes the correlations between markers for tissue metabolic stress and 
markers for free radical generation, namely GSH, GSSG and lipid-peroxides in patients with 
severe COPD. Metabolic stress was assessed by measuring blood pH, lactate and 
hypoxanthine concentration.  
 Several strategies can be thought of to modulate the oxidant / antioxidant balance. We 
have studied the effect of pulmonary rehabilitation on exercise-induced oxidative stress in 
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patients with severe COPD (chapter 9). Seven patients with COPD were enrolled in a 12-
week lasting pulmonary rehabilitation program, consisting of dynamic and isometric strength 
training exercises, and training of specific daily life activities. Patients performed whole body 
exercise and exercise by different muscle groups of upper and lower extremities. Before and 
after pulmonary rehabilitation, patients performed incremental cycle ergometry until maximal 
load. Blood was analysed for markers for free radical generation and for lactate at rest and 
after exercise.  
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Respiratory muscle dysfunction in chronic obstructive pulmonary disease 
Dysfunction of the respiratory muscles, especially the diaphragm, is known to occur in 
patients with severe COPD (14,55,126). Weakness of the diaphragm is part of a generalised 
process, involving all (respiratory and peripheral) skeletal muscles. Causative factors for 
respiratory muscle dysfunction in COPD include disturbances in electrolytes (9), hypercapnia 
(79), forward failure (73) and prolonged use of oral corticosteroids (38). In addition, the 
altered geometry of the thorax in severe emphysema compromises the ventilatory pump 
function of the diaphragm (36). Malnutrition, which frequently occurs in moderate to severe 
COPD (42), could also play a role in respiratory muscle dysfunction in COPD. Recent studies 
indicated that wasting of fat-free mass in COPD is associated with peripheral skeletal muscle 
weakness (43). However, scarce data are available regarding the effects of malnutrition on 
respiratory muscle strength. Maximal inspiratory pressure (PImax) in nutritional depleted 
COPD patients (FEV1 45.5 ± 15.1 % pred.) was lower in comparison to non-depleted COPD 
patients, but this did not reach statistical significance (42).  
Little is known about the underlying mechanisms of muscle dysfunction and the 
structural alterations that occur in the diaphragm with COPD. Levine et al (98) have shown 
that the diaphragm in severe COPD (FEV1 33 ± 4% pred.) has a higher proportion of type I 
(slow) fibres and a lower proportion of type II (fast) fibres compared to non-COPD subjects. 
Recently, it has been shown that a strong correlation exists between pulmonary functional 
residual capacity and proportion of slow myosin heavy chain fibres in the diaphragm (110). 
This fast to slow fibre transition in the diaphragm can be regarded as an advantageous 
adaptation, since it will attenuate fatigability of the diaphragm (104). However, eventually 
most COPD patients die from respiratory muscle failure. Apparently, at some point clinical 
relevant respiratory muscle dysfunction occurs in COPD. It has been shown that besides slow 
to fast fibre transition other processes occur in the diaphragm as well. For instance, Campbell 
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et al (22) demonstrated that in 17 out of 22 patients with none to moderate airway obstruction 
morphological changes were present in the intercostal muscles (variation in fibre size, 
splitting and atrophy), but not in the latissimus dorsi muscle. Fibre atrophy was significantly 
correlated to airway obstruction. Hards et al (61) also found evidence for morphologic 
abnormalities in the internal and external intercostals muscle of patients with mild COPD.  
Respiratory muscle dysfunction contributes to the complaint of dyspnoea and the onset 
of hypercapnia. The reduction of peripheral and respiratory muscle function contribute to 
reduced exercise tolerance (55). Generalised muscle weakness in these patients has been 
recognised as a main cause of health care utilisation (37).  
Skeletal muscles generate free radicals (FR) at rest and production increases during 
contractile activity (35,134). Overproduction of FR may result in a disturbance between the 
pro-oxidant and antioxidant balance in favour of the former and is called oxidative stress. This 
phenomena has been demonstrated to occur in skeletal muscle under circumstances such as 
skeletal muscle fatigue (6) and sepsis-induced muscle dysfunction (147,154) A large body of 
literature indicates that oxidative stress impairs skeletal muscle contractile performance 
(12,29,87,134,160). 
The chronically elevated load imposed on the diaphragm in severe COPD may 
enhance generation of FR, which in turn may further impair contractility of the diaphragm. In 
the present review we will summarize current knowledge on the role of FR in respiratory 
muscle dysfunction and discuss the relevance to patients with COPD. Possible strategies to 
modulate antioxidant defences in vivo will be reviewed.  
 
Free radicals and antioxidants in striated muscle contractility 
FR are molecules capable of independent existence containing one or more single 
electrons in an orbital. Since electrons usually are more stable when paired, radicals are 
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generally more reactive than non-radicals (122). A frequently used term is reactive oxygen 
species (ROS), which represents oxygen centred FR, such as superoxide anion (O2•-), and 
hydroxyl radical (HO•) and intermediates in FR reactions, e.g. hydrogen peroxide (H2O2) and 
hypochlorous acid (HOCl). Nitric oxide (NO) is a well known example of a nitrogen centred 
FR. 
The observation that increased contractile activity enhances generation of FR in 
striated muscle prompted investigators to study the effects of FR on skeletal muscle function 
and excitation-contraction coupling in particular. The latter is defined as the process of 
coupling chemical and electrical signals at the cell surface to the intracellular release of 
calcium (Ca2+) and ultimately contraction of muscle fibres (26). Briefly, upon binding of 
acetylcholine (ACh) to its receptor on the sarcolemma an action potential is generated. This 
action potential activates voltage-sensitive receptors in the T tubules. These so-called 
dihydropyridine receptors (DHPR) are mechanically coupled to ryanodine receptors (RyR), 
present on the sarcoplasmic reticulum (SR). Activation of the DHPR induces conformational 
changes in this receptor, thereby opening the RyR, resulting in Ca2+ release from the SR. 
Elevated cytosolic Ca2+ ([Ca2+]i) stimulates other RyR, not directly coupled to DHPR, to 
release Ca2+ from the SR. This positive feedback mechanism is called calcium-induced 
calcium release. Elevated [Ca2+]i enhances binding of Ca2+ to the troponin complex. The latter 
is the binding site for Ca2+ on the contractile proteins and is associated with the actin filament. 
Binding of Ca2+ to troponin is thought to induce a conformational change of troponin 
resulting in an increase in the availability of myosin-binding sites on actin, initiating 
contraction by facilitating cross-bridge cycling, i.e. the cyclic interaction between actin and 
myosin. Contraction is terminated when [Ca2+]i is re-sequestered in the SR by Ca2+ ATPases.  
FR can interfere with excitation contraction coupling at several sites. By isolating the 
SR from skeletal muscle fibres it was demonstrated that FR affect Ca2+ release through the 
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RyR in a dose dependent fashion. Submillimolar concentrations of H2O2 activate the RyR, 
whereas at millimolar concentration H2O2 inhibited channel activity (45). Similar studies 
revealed that NO inhibits Ca2+ release via the RyR channel (111). As with ROS the effects of 
NO are concentration-dependent: at low concentration NO prevents RyR channel opening, 
whereas higher concentrations activate the channel (1). The ability of NO to decrease SR Ca2+ 
release has been shown in intact fibres as well (69). FR exert their effects on SR Ca2+ release 
by modifying thiol groups present on the RyR (1,111). Other possible targets for FR in 
excitation-contraction coupling include hyper reactive thiols groups present on the myosin 
head (125), reactive cysteine residues present on the troponin complex (28,127) and Ca2+ 
ATP-ases (142). FR may also reduce the amplitude of action potentials (33).  
The effects of FR generated by skeletal muscle fibres do not only affect excitation 
contraction coupling, but other physiological processes as well. FR affect mitochondrial 
respiration through competitive interaction with the oxygen binding site of cytochrome 
oxidase (30) and affect insulin-independent glucose uptake in muscle fibres (139). NO 
generated by skeletal muscle is assumed to play a role in exercise-induced vasodilatation as 
well (78). In addition, FR are involved in many cellular process, including apoptosis, 
inflammation and gene regulation (31,144). For instance, recent in vitro studies have 
demonstrated that FR are needed for tumour necrosis factor-α (TNF-α)-induced nuclear factor 
kappa-ß (NF-κß) activation (101). Although these processes are potentially relevant to 
respiratory muscle function in COPD, the present review will focus on the direct effects of FR 
on excitation-contraction coupling.  
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SOURCES AND CHEMICAL PROPERTIES OF FR 
Fig. 1 shows schematically the well-known sources for FR in skeletal muscle. The electron 
transport chain in the mitochondria is an important source for the formation of ROS (27,49). 
1–2% percent of electron flow ‘leaks’ of onto O2 to form O2•- (56). Consequently, it has been 
proposed that elevated oxygen consumption results in increased generation of ROS.  
 
Figure 1. Schematic representation of formation of FR in skeletal muscle. Important sources for superoxide 
(O2-•) include mitochondrial respiratory chain and cytosolic xanthine oxidase (XO). Superoxide can be converted 
to the very reactive hydroxyl radical (•OH-), or react with nitric oxide (•NO), resulting in the formation of 
peroxynitrite (ONOO). These FR may induce damage to DNA, RNA, proteins, or induce FR chain reactions in 
lipid membranes. FR may also induce reversible oxidation of thiols, resulting in modification of receptor / 
protein function. See text for further explanation. nNOS = neuronal type nitric oxide synthase; eNOS = 
endothelial type NOS; iNOS = inducible NOS; H2O2 = hydrogen peroxide; MPO = myeloperoxidase; HOCl = 
hypochlorous acid; GSH = reduced glutathione; GSSG = oxidised glutathione.  
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Cytosolic xanthine oxoreductase (XOR) plays a role in purine nucleotide degradation. This 
enzyme can be present as the dehydrogenase form (XD) or the oxidase form (XO). Under 
physiological conditions XOR mainly exists as the former, which uses NAD+ for electron 
transfer, resulting in the formation of NADH. In contrast, XO uses O2 for electron transfer 
resulting in the formation of superoxide: 
 
xanthine + H2O + 2O2     uric acid + 2O2-• + 2H+ 
 
Generation of superoxide by XO plays an important role in ischemia/reperfusion injury (108). 
Expression of this enzyme has been demonstrated in peripheral and respiratory muscles of 
rodents (2,92) and in peripheral skeletal muscle of humans (62,66,67). XOR expression in the 
human respiratory muscles has not been confirmed yet. 
Polymorph neutrophils (PMN’s) can generate the extremely potent pro-oxidant 
hypochlorous acid (HOCl). The reaction involves the myeloperoxidase (MPO)-catalysed 
oxidation of Cl- ions by H2O2 (13). PMN infiltration is increased in skeletal muscle after 
prolonged exercise (46). Moreover, the potential of PMN’s to form ROS is increased after 
exercise in humans (162). Thus, under certain conditions FR generated by PMN’s may induce 
damage to skeletal muscle fibres. Other sources of FR in skeletal muscle include the cytosolic 
enzyme aldehyde oxidase (27) and the arachidonic acid cyclooxygenase pathway (91).  
NO is generated enzymatically by nitric oxide synthase (NOS). Three isoforms of 
NOS (Type I, II and III) have been identified. Type I and III, or neuronal (nNOS) and 
endothelial NOS (eNOS) respectively, are present in rat (88) and human (48) skeletal muscle. 
In rodents type I NOS expression is higher in fast compared to slow twitch skeletal muscle 
fibres (87). Type III NOS co-expresses histochemically with mitochondrial markers (48), 
indicating expression in proximity of mitochondria. 
XO 
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Activation of type I and III NOS is dependent on elevated [Ca2+]i. While type I and III 
are constitutive, type II NOS is an inducible form (iNOS). The latter probably plays a role in 
endotoxin-induced muscle dysfunction, since it has been demonstrated that injection of E. 
Coli endotoxin, induced expression of iNOS in the diaphragm of mice (164).  
 The formation of very reactive FR in vivo is of special interest. In the so-called 
‘Fenton reaction’ iron (Fe2+) dependent decomposition of H2O2 results in the formation of a 
hydroxyl radical (59): 
 
Fe2+ +  H2O2   Fe3+  +  HO•- +   OH- 
 
 The Fenton reaction is of importance since it involves the conversion of a moderate 
reactive FR into an extremely reactive FR (59). The formation of a very reactive FR from a 
less reactive one also occurs in the following reaction (131):  
 
O2•-   +   •NO    ONOO- 
 
 Since the rate constant of superoxide to NO is many times higher than the rate 
constant of superoxide to its endogenous antioxidant superoxide dismutase (SOD) (131), the 
formation of peroxynitrate (ONOO-) in vivo is likely. These very reactive FR are potentially 
hazardous to normal cell function due to their ability to react with vital cellular components 
such as lipids, proteins, DNA and RNA. 
Cigarette smoke is a rich source of FR, containing over 1015 organic radicals and 500 
ppm NO per puff (132). Most of these FR are highly reactive and short lived (< 1.0 s). Due to 
the short half-life time and strong antioxidant capacity of the epithelial lining fluid and blood, 
it is unlikely that FR derived from cigarette smoke directly alter skeletal muscle function. 
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However, it has been demonstrated that circulating neutrophils from smokers have an 
enhanced oxidative burst (103). As mentioned above exercise is known to recruit neutrophils 
to contracting skeletal muscle (46). Thus it is possible that skeletal muscles of smokers have 
higher oxidative load in comparison to non-smokers. Also, a reduction in total antioxidant 
capacity has been demonstrated in plasma of smokers (133). It could be speculated that 
impaired antioxidant screen as a result of smoking may compromise muscle function. 
However, no studies addressed this pathway.  
 
 
ANTIOXIDANT DEFENSES 
 In skeletal muscle protection from the deleterious effects of FR is provided by many 
strategies that aim to inhibit the propagation of FR reactions. An antioxidant is any substance 
which, when present at low concentrations compared with those of an oxidisable substrate, 
significantly delays or prevents oxidation of that substrate (58). Glutathione (L-γ-glutamyl-L-
cysteinylglycine) is an abundant and ubiquitous antioxidant. Its antioxidant power is closely 
associated with its role in providing the cell its reducing milieu. Intracellular glutathione 
metabolism is regulated by complex pathways (109). Reduced glutathione (GSH) serves as an 
antioxidant by reacting directly with FR and by providing substrate for glutathione peroxidase 
(GPX). Both direct and enzymatic oxidation of GSH results in the formation of oxidised 
glutathione (GSSG), which is reconverted to GSH by glutathione reductase (GR). Thus, this 
latter enzyme catalyses equilibrium between GSH and GSSG that greatly favours the former 
(109). Therefore, intracellular ratio of GSSG/GSH, a common ratio to express the degree of 
oxidative stress (149), is usually kept low (± 5%), to maintain a reducing state of the cytosol. 
Thus, tissue glutathione status depends on the direct interaction of GSH with oxidants, the 
activity of the GPX and GR redox cycle and on the ability of tissues to synthesise GSH.  
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In skeletal muscle glutathione concentration is correlated with oxidative capacity. In 
the rat soleus muscle (predominantly oxidative fibres), GSH concentration is higher compared 
to vastus lateralis muscle (predominantly glycolytic fibres) (77). As with GSH, activity of 
GPX, GR and catalase are higher in highly oxidative skeletal muscle fibres compared to fibres 
with lower oxidative capacity (77). 
Other enzymatic antioxidants include SOD and catalase. These two enzymes 
essentially act in concert in the following manner: 
 
2O2-•  +  2H+      H2O2  +  2O2 
 
 
2H2O2        2H2O  +  O2 
 
 
Non-enzymatic antioxidants include α-tocopherol (vitamin E) and ascorbic acid 
(vitamin C). The former is a lipid soluble chain breaking antioxidant that reacts rapidly with 
lipid-peroxyl radicals resulting in the formation of the less reactive α-tocopheroxyl radical. In 
addition, α-tocopherol can also scavenge other FR such as •OH. Ascorbic acid is a water 
soluble antioxidant which may be important in reducing the α-tocopheroxyl radical, although 
the relevance of this process in vivo needs to be determined (107).  
Specific NOS inhibitors, such as NG-NG-dimethylarginine, NG-N’G-dimethylarginine 
and Protein Inhibitor of Nitric oxide synthase (PIN) exist in vivo (75,169). Recently, the 
expression of PIN has been demonstrated in rodent and human diaphragm (57). However, the 
functional role of these inhibitors remains to be investigated.  
 
SOD 
Catalase 
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Functional relationship between free radicals and striated muscle contractility 
There is good evidence that FR are essential for optimal respiratory muscle contractile 
function. In vitro studies revealed that the rat diaphragm generates FR. Scavenging ROS in 
this model through the addition of catalase decreased peak isometric force generation (134). 
Moreover, exposing non-fatigued skeletal muscle to ROS increases submaximal force 
generation (4,93). Intact single fibre studies revealed that short-term (3 min.) exposure to 
H2O2 increases submaximal force generation, but did not alter [Ca2+]i during activation, 
indicating that H2O2 increased Ca2+ sensitivity of the fibre (4). Similarly, blocking 
endogenous NO synthesis reduces maximal shortening velocity and maximal power output of 
the unfatigued rat diaphragm in vitro (117). Together, these studies demonstrate the 
physiological role of FR in maintaining optimal skeletal muscle contractility. 
However, overproduction of FR is associated with impaired contractile performance. 
Exposing non-fatigued intact single fibres to H2O2 for > 6 min. reduced in vitro force 
generation, whereas [Ca2+]i was increased (4). This indicates that prolonged oxidative stress 
reduces Ca2+ sensitivity of skeletal muscle fibres (I.E. less force production at higher [Ca2+]i). 
In addition, in vitro exposure of peripheral or diaphragm muscle strips to oxidative stress 
increased fatigue rate (12,93,94). Conversely, antioxidants such as N-acetylcysteine (NAC), 
catalase, SOD and the hydroxyl scavenger dimethylsulphoxide (DMSO) attenuated the rate of 
fatigue development in vitro (39,86,134). 
Exposure of rat diaphragm strips to the NO donor sodium nitroprusside (S-NP) 
depressed submaximal force generation (87). Perkins et al (125) showed that in skinned rat 
skeletal muscle fibres S-NP reduced isometric force generation through oxidation of 
contractile protein thiols.  
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Figure 2. Schematic model of force production as function of cellular redox balance as proposed by Andrade et 
al (4). The baseline redox balance (O) is to the left of the peak, into the reduction range. To obtain maximal 
contractile function FR are required (▼). However, overproduction of FR, resulting in oxidative stress, impairs 
contractile function of skeletal muscle (▲). Similarly, scavenging FR in unfatigued muscle, resulting in 
‘reductant stress’ also impairs contractility. (Figure from reference4, used with permission).   
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Apparently, force production is a function of redox status of the muscle fibre (4) (Fig. 
2). The baseline redox balance is to the ‘reduced site’ of the balance, since exposing 
unfatigued skeletal muscle fibres to low concentration of oxidants increases force generation. 
However, both oxidant and reductant stress impair force generation. The complexity of the 
effects of FR on force generation is also demonstrated in recent studies by Andrade et al (5). 
Exposing intact single skeletal muscle fibres to NO donors reduced Ca2+ sensitivity of the 
fibres, which would tend to decrease force generation. However, NO donors also increased 
[Ca2+]i during activation, which will increase force generation. Since these two effects 
occurred at the same time, force generation remained unaffected. The authors hypothesised 
that force production will depend on the fine balance between these opposing effects (5).  
A pivotal question in in vitro studies aiming at modulating the oxidant-antioxidant 
balance within tissue is the appropriate concentration of the FR donor or antioxidant. 
Currently, lack of knowledge exists regarding the physiological concentration of FR within 
tissue, and skeletal muscle fibres in particular. Although release of NO from skeletal muscle 
preparations has been demonstrated (10), these data provide limited information regarding 
NO concentration at (sub) fibre level. Since NOS has a specific distribution with muscle 
fibres, it is conceivable that NO concentration is not uniform within the muscle fibre. 
Variation in concentration within fibres will be even more pronounced in case of oxygen 
centred FR, due to the extreme short half life time, and thus small diffusion distances of these 
species. Consequently, it is difficult to establish whether the concentration of FR generated by 
a specific donor equals the physiological concentration of FR in tissue.  
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Figure 3 
 
Figure 3. Generation of FR starts at onset of contractions (from Kolbeck et al (89)). In panel A calculated 
levels for superoxide produced by isolated, perfused rat diaphragms are shown. Superoxide was detected by 
cytochrome C reduction. Signals were inhibited in the presence of the superoxide scavenger superoxide 
dismutase (SOD). The data in the lower panel (B) show isometric force production generated by the diaphragm 
when diaphragms were subjected to 500 ms 80 Hz train stimulation at a periodicity of one per minute. At 10 min 
on the time axis, the period of stimulation was increased to one per second. Immediately at the onset of fatiguing 
contractions generation of superoxide is significantly (*P<0.05) increased. After discontinuation of fatiguing 
contractions generation of superoxide decreases. (Figure from ref.89, used with permission). 
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Increased generation of free radicals by striated muscle contractions 
ANIMAL STUDIES 
In vitro studies 
Fatiguing contractions of the rat diaphragm increase the rate of FR generation (134) (Fig 
3)(89,135). Elevated generation of FR precedes the development of fatigue (89). Moreover, a 
significant inverse correlation has been observed between the impairment in force generation 
in the diaphragm during fatiguing contractions and the amount of superoxide released (135). 
Similarly, rat skeletal muscle also generates NO at rest, and generation increases after 
contractile activity (10).  
A limitation to in vitro models in studying the effects of oxidative stress on functional 
performance is that the tissue under investigation is removed from its physiological 
environment. This may have important effects on the redox state of the tissue. In vivo, skeletal 
muscles take up GSH from blood in order to attenuate intracellular GSH depletion. The 
absence of GSH and other scavengers in tissue bath experiments may affect functional 
responses of the tissue under investigation.  
In order to circumvent these disadvantages animal models have been used to study the 
effects of elevated generation of FR on skeletal muscle function in vivo.  
 
Exercise 
Electron Spin Resonance (ESR) spectroscopy is a reliable technique to establish generation of 
FR directly. This technique measures the energy changes that occur as unpaired electrons 
align in response to an external magnetic field. A very small population of FR and other 
paramagnetic compounds can be detected in samples composed predominantly of other 
substances. Disadvantages of this technique include its time consuming nature, expenses and 
in vivo toxicity of some of the spin traps (163). Using ESR spectroscopy, Davies et al (35) 
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were the first to demonstrate that strenuous exercise increases FR generation in peripheral 
skeletal muscles of rats. Later studies supported these observations. For instance, acute 
exercise has marked effects on skeletal muscle glutathione status. Both glutathione depletion 
(143) and elevation of the GSSG/GSH ratio (100) have been observed after an acute bout of 
exercise. Exercise increased GSSG concentration in the soleus and deep vastus lateralis 
muscle, but did not affect GSSG in the superficial vastus lateralis muscle, indicating fibre 
specific responses. In addition, acute exercise increased skeletal muscle GPX, GR and SOD 
activity (76), although other studies did not report such up regulation in antioxidant enzyme 
activity (143).  
Exercise increased lipid-peroxidation in contracting muscles (3,72), in a fibre type 
specific manner (3). The increase in lipid-peroxides after a strenuous bout of exercise in rats 
was more pronounced in the vastus muscle (fast twitch) compared to the soleus muscle (slow 
twitch, highly oxidative). These differences among fibre types may be the result of muscle 
fibre recruitment, differences in antioxidant capacity and amount of FR generated.  
Increased ventilation during exercise puts an elevated load on the respiratory muscles. 
PMN content, as estimated by MPO activity, was increased in the diaphragm after exercise 
(120). Moreover, these PMN’s appear to have a higher ability to generate superoxide upon 
stimulation with cytokines, suggesting that PMN’s may contribute to increased FR generation 
after exercise. In line with studies in peripheral skeletal muscle, antioxidant enzymes such as 
GPX and catalase have been shown to be up regulated in the diaphragm after exercise (120). 
No data have been published on the effects of exercise on NO production and NOS regulation 
in animal skeletal muscle.  
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Loading of respiratory muscles 
Inspiratory resistive breathing (IRB) is a well-known technique to load the respiratory 
muscles. Borzone et al demonstrated that IRB until pump failure results in elevated 
generation of FR in the diaphragm as indicated by increased ESR signal (18). Subsequent 
studies indicated that IRB until apnea has detrimental effects on in vitro contractility of the 
diaphragm. Impairment in force generation is accompanied by increased glutathione oxidation 
and lipid-peroxidation in the rat diaphragm (6,7,29,160,161).  
IRB also has marked effects on NO metabolism in respiratory muscles. Recently, it 
was demonstrated that 3 hours of IRB decreased diaphragmatic and intercostal muscle NOS 
activity although protein expression of type I and III NOS were not affected (50). 
Alternatively, in vivo electrical stimulation of rabbit peripheral skeletal muscle for 3 weeks 
significantly increased NOS activity and NOS protein expression (137). Although the precise 
mechanism behind these alterations is not clear yet, these studies indicate that NOS activity in 
respiratory muscles can be modulated by contractile activity. 
In situ dog diaphragm stimulation via the phrenic nerve resulted in a decline in force 
to 20% of initial value (157). The drop in force could be attenuated by administration of 
DMSO or with PEG-SOD (a long-acting type of SOD). Treatment with these antioxidants 
also attenuated diaphragm lipid-peroxidation (157).  
The emphysematous hamster is a well-known animal model for pulmonary 
hyperinflation. It has been shown that impaired force generation in the emphysematous 
hamster diaphragm is accompanied by increased ratio of GSSG/GSH (68).  
Together, these animal models demonstrate that impaired force generation of the 
respiratory muscles induced by elevated loading is accompanied, or even preceded by 
increased generation of FR. In some studies impairment in force generation was inversely 
correlated with the markers for FR generation (18,68).  
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Ischemia / reperfusion injury 
Ischemia / reperfusion injury is a clinical entity which is proposed to result from elevated 
generation of FR by the cytosolic enzyme XO (108). Although at first sight ischemia / 
reperfusion injury is not a clinical problem of interest to the diaphragm, there might be 
conditions resulting in area’s of deoxygenation, e.g. hypoxemia in concert with a degree of 
diaphragm hypoperfusion (severe arteriosclerosis, low output failure). Indeed, during 
hypovolemic shock, the contracting dog diaphragm releases substantial amounts of ATP 
degradation products like hypoxanthine (84), which is a primary substrate for XO. Since the 
diaphragm is relatively rich in XO, generation of superoxide is likely to occur in the 
diaphragm when ATP degradation products accumulate. Supinski et al (158) demonstrated 
that 3 hours of ischemia and subsequently 1 hour of reperfusion, impaired rat diaphragm 
contractility. The detrimental effects of ischemia / reperfusion on diaphragm contractility 
were blunted with DMSO (158). 
 
HEALTHY SUBJECTS 
Muscle cells export GSSG when subjected to oxidative stress (145). Blood glutathione may 
than reflect the glutathione status of less accessible tissues such as skeletal muscle. Supinski 
et al (155) demonstrated that during IRB enhanced glutathione oxidation occurs in 
contracting, but not in resting skeletal muscle. Thus elevated GSSG levels in blood after 
exercise originate, at least partly, from contracting skeletal muscles.  
 
Exercise 
In healthy subjects exhaustive physical exercise is associated with overproduction of FR as 
indicated by elevated glutathione-oxidation in blood (54,140,146) and skeletal muscle (32). 
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Furthermore, exhaustive exercise enhances lipid-peroxidation as indicated by elevated plasma 
lipid-peroxides (80-82,102) and increased pentane exhalation (40,82). When exercise is not 
exhaustive, blood glutathione oxidation and lipid-peroxidation do not occur, or at least to a 
lesser extend (23,102,106).  
Exercise-induced plasma lipid-peroxidation is accompanied by decreased plasma 
nitrite level (95). A possible explanation for these findings is that NO scavenges superoxide 
generated during exercise. This will reduce plasma nitrite formation after exercise. However, 
the role of NO formation during exercise needs to be studied in detail. Recent studies showed 
nNOS and eNOS expression in peripheral skeletal muscle (48) and diaphragm (57) of healthy 
subjects. nNOS co-expresses with mitochondrial markers and a predominance exists for type I 
fibres. Alternatively, eNOS is equally distributed among different fibres types and is mainly 
present in endothelium, which suggests a role for vaso-regulation. No studies are available on 
the effects of exercise on NOS activity in human skeletal muscle. 
 
COPD PATIENTS 
 
Exercise 
Viña et al (170) showed that exercise-induced blood glutathione-oxidation occurs in patients 
with COPD as well. Recently, we found that in COPD exercise-induced blood glutathione-
oxidation is accompanied by elevated plasma lipid-peroxides (70,71). These observations may 
have important implications. First, exercise limitation is a prominent feature of severe COPD. 
In contrast to healthy subjects, patients with severe COPD may get exhausted easily, for 
instance during daily life activities. The above-mentioned studies (70,71,170) suggest that this 
is accompanied by oxidative stress and FR-induced tissue damage. The respiratory muscles 
are likely to be a prominent source for elevated GSSG and lipid-peroxides, since, in contrast 
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to healthy subjects, in COPD patients the respiratory muscles utilise a substantial part (up to 
40-50%) of the total oxygen consumption at relatively light exercise (99). Furthermore, it is 
remarkable that the degree of exercise-induced blood glutathione oxidation is similar between 
healthy subjects and patients with severe COPD (Fig. 4). At first sight this is surprising since 
it is generally assumed that oxidative metabolism in the mitochondria is the most prominent 
source for generation of FR during exercise. Reduced oxygen consumption rate at maximal 
exercise that frequently occurs in COPD would be expected to attenuate formation of FR. 
Possible explanations for this obvious oxidative stress in COPD patients during exercise 
include disturbances in the mitochondrial respiratory chain, contribution of other sources 
besides the mitochondria to generation of FR during exercise, and impaired antioxidant 
defences in COPD.  
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Figure 4. Exercise causes blood glutathione oxidation in healthy subjects and patients with severe COPD. Data 
are derived from different studies, but blood was analysed in the same laboratory using the same methods. At 
rest GSSG/GSH ratio is similar between healthy subjects and patients with COPD. In both groups exhaustive 
exercise is associated with elevated blood glutathione oxidation. This tended to be more pronounced in COPD. 
*Significantly different from pre exercise value (P<0.05). Data from healthy subjects ref 140, data from COPD 
ref.71. GSH = reduced glutathione; GSSG = oxidised glutathione.  
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Impaired mitochondrial metabolism may occur in COPD. It has been shown that 
cytochrome-C oxidase activity in quadriceps muscle of patients with COPD is increased 
compared to healthy subjects (141). This may enhance generation of FR during exercise in 
COPD. On the other hand, release of partially reduced oxygen from cytochrome-C oxidase is 
unlikely because of the high binding affinity of cytochrome-C (90). Further studies are needed 
to determine the contribution of mitochondria to exercise-induced oxidative stress in COPD.  
An interesting possibility is that other sources besides the mitochondria contribute to 
FR generation during exercise. As mentioned, generation of FR by XO plays a key role in 
ischemia / reperfusion injury (108). At tissue level similarities exist between strenuous 
exercise and ischemia / reperfusion. During strenuous exercise accumulation of ATP 
degradation products, such as xanthine and hypoxanthine, occurs in skeletal muscle (47), 
thereby providing substrate for XO. This implies that in conditions of metabolic stress, 
resulting in ATP degradation, XO may generate superoxide. The release of hypoxanthine and 
urate from contracting skeletal muscles has been confirmed in humans (63,64,85). In addition, 
XO expression in human skeletal muscle is increased after strenuous exercise (66), which also 
favours the generation of FR by XO. Recently, we investigated the contribution of XO in 
exercise-induced FR generation in COPD patients (FEV1 1.1 ± 0.1 L) (71). Treatment with 
the XO inhibitor allopurinol (300 mg per day for 2 days) prevented exercise-induced blood 
glutathione-oxidation and lipid-peroxidation (Fig. 5), indicating that XO plays a prominent 
role in exercise-induced FR generation in COPD. Preliminary data indicate that XO also plays 
a prominent role in exercise-induced FR generation in healthy subjects (J. Viña, personal 
communication).  
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Figure 5. Xanthine oxidase is involved exercise-induced oxidative stress in COPD. Changes in GSSG/GSH 
ratio in arterial blood of control- and allopurinol treated COPD patients. Blood was collected at rest, 3 minutes 
after incremental cycle ergometry (post exercise) and 60 minutes after incremental cycle ergometry (recovery). 
In control patients GSSG/GSH ratio was significantly elevated post exercise, whereas in allopurinol treated 
patients exercise did not affect the ratio. B. Changes in malondialdehyde (MDA) concentration as indicator of 
free radical induced lipid-peroxidation in control- and allopurinol treated COPD patients. Plasma was collected 
at same time points as for A. In control patients exercise significantly elevated MDA post exercise and a further 
elevation was observed at recovery. In stead, in allopurinol treated patients exercise did not affect plasma MDA. 
*P<0.05 vs. pre exercise. GSH = reduced glutathione; GSSG = oxidised glutathione, MDA = malondialdehyde. 
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No studies have been published on the antioxidant status of the diaphragm in COPD. 
Levine et al (98) showed that type I fibre composition of the diaphragm in patients with 
COPD is increased. If this is associated with increased generation of FR or up regulation of 
the antioxidant screen remains to be investigated. In addition, little is known about NOS 
expression in peripheral or respiratory muscles in COPD. A preliminary study showed that 
NOS expression in quadriceps muscle of patients with COPD (N=7) was not different 
compared to healthy controls (21). However, the role of NOS in skeletal muscle dysfunction 
in COPD needs further investigation.  
 
Modulation of antioxidant balance 
Due to the increased awareness of deleterious effects of FR on tissue function, many studies 
have been performed aiming at either reducing generation of FR, or improving antioxidant 
balance.  
 
OXYGEN 
Oxidants are generated during hypoxia and antioxidants attenuate the deleterious effects of 
hypoxia on force generation in rat diaphragm (113). Therefore, it has been speculated that O2 
treatment reduces generation of FR. Indeed, under certain circumstances O2 supplementation 
appears to be effective in reducing oxidative stress. IRB-induced GSH depletion of the 
diaphragm was less severe in rats breathing 100% O2 compared to rats breathing room air 
(159). Also, task endurance was significantly longer in oxygen-supplemented rats. In humans 
O2 has been shown to reduce exercise-induced oxidative stress. In patients with severe COPD 
performing exhaustive cycle ergometry oxygen supplementation attenuated exercise-induced 
blood glutathione-oxidation (170). The underlying mechanisms are poorly understood. 
Supplementation with O2 attenuates exercise-induced hypoxemia in severe COPD. This might 
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have beneficial effects on glutathione status since hypoxemia inhibits glutathione synthesis 
(51). Further, it is likely that O2 supplementation delays ATP degradation during exercise and 
thereby limits accumulation of xanthine and hypoxanthine. This reduces the ability of XO to 
generate superoxide. Thus, O2 supplementation might be a useful strategy to reduce exercise-
induced oxidative stress, at least in severe COPD. The functional consequences of this 
mechanism in humans remain to be investigated.  
 
NUTRITION 
The diet provides important source for antioxidants. Well-known examples include vitamin E 
and C, ß-carotene and flavonoids.  
 
Animal studies 
Vitamin E plays a prominent role in respiratory and peripheral muscle function. Vitamin E 
deficiency increases lipid-peroxidation and glutathione oxidation in rat diaphragm (7). In 
addition, vitamin E deficiency is associated with impaired in vitro force generation of the 
diaphragm. IRB-induced impairment in in vitro force generation and elevation of GSSG 
levels in the diaphragm was more severe in vitamin E deficient compared to control rats (7). 
In limb muscle an acute bout of strenuous exercise decreases vitamin E content (138). 
Vitamin E deficiency increases oxidative stress in peripheral skeletal muscle, as indicated by 
elevated ESR signal (35) and increased lipid-peroxidation (35,165).  
Data on the effects of vitamin C on respiratory muscle function are not available. 
Vitamin C supplementation cannot counteract reduced exercise performance in vitamin E 
deficient rats (52). This is not surprising since these two antioxidants are proposed to act in 
concert; vitamin C can serve as a donor antioxidant for oxidised vitamin E, but due to its 
hydrophilic properties it is not able to scavenge lipid-peroxides directly  (20). Vitamin C 
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supplementation prior to treadmill exercise partially prevented blood glutathione-oxidation 
(140). Packer et al (123) demonstrated that vitamin C deficiency, but also high dose vitamin C 
supplementation, impairs exercise endurance in guinea pigs. In the presence of ferric ions 
vitamin C can act as a pro-oxidant. If this explains reduced exercise capacity in vitamin C 
supplemented animals is uncertain.  
Since selenium is an essential component for the synthesis of GPX, selenium 
deficiency attenuates skeletal muscle GPX activity (19). Selenium supplementation increases 
skeletal muscle GPX content but did, however, not prevent exercise-induced lipid-
peroxidation in rat skeletal muscle (19).  
 
Healthy subjects 
Encouraged by the beneficial effects of antioxidant supplementation in animals, similar 
studies have been conducted in humans, although the effects of nutritional supplementation on 
respiratory muscle function in humans has not been studied yet.  
In healthy subjects supplementation with vitamin E increased skeletal muscle vitamin 
E content (112) and decreased baseline level of plasma lipid-peroxides (153). Vitamin E 
supplementation reduced exercise-induced lipid-peroxidation, estimated by plasma lipid-
peroxides, pentane exhalation or excretion of lipid-peroxides in urine in healthy subjects 
(40,112,153). Moreover, supplementation accelerated recovery from downhill running-
induced muscle damage (24) and attenuated exercise-induced muscle lipid-peroxidation 
(112).   
Healthy subjects supplemented with a vitamin mixture (vitamin E and C and ß-
carotene) had lower baseline exhaled pentane and plasma lipid-peroxides compared to 
placebo (82). The elevation in exhaled pentane and plasma lipid-peroxides after exercise was 
significantly lower in supplemented compared to placebo treated subjects. Ingestion of GSH 
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and vitamin C for 7 days prior to exhaustive cycle ergometry attenuated exercise-induced 
blood glutathione oxidation in athletes (140).  
Together, these studies indicate that skeletal muscle antioxidant deficiency predisposes 
to FR induced tissue damage. Both animal and human studies showed that dietary antioxidant 
supplementation attenuates exercise-induced oxidative stress. However, no study showed any 
beneficial effect of antioxidant supplementation on exercise physiological parameters in 
human. 
 
COPD patients 
Nutritional depleted COPD patients have lower respiratory and skeletal muscle strength than 
non-depleted patients (42). No literature is available on antioxidant status of respiratory or 
limb skeletal muscles in COPD. Scarce literature is available concerning blood or muscle 
antioxidant capacity in patients with COPD. From studies by Viña et al (140,170) it can be 
derived that blood glutathione concentration is similar between healthy subjects and patients 
with COPD. Also, Trolox equivalent antioxidant capacity (TEAC), an assay used to determine 
antioxidant capacity of plasma, was not different between healthy subjects and patients with 
stable COPD (133). However, markers of plasma lipid-peroxidation were increased in stable 
COPD patients (133). 
Besides malnutrition, commonly used drugs in COPD may also contribute to deficient 
antioxidant screen. For instance, theophylline has been shown to decrease vitamin B6 activity. 
The latter facilitates the availability of selenium for GPX synthesis (171).  
 
TRAINING  
Exercise training has marked effects on skeletal muscles. For example, elevated oxidative 
capacity, estimated by citrate synthase (CS) activity, is increased after training in both rats 
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(72) and human (152). Since elevation of oxidative capacity may enhance generation of FR, 
the effects of training on antioxidant capacity have been the subject of many studies.  
 
Animal studies 
Intermittent inspiratory muscle training increases type II fibre cross sectional area of the 
diaphragm (16). Alternatively, chronic loading of the respiratory muscles induced by 
pulmonary hyperinflation (44) or tracheal binding (83), but also exercise training 
(74,116,120,128,130) increased oxidative capacity of the diaphragm. The increase in 
oxidative capacity of the diaphragm was accompanied by elevated activity of antioxidant 
enzymes such as GPX (119,120,129,151) and catalase (120). 
Enzymatic antioxidant activity such as GPX (34,60,76,92,128,143,165), GR (124,143) 
and SOD (34,118,128) has been shown to increase after treadmill training in rat limb skeletal 
muscle. In contrast, training did not alter catalase activity (92,128). The response of 
antioxidant enzymes differs among muscles. Up regulation is more pronounced in highly 
oxidative muscles (34,60,128,143), although the opposite has been shown too (96). 
Nevertheless, in general, it appears that training-induced elevation in skeletal muscle 
oxidative capacity is accompanied by elevation in antioxidant enzyme capacity.  
Nonenzymatic antioxidants respond to training as well. Training increased glutathione 
content of the gastrocnemius muscle in dogs and attenuated exercise-induced glutathione 
depletion in skeletal muscle (143). Skeletal muscle vitamin E content has been shown to be 
unresponsive (53) or to be reduced (166) after training. 
To our knowledge, only one study has appeared on the effects of training on NO 
generation in skeletal muscle. Balon and Nadler (11) showed that 8 weeks of treadmill 
running increased both nNOS and eNOS expression in rat soleus muscle.  
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Healthy subjects 
Respiratory muscle training may improve inspiratory and expiratory muscle strength in 
healthy subjects (97). However, no data have been published on the effects of training on 
oxidative or antioxidant capacity of the respiratory muscles in healthy subjects.  
The effect of short-term exercise training on skeletal muscle antioxidant enzyme 
activity in healthy subjects is controversial. Seven weeks of sprint cycle training increased 
skeletal muscle GPX and GR activity, but did not alter SOD activity (65). Alternatively, 8 
weeks of aerobic cycle training increased CS activity of the vastus lateralis muscle, but did 
not alter GPX and SOD activity, nor GSH and vitamin E content (167).  
 
COPD patients 
Exercise training in patients with COPD increases effectiveness of ventilation without 
improvement of lung function (25), indicating that extra-pulmonary factors contribute to 
exercise limitation in COPD. It has been shown that under certain conditions respiratory 
muscle training increases respiratory muscle force in COPD (150), which may contribute to 
effectiveness in ventilation. However, only one study has been published regarding the 
oxidative capacity of the diaphragm in COPD. Levine et al (98) demonstrated that the 
percentage of type I fibres in the diaphragm in COPD is higher compared to healthy controls. 
This is in line with observations from animal studies, which revealed that increased load on 
the respiratory muscles is associated with increased oxidative capacity (44,83). No data are 
available on the antioxidant status of the respiratory muscles in COPD.  
Maltais et al (105) reported that 12 weeks of exercise training increased CS activity of 
peripheral muscles in patients with severe COPD (FEV1 0.99 l). Again, no data on limb 
skeletal muscle antioxidant enzyme activity are available in COPD patients. 
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PHARMACOLOGICAL INTERVENTIONS 
No drug aiming to improve respiratory or peripheral skeletal muscle antioxidant capacity has 
been registered. NAC is an antioxidant drug commonly used in clinical practice. Two possible 
antioxidant mechanisms have been proposed for this thiol containing antioxidant. Firstly, 
NAC may have direct FR scavenging properties. ROS may react with NAC resulting in the 
formation of NAC disulphide (8,115). The significance of this mechanism of action in vivo is 
questionable since the bioavailability of total NAC is only ~9% (17,121) and of the reduced 
form is even lower (~4%) (121), which is probably due to the extensive first pass metabolism 
(121). Therefore, a direct scavenging action of NAC in vivo is only likely to be significant 
when administered iv or per inhalation. Secondly and of more importance, NAC may also 
exert its antioxidant effects indirectly by facilitating GSH biosynthesis (114).  
 
Animal studies 
NAC administration improved efficiency of the glutathione redox cycle and contractile 
performance of the rat diaphragm. For instance, iv administration of NAC prior to IRB, 
attenuated glutathione depletion of the diaphragm (160,161). Furthermore, NAC treated 
animals tolerated IRB better compared to non treated rats, as indicated by increased loading 
endurance and higher pressure generation of the inspiratory muscles during IRB (161). 
Alternatively, the deleterious effects of IRB on in vitro force generation of the diaphragm 
were not reduced by NAC (160,161). This is not surprising since in both groups IRB was 
continued until apnea and thus a same critical level of fatigue of the inspiratory muscles was 
reached. In situ fatigability of the diaphragm imposed by repetitive stimulation of the phrenic 
nerve was significantly reduced in NAC treated rabbits (148).  
Administration of the XO inhibitor allopurinol prior to an acute bout of exercise 
shortened the duration of GSH depletion in the soleus muscle in mice (41). More important, 
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allopurinol attenuated exercise-induced morphological damage, such as irregularities in 
myofibrillar organisation, intrafibre oedema and mitochondrial swelling, in soleus muscle 
(41). This is an important finding since it indicates that inhibition of FR generation attenuates 
morphological damage to skeletal muscle. However, allopurinol did not alter the course of 
IRB, nor does it prevent IRB-induced elevation of lipid-peroxidation in the diaphragm (156). 
Treating rats with the NOS inhibitor L-NAME prior to IRB decreased NOS activity of 
the diaphragm (15). However, it did not affect the course of IRB, i.e. endurance and pressure 
developed, nor in vitro force development of the diaphragm after IRB.  
 
Healthy subjects 
No studies are available on the effects of treatment with NAC on glutathione levels in 
respiratory muscles. However, NAC may have beneficial effects on respiratory muscle 
function in healthy subjects. Breathing against an inspiratory resistance induces fatigue of the 
diaphragm. The fall in force can be assessed by measuring twitch tension of the diaphragm 
via electrical stimulation of the phrenic nerves. NAC (150 mg/kg bodyweight iv, 1 hour prior 
to inspiratory resistive breathing) increased loading endurance and attenuated the fall in 
twitch tension of the diaphragm after loaded breathing (168). NAC did, however, not affect 
the rate of recovery from diaphragm fatigue. This is however to be expected since the 
antioxidant properties of NAC will attenuate the deleterious effects of FR on muscle function, 
but FR are not assumed to play a key role in recovery from fatigue.  
Similarly, NAC has been shown to reduce the fatigue rate of limb skeletal muscle in 
vivo. Reid et al (136) demonstrated that the rate of fatigue development can be attenuated by 
pre treatment with NAC. Fatigue was induced by repetitive electrical stimulation of the 
tibialis anterior muscle. Force development was measured throughout the fatigue induction. In 
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NAC treated subjects (150 mg/kg bodyweight, iv) the rate of fatigue development was 
significantly lower compared to saline treated subjects.  
Oral administration of NAC (800 mg/day po for 2 days) did not affect blood GSH, but 
attenuated exercise-induced blood glutathione oxidation in healthy subjects (146).  
 
COPD patients 
No studies are available regarding the effects of NAC treatment on skeletal muscle function 
and exercise-induced oxidative stress in patients with COPD. It was recently demonstrated 
that allopurinol inhibits exercise-induced blood glutathione oxidation and plasma lipid-
peroxidation in severe COPD (Fig 5) (71). The effects of NOS inhibition on muscle function 
in COPD have not been investigated yet.  
The question if administration of agents aiming at attenuation of perturbation in the 
oxidant-antioxidant balance should be acute or chronic is of major clinical and physiological 
interest, but not easy to answer. If the dysbalance between oxidants and antioxidants during 
exercise in COPD is the result of depletion in endogenous antioxidants (i.e. due to 
malnutrition), administration should be continued until the antioxidant screen is restored. 
However, if overproduction of FR is the result of upregulation of enzymes involved in FR 
generation, enzyme inhibitors (i.e. allopurinol) should probably be administered chronically.   
 
 
Conclusions and future research 
FR are important modulators of skeletal muscle contractility. Although, required for optimal 
contractile function, overproduction of FR may have opposite effects. Generation of FR by 
skeletal muscle is increased during contractile activity. Since the load imposed on the 
diaphragm in patients with severe COPD is increased, it might be speculated that this is 
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accompanied by elevated generation of FR. This may in turn contribute to respiratory muscle 
dysfunction. However, no direct data are available to support these speculations.  
Future research should focus on the antioxidant status of respiratory muscles in 
humans, in particular in patients with COPD. The effects of long-term antioxidant 
supplementation on peripheral and limb skeletal muscle must be assessed. Also, the role of 
specific pathways for the generation of FR should be assessed in COPD. This may result in 
the application of drugs targeting these pathways.  
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Abstract 
Limited data are available on the effects of nitric oxide (NO) on skeletal muscle intracellular 
calcium ([Ca2+]i) regulation. In the present study we used real-time confocal microscopy to 
examine the effects of two NO donors on acetylcholine (ACh, 10µM) and caffeine (10 mM) 
induced [Ca2+]i responses in C2C12 mouse skeletal myotubes. We hypothesized that NO 
reduces [Ca2+]i in activated skeletal myotubes through oxidation of thiols associated with the 
sarcoplasmic reticulum Ca2+ release channel. Exposure to diethylamine NONOate (DEA-NO) 
reversibly increased resting [Ca2+]i level, and resulted in a dose dependent reduction in the 
amplitude of ACh-induced Ca2+ transients. Exposure to 10 µM DEA-NO reduced the 
amplitude to 75 ± 7% of initial value, whereas 100 µM DEA-NO reduced the amplitude to 22 
± 14% of initial value. These effects of DEA-NO were partly reversible after subsequent 
exposure to dithiotreitol (DTT; 10 mM). Pre exposure to DEA-NO (1, 10, 50 µM) also 
reduced the amplitude of caffeine-induced Ca2+ transients. Similar data were obtained using 
the chemically distinct NO donor S-nitroso-N-acetylpenicillamine (SNAP; 100 µM). These 
data indicate that NO reduces SR Ca2+ release in skeletal myotubes, probably by modification 
of hyperreactive thiols present on the ryanodine receptor.  
 
Introduction 
Nitric oxide (NO) has been shown to modulate in vitro contractility of skeletal muscle 
(13,21,24). For instance, exposing rat diaphragm muscle strips to the NO donor sodium 
nitroprusside (S-NP) reduces submaximal force generation (13). However, the mechanisms of 
NO action on skeletal muscle are being worked out. Nitric oxide synthase (NOS) is the 
physiological source for NO and its expression has been confirmed in rodent and human 
skeletal muscle (13,14,23). Generation of NO by skeletal muscles is enhanced by contractile 
activity (4,13). The inhibitory effects of NO on force production could result from 
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interference of NO with intracellular Ca2+ ([Ca2+]i) regulation. One potential target is the 
sarcoplasmic reticulum. For instance, the NO donor S-nitroso-N-acetylpenicillamine (SNAP) 
reduced caffeine-induced Ca2+ release in isolated skeletal muscle SR vesicles (19). However, 
in intact mouse skeletal muscle fibers, SNAP increased [Ca2+]i during submaximal activation, 
without altering force generation (3). These studies (3,19) are not necessarily conflicting, 
since in intact cells [Ca2+]i depends on other factors besides SR Ca2+ release, such reuptake 
and intracellular buffering of Ca2+, which could be differentially modified by NO.   
 In skeletal muscle, Ca2+ is released from the SR via ryanodine receptor (RyR) 
channels. Hyperreactive thiols present on this channel (16) have been shown to be regulators 
of the open probability of this channel (19,27,29,31). Previous studies in skeletal muscle SR 
vesicles indicated that NO increases the open probability of the RyR channel in the absence of 
a RyR agonist (27). However, other studies suggest that NO reduces RyR channel mediated 
Ca2+ release in caffeine activated vesicles (19). Few studies have been performed on the 
effects of NO on SR Ca2+ release in intact cells. In a recent study it was shown that in single 
fibers of mice, NO increases [Ca2+]i during submaximal activation (3). However, it was 
uncertain whether this was the result of increased RyR channel mediated Ca2+ release, or 
impaired Ca2+ reuptake.  
The purpose of the present study was to investigate the effects of NO on SR Ca2+ 
release in intact skeletal muscle cells. We measured [Ca2+]i responses through confocal real-
time imaging in fluo-3 loaded C2C12 skeletal myotubes, which were activated by ACh and 
the RyR agonist caffeine. Myotubes were exposed to different NO donors at different 
concentrations. In order to test the possible involvement of sulfhydryl-oxidation, myotubes 
were exposed to the reducing agent dithiotreitol (DTT) after exposure to NO donors. We 
hypothesized that NO reduces [Ca2+]i in activated skeletal myotubes through oxidation of 
thiols associated with the SR Ca2+ release channel.  
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Methods 
Cell Culture 
C2C12 myoblasts (American Type Culture Collection (ATCC), Manassas, VA) were grown 
on 25 mm glass coverslips (37°C, 5%CO2) in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS; Gibco, Grand Island, NY). The 
medium also contained 100 U/ml penicillin, 100 µg/ml streptomycin and 2.5 µg/ml 
amphotericin B. When cells reached confluence, FBS was substituted by 10% horse serum 
(Gibco) to enhance differentiation into myotubes. Experiments were performed 4-6 days after 
serum replacement and within 10 days. Under our experimental conditions, spontaneous 
contractions were observed sporadically and were used as an index of myotube 
differentiation. All sets of experiments were performed on myotubes from at least two 
different passages.   
 
Intracellular Ca2+ imaging 
Cytoplasmic free Ca2+ levels were determined by fluo-3 fluorescence. Plated myotubes were 
incubated in 5 µM fluo-3 AM (Molecular Probes, Eugene, OR) in Hanks’ balanced salt 
solution (HBSS) at room temperature for 45 min and subsequently washed with HBSS. The 
cover slip was placed in an open slide chamber (Warner Instruments, Hamden, CT) mounted 
on a Nikon Diaphot inverted microscope. The chamber was perfused with HBSS at 1-2 
ml/min at room temperature.  
Details on the techniques for real-time confocal imaging of [Ca2+]i have been 
previously described (25). Briefly, an OdysseyXL real-time confocal microscope (Noran 
instruments, Middleton, WI) with an Ar-Kr laser and mounted on a Nikon Diaphot inverted 
microscope was used to visualize fluo-3/AM (Molecular Probes, Eugene OR) loaded 
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myotubes. The confocal system was controlled through a Silicon Graphics Indy workstation 
and manufacturer-supplied software. A Nikon 40X/1.3 oil immersion objective lens was used 
to visualize the myotubes. Image size was set at 640 X 480 pixels and the pixel area was 
calibrated using a standard micrometer (0.063 µm2/pixel). The 488 nm laser line was used to 
excite fluo-3 for calcium imaging, and emissions were collected using a 515 nm long-pass 
filter and high sensitivity photomultiplier tube. Based on preliminary studies, laser intensity 
and photomultiplier gain were set to ensure that pixel intensities were within 25 and 255 gray 
levels (GLs). To minimize bleaching, laser exposure time was kept as short as possible. The 
Odyssey confocal system is capable of acquiring 480 frames/s. However, we found that an 
acquisition rate of 30 frames per second was sufficient for measuring amplitudes of [Ca2+]i 
responses. Eight regions of interest (ROI) of 5 x 5 pixels were defined prior to each 
experiment. From each [Ca2+]i transient, amplitude and rise time were calculated. Rise time 
was calculated in ms/amplitude. Fig 1 shows how the amplitudes were defined.   
 The fluo-3 fluorescence was transformed to [Ca2+]i by a pseudoratio method (5) using 
the following equation:  
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where Kd is the dissociation constant for fluo-3 (435 nM), F is the fluorescence intensity and 
F0 is the intensity at rest at each position. The [Ca2+]i at rest ([Ca2+]i, rest) for this F0 was 
assumed to be 80 nM.  
 
Selection of Myotubes 
At confluence, the coverslip was typically dense with myotubes and undifferentiated cells. 
Only large, intact myotubes were used for [Ca2+]i measurements. Usually it was possible to 
visualize 2-3 myotubes in one focus. Since 8 ROI were defined during each experiment, more 
than one ROI was defined in each myotube. The [Ca2+]i response upon stimulation of the 
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myotubes is usually heterogeneous (see results). Therefore, only the ROI displaying the 
highest initial amplitude within a certain myotube was used for subsequent analysis.  Cells 
from one cover slip were used for only one experimental protocol. Occasionally, myotubes 
partially detached from the coverslip during the experiment. Data from those myotubes were 
omitted from analysis.  
 
Ca2+ regulation in myotubes 
Effect of ACh on [Ca2+]i 
To determine the maximal concentration for ACh to stimulate myotubes, the dose response 
relationship was studied. After measurement of [Ca2+]i under resting conditions, myotubes 
were sequentially exposed to a range of ACh concentrations (10, 100, 1000 µM). To ensure 
optimal refilling of the internal Ca2+ stores, the tissue chamber was perfused with standard 
HBSS for 10 minutes between different concentrations of ACh. From these experiments it 
appeared that a maximal [Ca2+]i response was acquired at 10 µM ACh. Higher concentrations 
did not further increase the amplitude of transients. Therefore, in subsequent experiments 
ACh concentration was 10 µM.  
 
Effect of Extracellular Ca2+ on ACh-induced [Ca2+]i Responses 
Elevation of [Ca2+]i upon stimulation with ACh in C2C12 myotubes may partly result from 
calcium influx (8). Furthermore, Ca2+ influx may also induce Ca2+ induced Ca2+ release. To 
determine the contribution of Ca2+ influx in our preparation, myotubes were successively 
exposed to ACh in standard HBSS and ‘zero Ca2+ HBSS’. Prior to exposure to ACh in ‘zero 
Ca2+ HBSS’, extracellular Ca2+ was washed out for 60 s. with zero Ca2+ HBSS. The zero Ca2+ 
HBSS had similar composition as standard HBSS, only 2.0 mM CaCl2 was substituted by 2.0 
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mM ethylene glycol-bis(ß-aminoethyl ether) N,N,N’-tetraacetic acid (EGTA). In time 
controls, both ACh stimulations were conducted in the presence of extracellular Ca2+.  
 In accordance with previous studies (7), it appeared that ACh-induced elevation in 
[Ca2+]i partly resulted from Ca2+ influx (see results). Since the present study aims to 
investigate the effects of NO on SR Ca2+ release, in all subsequent experiments ACh 
stimulations were conducted in the absence of extracellular Ca2+. However, to ensure optimal 
reloading of intracellular Ca2+ stores, myotubes were exposed to standard HBSS between all 
stimulations. Prior to the exposure to ACh, the tissue chamber was perfused with zero Ca2+ 
HBSS for 1 min to wash out extracellular Ca2+.  
 
Effects of Ryanodine and Xestospongin D (XeD) on [Ca2+]I Responses 
In C2C12 myotubes, Ca2+ release from intracellular stores upon activation with ACh may be 
mediated via both ryanodine and 1,4,5-trisphosphate (IP3) sensitive stores (8). In order to 
determine the contribution of each of these stores, we used the RyR blocker (100 µM) 
ryanodine and the membrane permeable inositol IP3 receptor (IP3R) blocker Xestospongin D 
(XeD, 10 µM) (6). Xestospongins comprise a group of membrane permeable IP3R blockers 
purified from marine sponges. Stock solutions of XeD (Calbiochem) were kept frozen. Just 
before use, XeD was thawed and subsequently diluted until 10 µM with HBSS. This 
concentration was chosen since it has been shown to effectively block the IP3R, without 
exhibiting significant effects on the RyR (6).  
 Following measurement of the initial ACh-induced [Ca2+]i response, myotubes were 
washed and then exposed to 100 µM ryanodine for 10 min, and subsequently re-exposed to 
ACh. In a second set of experiments the effect of 10 µM XeD was determined in a similar 
protocol.  
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In a third set of experiments the effect of ryanodine on caffeine-induced [Ca2+]i 
transients was studied.  
   
NO and Ca2+ regulation in Myotubes 
Effect of Diethylamine NONOate (DEA-NO) on ACh-induced [Ca2+]i Transients  
Following measurement of ACh-induced [Ca2+]i transients, myotubes were exposed to 
standard HBSS for 5 min., to ensure optimal reloading of internal Ca2+ stores. Subsequently, 
myotubes were exposed to one concentration of DEA-NO (10, 50 or 100 µM, Calbiochem) 
for 10 min. prior to second ACh stimulation. The intracellular stores were then reloaded and 
myotubes were exposed to the reductant 1,4-dithiothreitol (DTT) prior to the final ACh 
stimulation in the continued presence of DTT.  
 
Effect of DEA-NO on Caffeine-induced [Ca2+]i transients  
To determine whether the effects of DEA-NO on ACh-induced [Ca2+]i transients were the 
result of modification of the RyR Ca2+ channel, the experiments with DEA-NO were repeated 
using the RyR agonist caffeine (10 mM) instead of ACh. Since 50 and 100 µM DEA-NO had 
similar effects on ACh-induced [Ca2+]i responses (see results), lower concentrations of DEA-
NO (1, 10 and 50 µM) were used to study the effect of NO on caffeine-induced [Ca2+]i 
release. A similar protocol was used for time controls, only DEA-NO was omitted from 
HBSS solutions.  
 
Effect of SNAP on Caffeine-induced [Ca2+]i transients 
Theoretically, the effects of DEA-NO on [Ca2+]i transients could be the result of a NO 
independent action of this donor. To rule out this possibility, the caffeine experiments were 
repeated using the chemically distinct NO donor SNAP (100 µM) instead of DEA-NO.  
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Statistics 
The effects of various interventions on [Ca2+]i handling were evaluated by determining 
changes in the amplitude of [Ca2+]i transients. Data were analyzed with SPSS/PC+, version 
9.0. (SPSS Inc. Chicago, IL). The results are expressed as means ± SE. To compare 
independent groups (e.g. ACh-responses in time control and ryanodine treated myotubes), the 
Mann Whitney U test was used. For two related events (i.e. ACh-response in XeD compared 
to subsequent exposure to ryanodine), the Wilcoxon test was used. Significance was set at 
P<0.05 level. The numbers of myotubes are given with the results for each experimental 
protocol.  
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Results 
General characteristics 
Myotubes exposed to either ACh or caffeine in the absence of extracellular Ca2+ did not 
exhibit diffuse elevation in [Ca2+]i, but rather focal areas of high responsiveness were present 
(Fig. 1). This heterogenecity has been recognized previously (7,10) and is thought to be the 
result of a heterogeneous distribution of the SR (10).  
 
 
 
Figure 1. Schematic representation of ACh-induced [Ca2+]i transients in the absence of extracellular Ca2+ in a 
fluo-3 loaded C2C12 skeletal myotube. The amplitude of the transients was not uniform among the myotube (see 
text for explanation).  
 
nM
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Figure 2. Effect of extracellular Ca2+ on ACh-induced [Ca2+]i transients in skeletal myotubes. Note the 
reduction in amplitude and absence of sustained elevation when ACh was introduced in the absence of 
extracellular Ca2+.  
 
ACh
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Effect of extracellular Ca2+ on ACh-induced [Ca2+]i Responses 
Omission of Ca2+ from the extracellular medium altered the shape and reduced the amplitude 
of ACh-induced [Ca2+]i transient (Fig. 2). Exposing myotubes to ACh in the presence of 
extracellular Ca2+ resulted in a rapid and sustained elevation of [Ca2+]i. However, when 
extracellular Ca2+ was omitted, ACh induced a rapid monophasic response (Fig. 2). The 
amplitude of this latter response was 62.5 ± 4.6% of the response in the presence of Ca2+, as 
compared to 98.2 ± 9.8% in time controls. (n = 10; P < 0.05 vs. time control). However, 
omission of extracellular Ca2+ did not affect rise-time/amplitude of the transient (66 ± 11 
ms/nM in the presence of extracellular Ca2+ versus 99 ± 25 ms/nM in the absence of 
extracellular Ca2+, P > 0.05).  
 
Effects of Ryanodine and XeD on [Ca2+]i transients 
Exposure to 100 µM ryanodine resulted in a significant reduction in the amplitude of ACh-
induced [Ca2+]i transients (49 ± 9 nM vs. 21 ± 6 nM before and after exposure to ryanodine 
respectively; n = 11, P < 0.05). In time controls no significant change in amplitude of Ach 
induced [Ca2+]i response was found (n = 9, P > 0.05). Caffeine-induced [Ca2+]i responses were 
also severely reduced after exposure to 100 µM ryanodine (amplitude 48 ± 9 nM and 12 ± 4 
nM respectively, n = 12; P<0.05). Again, in time controls no change in amplitude of caffeine-
induced calcium response was found (n = 10, p > 0.05).  
Pre-exposure to 10 µM XeD significantly reduced the amplitude of ACh-induced 
[Ca2+]i transients (41 ± 12 nM vs. 19 ± 7 nM before and after exposure to XeD respectively; n 
= 5, p < 0.05). As expected, pre-exposure to XeD did not affect caffeine-induced [Ca2+]i 
responses (n = 10, P > 0.05).   
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Effect of DEA-NO on Baseline [Ca2+]i 
The effect of DEA-NO on baseline [Ca2+]i was determined by measuring fluorescence just 
prior to activation of the myotube. The baseline [Ca2+]i data for ACh and caffeine are grouped 
for corresponding concentrations of DEA-NO (10 and 50 µM). The effect of 100 µM DEA-
NO was tested only in myotubes exposed to ACh. Baseline [Ca2+]i was significantly higher 
after exposure to either 10 or 50 µM DEA-NO (Table 1; n > 15 per group). The effect of 
DEA-NO on baseline [Ca2+]i was reversible after exposure to DTT. At 100 µM DEA-NO 
elevation in baseline did not reach statistical significance (n = 9).  
 
Table 1: Effect of DEA-NO on baseline Ca2+ in skeletal myotubes 
   
 DEA-NO DTT 
   
Time control  94 ± 2 94 ± 2 
DEA-NO 10µM 106 ± 3* 91 ± 3 
DEA-NO 50µM 106 ± 3* 87 ± 3 
DEA-NO 100µM 102 ± 5 91 ± 7 
 
Values represent mean percentage of initial intracellular Ca2+ concentration ± SE.  
* Indicates significant (P<0.05) difference from time control. 
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Effect of DEA-NO on Amplitude of ACh-induced [Ca2+]i Transients 
In time controls, amplitudes were not significantly different in three subsequent activations (n 
= 9, p > 0.05). Exposure to DEA-NO resulted in a reduction in the amplitude of [Ca2+]i 
responses to ACh. A representative trace is shown in Fig 3A. In myotubes exposed to 10 µM 
DEA-NO. Amplitude of the transient was 75 ± 7% of time control, n=11 and n=13 
respectively; Fig. 3B). Exposure to 50 or 100 µM DEA-NO further reduced the amplitude of 
the [Ca2+]i response (n=11 and n=9, respectively). Subsequent exposure to DTT reversed the 
effects of 50 and 100 µM DEA-NO. However, DTT did not reverse the effects of 10 µM 
DEA-NO in all fibers.  
 
Figure 3A. Effect of DEA-NO on ACh-induced [Ca2+]i transients. Representative trace showing that exposure 
to DEA-NO reduced the amplitude of ACh-induced [Ca2+]i transients. Subsequent exposure to DTT partly 
reversed the effects of DEA-NO.  
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Figure 3B: Relative changes of ACh-induced [Ca2+]i responses as a result of exposure to either 10, 50 or 100 
µM DEA-NO and subsequent exposure to DTT.  
Results are expressed as means ± SE. * Significantly different from time control. 
 
Effect of DEA-NO on Amplitude of Caffeine-induced [Ca2+]i Transients 
Exposure to 1.0 µM DEA-NO did not affect the amplitude of the caffeine-induced [Ca2+]i 
responses (Fig. 4; n = 4, p > 0.05). However, the amplitude of caffeine-induced [Ca2+]i 
responses was significantly reduced after exposure to either 10 or 50 µM DEA-NO (n = 9 and 
n = 6, respectively, P < 0.05). For example, 50µM DEA-NO reduced amplitude from 34 ± 6 
nM initially to 13 ± 5 nM after DEA-NO exposure. After exposure to DTT, amplitude of the 
transient was 92 ± 20% and 88 ± 27% of baseline amplitude in myotubes exposed to 10 and 
50 µM DEA-NO respectively (Fig. 3B).  
 
Effect of SNAP on Caffeine-induced [Ca2+]i Transients 
Exposure to 100µM SNAP (n = 10) significantly reduced the amplitude of caffeine-induced 
[Ca2+]i transients (42 ± 8 nM before vs. 30 ± 7 nM after exposure to SNAP; n = 10 and n = 9 
respectively). Subsequent exposure to DTT reversed the effects of SNAP (amplitude after 
exposure to DTT was 43 ± 9 nM, p > 0.05 compared to initial amplitude). 
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Figure 4. Effect of DEA-NO on caffeine-induced [Ca2+]i transients. Relative changes [Ca2+]i responses as a 
result of exposure to DEA-NO at different concentrations. Subsequent exposure to DTT partly reversed the 
effects of DEA-NO. Note the potentiation in [Ca2+]i in time controls.  
Results are expressed as means ± SE. *Significantly different from respective time control. 
 
 
Discussion 
The present study demonstrates that DEA-NO decreases the amplitude of ACh-induced 
[Ca2+]i transients in mouse skeletal myotubes. The effects of DEA-NO were partly reversible 
after exposure to DTT, indicating that thiol modification contributes to these effects. The fact 
that both DEA-NO and the chemically distinct NO donor SNAP have similar effects on 
caffeine-induced [Ca2+]i transients suggests that the reduction in the height of amplitude of the 
[Ca2+]i transients result from thiol modification of the RyR Ca2+ release channel.  
 
Cultured Myotubes 
C2C12 mouse skeletal myotubes were used to study the effects of NO on SR Ca2+ release. A 
potential issue with such a preparation is whether these findings are also applicable to mature 
skeletal muscles. C2C12 myotubes reach a considerable degree of differentiation as indicated 
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by the expression of fast twitch skeletal muscle troponin T, α-actin and tropomyosin (17). 
Permeabilized myotubes generate measurable force when perfused with Ca2+, and the 
concentration needed to generate 50% of maximal force (pCa50) was within the range of 
mature rat skeletal muscle fibers (17). In the present study, we purposely selected myotubes 
that were clearly differentiated as indicated by the presence of at least some sarcomere 
pattern.  
 Mechanisms of [Ca2+]i handling in C2C12 myotubes have been investigated in detail 
by other investigators (7-11). Two striking differences in [Ca2+]i regulation between mature 
skeletal muscle fibers and myotubes have been shown. First, elevation of [Ca2+]i upon 
stimulation with ACh is partly the result of Ca2+ influx through voltage gated Ca2+ channels, 
whereas, in mature skeletal muscle fibers the contribution of calcium influx during activation 
is considered to be of limited significance. Indeed, we found that omission of Ca2+ from the 
extracellular medium altered the shape and reduced the amplitude of ACh-induced [Ca2+]i 
transients. To circumvent the contribution of Ca2+ influx, our studies were conducted in the 
absence of extracellular Ca2+. Second, it has been suggested that ACh-induced [Ca2+]i 
transients partly result from release of Ca2+ from IP3 sensitive stores (7-9), whereas this 
pathway is considered to be of limited relevance in mature skeletal muscle (18). In our culture 
preparation we found a significant contribution of IP3 sensitive stores in ACh-induced [Ca2+]i 
transients. When myotubes were pre-exposed to XeD, which is a membrane permeable non-
competitive IP3R blocker (6), amplitudes of transients elicited by ACh were attenuated by 
~54%. On the other hand, ryanodine reduced the amplitude of ACh-induced [Ca2+]i transients 
by ~50%. This suggests that IP3R and RyR Ca2+ release channels have about equal 
contribution to ACh-induced elevation in [Ca2+]i in skeletal myotubes. As expected, XeD did 
not affect caffeine-induced Ca2+ transients. To omit contribution of Ca2+ release via IP3R, 
additional experiments were performed with the RyR agonist caffeine.  
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NO donors 
Since in its pure form NO is highly reactive and has limited solubility in aqueous buffers, it is 
difficult to predictably deliver it into biological systems without decomposition. Therefore, 
NO donors are frequently used to study the (patho)physiological effects of NO on tissue 
function. However, a perennial question with the use of NO donors is the validity of equating 
the donor to the production of NO. Numerous chemically distinct NO donors are 
commercially available. We chose DEA-NO, which belongs to the group of NO-nucleophile 
adducts. This type of donor with the general structure [XN(O)NO]-, spontaneously releases 
NO (20). The rate of release is only dependent on pH, temperature and the structure of the 
nucleophilic residue (20). It is easy to control the initiation of the release of NO from DEA-
NO by adjusting pH and temperature of the stock solution. To verify that the observed effects 
were mediated via NO, part of the experiments were repeated using the chemically distinct 
NO donor SNAP. In addition, previous studies have shown that the parent compounds for 
DEA-NO (up to 300µM) and the breakdown products do not affect force generation in 
smooth muscle (12).  
 
Mechanisms of NO action 
It has been shown that thiol groups present on the RyR Ca2+ release channel play a role in the 
regulation of its open probability (1). NO can react with thiol groups via either S-nitrosylation 
or by influencing disulphide formation (26). Therefore, the RyR Ca2+ release channel is a 
possible target for NO. The present study supports the hypothesis that NO may modulate SR 
Ca2+ release by modulating thiol groups in intact cells. DEA-NO had dose dependent effects 
on ACh-induced [Ca2+]i responses, and these effects were partly reversible after exposure to 
the reducing agent DTT. Although ACh in vivo initiates the excitation-contraction coupling 
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cascade, these data do not indisputably indicate that the RyR Ca2+ release channel was the 
primary target for NO, since other proteins involved in excitation contraction coupling contain 
thiol groups as well. Therefore, experiments were repeated using the RyR agonist caffeine. 
Data from these latter experiments showed that two distinct NO donors reversibly decreased 
the amplitude [Ca2+]i transients. This indicates that the effects of NO on [Ca2+]i transients 
were mediated by modification of thiols on the SR RyR Ca2+ release channel. Data from the 
present study are in line with observations from previous studies using isolated SR vesicles. 
Exposing SR vesicles to SNAP has been found to reduce the rate of caffeine-induced Ca2+ 
release (19). In addition, the open probability of the RyR Ca2+ release channel in lipid bilayers 
is reduced after exposure to 100 µM SNAP (19), which is a similar concentration to that used 
in the present study. Decreased open probability of the channel after exposure to NO may be 
the result of the inhibitory effect of NO on intersubunit cross-linking of thiol groups on the 
RyR channel, thereby preventing oxidant-induced activation of the channel (2). In contrast, at 
high concentration SNAP increases RyR Ca2+ release channel open probability (2,27), 
indicating differential concentration-dependent effects of NO.  
Reduced [Ca2+]i transients after pre-exposure to NO donors may also result from 
increased SR Ca2+ ATPase activity. Although we could not definitely exclude this possibility, 
it is however an unlikely explanation. Studies using SR vesicles indicated that NO donors did 
not affect (19), or even inhibited Ca2+ reuptake (27). Furthermore, in intact skeletal muscle 
fibers, Ca2+ uptake was decreased due to treatment with NO donors (3). In the present study 
we studied the effects of NO donors only on the amplitude of the [Ca2+]i transients. The 
maximal amplitude is reached quickly after the initiation of the transient (Fig. 1) and is 
therefore primarily dependent on the rate of SR Ca2+ release. In contrast, the height of the 
plateau after the maximal amplitude is determined by the equilibrium between Ca2+ release 
and reuptake in the SR and efflux from the myoplasm. Together, it is unlikely that the effects 
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of NO donors on the amplitude of [Ca2+]i transients arise from increase in SR Ca2+ ATPase 
activity.     
Baseline [Ca2+]i levels were elevated after exposure to DEA-NO. This is in line with 
studies on intact mouse single fibers (3) and may be the result of inhibition of Ca2+ ATPase 
activity (3,27) or increased Ca2+ leak from the SR (27). It is tempting to speculate whether a 
direct relation exists between NO donor-induced elevation in baseline [Ca2+]i and the 
reduction in the amplitude of ACh and caffeine-induced [Ca2+]i transients. In theory, 
increased Ca2+ leak through RyR Ca2+ release channels may partly deplete the SR, which in 
turn might reduce the amplitude of ACh and caffeine-induced [Ca2+]i transients. The 
relationship between luminal SR [Ca2+] and RyR Ca2+ release channel function has been the 
subject of several recent studies. For instance, it has been shown that an inverse correlation 
exists between SR luminal Ca2+ concentration and open probability of the RyR Ca2+ release 
channel (28). However, in skinned skeletal muscle fibers the apparent rate constant of 
caffeine-induced SR Ca2+ efflux did not significantly change when the SR loading level was 
decreased to one-third of maximal loading (15). Although studying the effects of NO donors 
on SR luminal Ca2+ was beyond the scope of the present study, we do not believe that 
depletion of SR luminal Ca2+ explains the NO donors mediated reduction in ACh and 
caffeine-induced [Ca2+]i amplitudes. First, between subsequent stimulations, myotubes were 
incubated in HBSS containing 2.0 mM Ca2+ for 10 min to refill the SR. Second, studies on 
single RyR Ca2+ release channels support a direct role for NO donors in decreasing the open 
probability of these channels (19).  
 Our data are in apparent conflict with a recent report by Andrade et al (3), which 
found that exposing intact mouse skeletal muscle fibers to NO donors increases [Ca2+]i during 
submaximal electrical stimulation. However, differences in experimental set-up between the 
latter and the present study may partly explain these discrepancies. First, in their study, [Ca2+]i 
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responses were studied during submaximal activation, while we investigated the effects of NO 
on maximal [Ca2+]i activation. Previous studies using an in situ skeletal muscle preparation 
indicated that the effects of NO depend on contraction pattern and frequency of stimulation 
(22). SNAP did not affect twitch force at 0.5 Hz, but decreased twitch force at 1.5 and 4.0 Hz. 
Also, SNAP decreased tetanic force at 40 Hz, but not did not affect tetanic force at 12 Hz 
(22). Likewise, NO differently affects SR Ca2+ release in non-activated and activated SR 
vesicles. In the former, NO donors increased Ca2+ release (27), whereas in vesicles exposed to 
caffeine, NO donors decreased Ca2+ release (19). It is unknown how the degree of stimulation 
determines the effect of NO on force generation and Ca2+ release. Second, we determined the 
effect of NO donors on the amplitude of the [Ca2+]i response, whereas Andrade et al (3) 
measured [Ca2+]i when a clear plateau was reached. As mentioned earlier, the maximal 
amplitude and the plateau of a [Ca2+]i response partly depend on different processes in Ca2+ 
handling. Indeed, Andrade et al (3) found that Ca2+ ATPase activity was decreased by S- 
nitroso-N-acetylcysteine (SNAC), which could, at least partly, explain the observed elevation 
in [Ca2+]i during submaximal activation in their study. Together, the picture emerges that NO 
has complex effects on [Ca2+]i handling, acting on different steps in the excitation-contraction 
coupling cascade and effects depend on concentration of NO and the extent of skeletal muscle 
activation.   
 
Conclusions 
Westerblad et al (30) showed that [Ca2+]i in mouse skeletal muscle fibers is reduced during 
low frequency fatigue, which was probably the result of impaired SR Ca2+ release. It has been 
shown that repetitive electrical stimulation of skeletal muscle at either 25 Hz (13) or 100 Hz 
(4), enhances generation of NO. Our data indicate that NO impairs SR Ca2+ release. Thus, it 
could be speculated that reduced SR Ca2+ release during low frequency fatigue (partly) results 
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from elevated generation of NO. However, further studies are needed to prove such a 
mechanism.  
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Abstract 
The effects of the nitric oxide (NO) donor, spermine NONOate (Sp-NO, 1.0 mM), on cross-
bridge recruitment and cross-bridge cycling kinetics were studied in permeabilized rabbit 
psoas muscle fibers. Fibers were activated at varying calcium concentrations (pCa), and the 
pCa at which maximum force (Fmax; pCa 4.0) and ~50% Fmax (pCa50 5.6) were determined. 
Fiber stiffness was determined using 1 kHz sinusoidal length perturbations, and the fraction of 
cross-bridges in the force generating state (αfs) was estimated by the ratio of stiffness during 
maximal (pCa 4.0) and submaximal (pCa 5.6) Ca2+ activation to stiffness during rigor (at pCa 
4.0). Cross-bridge cycling kinetics were evaluated by measuring the rate constant for force 
redevelopment (ktr) after quick release (by 15% of optimal fiber length, L0) and restretch of 
the fiber to L0. Exposing fibers to Sp-No for 10 min reduced force and αfs at maximal and 
submaximal (pCa50) Ca2+ activation. However, the effects of Sp-No were more pronounced 
during submaximal Ca2+ activation. Sp-NO also reduced ktr, but only during submaximal 
Ca2+ activation. We conclude that Sp-NO reduces Ca2+ sensitivity by decreasing the number 
of cross-bridges in the strongly bound state and also impairs cross-bridge cycling kinetics 
during submaximal activation.  
 
Introduction 
In skeletal muscles mechanical action results from the cyclic interaction between actin and 
myosin, which is regulated primarily by Ca2+ release from the sarcoplasmic reticulum and 
subsequent binding to troponin C (TnC). In the Huxley-Simmons model of muscle 
contraction, cross-bridges cycle between two functional states: a force generating state, in 
which cross-bridges are strongly bound to actin and a non-force generating state, in which 
cross-bridges are detached from or weakly attached to actin (16,17). Two apparent rate 
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constants, one for cross-bridge attachment (fapp) and another for cross-bridge detachment 
(gapp), describe the transitions between the two primary functional states of cross-bridges.   
Skeletal muscles express nitric oxide synthase (NOS), which is the primary source for 
nitric oxide (NO) in vivo (19,20). It has been demonstrated that skeletal muscles generate NO 
at rest, which is enhanced by contractile activity (2,19). Exposing skeletal muscle fibers to 
NO has been shown to impair contractile activity in vitro (19,26). One of the proposed 
mechanisms by which NO might affect contractility is a reduction in Ca2+ sensitivity of force 
generation (1,26). A reduction in Ca2+ sensitivity may be due to impaired Ca2+ activation of 
the thin filaments. Indeed, in single permeabilized psoas fibers we demonstrated that exposure 
to a NO donor, sodium nitroprusside, caused a rightward shift in the force pCa curve (26). In 
intact single fibers from the mouse flexor brevis, Andrade et al also observed that exposure to 
a NO donor caused a rightward shift in the force/Ca2+ relationship (1).  
The effect of NO on cross-bridge cycling kinetics remains more controversial. Some 
studies have reported that exposing fibers to a NO donor causes a slowing of maximum 
shortening velocity (Vo) (13,26), but in the study by Andrade et al, exposure of intact fibers to 
a NO donor did not affect Vo (1). The effect of NO on cross-bridge cycling kinetics has also 
been evaluated by measuring the rate of force redevelopment (ktr) (1,13). Andrade et al found 
that exposure to a NO donor had no effect on ktr in intact fibers (1), whereas Galler and 
colleagues (13) reported that exposure to an NO donor caused a slowing of ktr. In both of 
these studies ktr was measured only during maximum activation, and it possible that the effect 
of NO on cross-bridge cycling kinetics is more pronounced during submaximal Ca2+ 
activation. Accordingly, in the present study we hypothesize that the depressant effects of NO 
on muscle fiber force and ktr are more pronounced during submaximal Ca2+ activation.  
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Methods 
Permeabilized rabbit psoas single fiber preparation 
Permeabilized single fibers were prepared from glycerinated rabbit psoas muscle (Ward’s 
Natural Scientific Establishment). A 1 cm strip of muscle tissue was excised and placed in a 
relaxing solution of the following composition (in mM) 7.0 ethylene glycol-bis(ß-aminoethyl 
ether)-N, N, N’, N’-tetraacetic acid, 1 free Mg2+,  4.42 MgATP2-, 20 imidazole, 15 creatine 
phosphate, 1 mg/ml creatine phosphokinase and sufficient KCl to adjust the ionic strength to 
150 mM. The pH was adjusted to 7.0 with KOH. The negative log free Ca2+ concentration 
(pCa) of the relaxing solution was 9.0. Single fibers were then dissected using fine forceps 
under a microscope. These fibers were kept for 30 min. in a skinning solution that was of the 
same composition as the pCa 9.0 solution, except that 1% Triton X-100 was added. The 
temperature of the skinning solution was 15°C to thermoequilibrate the fibers prior to 
measurements.  
The activating solutions had the same composition as the relaxing solution, except that 
the pCa was adjusted to range between 7.0 and 4.0 with the following steps: 7.0, 6.5, 6.2, 6.1, 
6.0, 5.9, 5.8, 5.7, 5.6, 5.5, 5.4, 5.3, 5.2, 5.1, 5.0, 4.5, 4.0. The solution for maximum rigor 
activation had the same composition as pCa 4.0, except that MgATP was omitted. The final 
concentrations of free Ca2+, ligand and Ca2+-ligand complexes were calculated by using a 
computer program described by Fabiato and Fabiato (11) and the formation constant by Godt 
and Lindley (14).  
 
Measurement of fiber mechanical properties 
Fibers were mounted in a temperature-controlled flow through acrylic chamber (volume 120 
µl) with a glass coverslip bottom. Fixation of fiber ends with gluteraldehyde reduced 
compliance at the attachment points and two stainless steel hooks were used to mount the 
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fiber horizontally in the chamber with aluminum foil T clips. One end of the fiber was 
attached to a force transducer (Aksjeselskapet, AE-801) with a resonant frequency of 5 kHz, 
while the other end was attached to a servo motor (General Scanning, G120DT), with a step 
of 800 µs. First order laser (He-Ne laser, UDT Sensors Inc., LSC 30D) diffraction was used to 
determine sarcomere length, which was held constant at 2.5 µm. Signals were recorded using 
Labview-based software and data acquisition board.  
Fiber stiffness was determined using 1 kHz sinusoidal length perturbations (0.5% of 
optimal length, L0) and normalized for fiber cross-sectional area. With the assumption that the 
stiffness per cross-bridge does not vary, stiffness provides an estimation of the number of 
strongly bound cross-bridges at any given level of Ca2+ activation (12). Stiffness was 
measured when fibers were in relaxing solution, during submaximal (pCa 5.6) maximal (pCa 
4.0) Ca2+ activation, and during maximum rigor activation (pCa 4.0). It was assumed that 
during rigor activation, all cross-bridges are in the strongly bound state; therefore, the ratio of 
stiffness during Ca2+ activation to rigor activation provided an estimate of the fraction of 
cross-bridges in the strongly attached state (αfs).  
During submaximal (pCa 5.6) maximal (pCa 4.0) Ca2+ activation, ktr was measured 
according to the method described by Brenner and Eisenberg (7). In this procedure, fibers 
were rapidly released by ~15% of L0 and after ~50 ms fiber length was restretched to L0. With 
the rapid release and restretch, cross-bridges detach, and force drops to zero. Thereafter, 
cross-bridges reattach and force redevelopment occurs. For each fiber, ktr was determined 
using a computer algorithm for least squares fit of a first order exponential.  
 
NO donor 
The NO donor spermine NONOate (Sp-NO, Calbiochem, La Jolla, CA) was used to study the 
effects of NO on Ca2+ sensitivity and cross bridge cycling kinetics. Sp-NO was stored at –
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80°C as a stock solution (50 mM) in degassed Trizma base solution (Sigma Chemical, St 
Louis, MO), pH 8.80. The stock solution was thawed just before use. In pilot experiments 
using aequorin luminescence to measure free Ca2+ concentrations in the bath, we found that 
Sp-No chelates Ca2+. Therefore, during the Ca2+ testing portions of the experiments, no Sp-
NO was present in the bathing medium. Accordingly, fibers were exposed to Sp-NO for 10 
min while they were perfused with relaxing solution, and before Ca2+ activation, Sp-NO was 
washed from the chamber for 60 s using standard relaxing solution.  
Chemiluminescence analysis was used to estimate NO concentration induced by Sp-
NO. was measured to determine the NO concentration the fiber was exposed to during 
experiments. 1 mM Sp-NO was dissolved in pCa 9.0 solution at 15°C. After 10 min this 
solution was rapidly frozen until –80°C. NO was measured using chemiluminescence (Sievers 
Nitric Oxide Analyzer Model 270B, Boulder, CO). Chemiluminescence analysis showed that 
the control solutions contained 3.7 µM NOx. However, in pCa solutions incubated with 1 mM 
Sp-NO for 10 min the NOx concentration increase to 892 ± 58 µM. It should be noted that this 
method is not specific for free NO, but also other oxidative products of NO such as NO2 and 
NO3 (NOx). Details on the measurement of NO have been published elsewhere (22). 
 
 
Experimental protocols 
Determination of [Ca2+] generating 50% maximal force (pCa50) 
Following measurement of baseline force (pCa 9.0) fibers were successively perfused with 
solutions containing incremental concentrations of Ca2+ (steps see above). Each time a clear 
plateau was reached, the next pCa solution was perfused through the fiber chamber. From the 
resulting force-pCa curve, the pCa50 was determined using sigmoid regression analysis 
(SigmaPlot; Fig. 1). The calculated pCa50 was 5.6 (see results) and was used in subsequent 
experiments for submaximal Ca2+ activation. 
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Measurement of dose-response relationship of Sp-NO 
In preliminary studies, the dose response relationship of Sp-NO on force generation was 
tested. This relationship was only assessed on submaximal force. Testing dose-response 
relationship on the other experimental measurements (maximal force, ktr and stiffness) as well 
would require numerous additional experiments, since repeated determination of all these 
measurements results in significant run down in force in control fibers. Accordingly, 
following measurement of force at pCa 4.0 and at pCa 5.6, the fibers were successively 
exposed for 10 min to a range of Sp-NO concentrations (100, 500 and 1000 µM) dissolved in 
relaxing solution. Between the different concentrations force generation at pCa 5.6 was 
determined. A similar protocol was used for time controls, only Sp-NO was omitted from the 
relaxing solution. These experiments revealed that 1000 µM Sp-NO reduced submaximal 
force to 81 ± 7% of baseline value. No reduction in force generation was observed at lower 
concentration of Sp-NO. Therefore, in all subsequent experiments using Sp-NO the final 
concentration was 1.0 mM. Although this concentration seems to be high, it should be noted 
that all experiments had to be performed at 15°C. This low temperature will reduce the release 
rate of NO from Sp-NO.  
 
Effect of Sp-NO on cross-bridge recruitment and cycling kinetics 
To determine baseline properties the fiber chamber was successively perfused with pCa 9.0, 
pCa 4.0 rigor, pCa9.0, pCa 5.6, pCa 4.0 and pCa 9.0. Subsequently, the fiber was exposed to 
pCa 9.0 containing 1 mM Sp-NO for 10 min. Then Sp-NO was washed out and the force 
measurements were repeated, though the order of introducing the solutions was different (pCa 
9.0, 5.6, 4.0, 9.0, 4.0 rigor and 9.0, respectively). The order of activation after exposure to Sp-
NO was changed since pilot experiments revealed that pCa 4.0 rigor activation significantly 
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reduced force at pCa 5.6 in time controls. Consequently, rigor force was measured after 
measurement of submaximal force. 
 Fiber stiffness was measured at pCa 9.0, both prior to submaximal- and rigor 
activation and during all subsequent activations (pCa 5.6, 4.0 and 4.0 rigor). ktr was 
determined at pCa 5.6 and pCa 4.0. A similar protocol was used in time controls, only Sp-NO 
was omitted.  
 A potential issue using NO donors is whether the observed effects are mediated via 
NO or via the parent compound and degradation products. To verify that NO was the 
mediator of changes in force production, 100 µM oxyhemoglobin (OxyHb) was used to 
scavenge NO in the presence of Sp-NO. OxyHb was prepared by mixing 330 mg of bovine 
hemoglobin (Sigma Chemical, St. Louis, MO, U.S.A.) in 5 ml phosphate buffer solution. 
Hemoglobin was reduced to OxyHb by the addition of 35 mg of sodium hydrosulfite (Sigma) 
and passed through a 250 ml sephadex G50 column. A co-oximeter (Instrumentation 
Laboratory, Lexington, MA, U.S.A.) was used to determine the concentration of the OxyHb. 
In addition, experiments were conducted using degraded Sp-NO, which was obtained by 
maintaining the Sp-NO stock solution for 6 h at room temperature. Degraded Sp-NO was used 
in similar experimental protocols as described above.  
 
Statistics 
Data were analyzed with SPSS/PC+, version 9.0 (SPSS Inc. Chicago, IL). Between group 
data were compared using the independent variable T test (e.g. difference in baseline force 
between time control and Sp-NO treated fibers). Within-group data were compared using two 
tailed dependent variables T test (e.g. difference in force due to Sp-NO treatment within 
group). Statistical significance was accepted at P<0.05. All data are presented as means ± 1 
SE. 
Nitric oxide and single fiber mechanics 89 
 
Results 
Measurement of  pCa50 
Force-pCa2+ characteristics of psoas fibers were determined to identify the pCa50 (Fig 1). At 
pCa 4.0 force reached a clear plateau. Therefore, in subsequent experiments, pCa 4.0 was 
used for measuring Fmax. Furthermore, calculated pCa50 was 5.62 (coefficient of variation 
1.7%). Accordingly, in subsequent experiments, pCa 5.6 was used for measuring submaximal 
force.  
 
 
Figure 1: Force calcium characteristics in Triton-X skinned single rabbit psoas fibers exposed to incremental 
Ca2+ concentrations (pCa). Ca2+ concentration is expressed as pCa (–log [Ca2+]). From the calculated force-pCa 
curve, pCa50 was calculated. 
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Table 1. Effect of Sp-NO on force generation in permeabilized rabbit psoas single fibers 
(N/cm2) 
 
 
 
Values are means ± SE. A indicates significant (P<0.05) difference compared to pre exposure, B indicates 
significant (P<0.05) difference compared to time control 
 
Effects of Sp-NO on maximal and submaximal force 
Exposure to Sp-NO significantly reduced force generated at pCa 4.0 and pCa 5.6 (Table 1). 
The ratio of force generated by pCa 5.6 to Fmax was significantly reduced in Sp-NO treated 
fibers (44 ± 2% pre exposure vs. 36 ± 2% post exposure, P < 0.05), but not in time controls 
(39 ± 4% vs. 40 ± 4%, P > 0.05), indicating that Sp-NO reduced Ca2+ sensitivity of force 
generation. Pre exposure force tended to be lower in the Sp-NO group compared to time 
controls. In addition, significant run down in force generation was observed at pCa 4.0 and 
pCa 4.0 rigor. Therefore, forces are also expressed as percentage of pre exposure value 
(Figure 2A-C).  
   
 Time Control Spermine-NO 
     
 Preexposure Postexposure Preexposure Postexposure 
N  9  8 
pCa 5.6  2.87 ± 0.46 2.88 ± 0.46 2.6 ± 0.3 1.9 ± 0.2A,B 
pCa 4.0 5.84 ± 0.76 5.75 ± .74 5.9 ± 0.7 5.3 ± 0.6A,B 
pCa 4 Rigor 6.05 ± 0.83 5.81 ± 0.72 6.6 ± 0.7 5.5 ± 0.6A,B 
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Figure 2: Development of force in skinned single rabbit psoas fibers. A. submaximal force (pCa 5.6), B 
maximal force (pCa 4.0), C. maximal rigor force (pCa 4.0 Rigor). Values are means ± SE. Exposure to 1.0 mM 
Sp-NO for 10 min significantly reduced submaximal and maximal force generation. The effects of Sp-NO were 
more pronounced on submaximal force generation. Results are presented as means ± SE. *P<0.05 compared to 
time control.  
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Exposure to Sp-NO did not affect force generated at pCa 4.0 rigor in comparison to time 
control. Force generation at pCa 5.6 was significantly reduced after exposure to Sp-NO in 
comparison to time controls (75 ± 4% vs. 99 ± 4% of pre exposure value respectively, 
P<0.05). Similarly, exposure to Sp-NO reduced maximal force in comparison to time controls 
(91 ± 1% vs. 97 ± 1% of pre exposure value respectively, P<0.05). Exposure to degraded Sp-
NO did not affect force generation at any level of activation (n=7, fig. 2). Furthermore, the 
effect of Sp-NO on submaximal force generation was abolished in the presence of OxyHb 
(results not shown). 
 
Effect of Sp-NO on αfs  
αfs was measured to determine actomyosin filament overlap. At pCa 4.0, approximately 75% 
of the available cross-bridges were in the strongly attached state, whereas this percentage was 
lower during submaximal activation (Fig. 3). Both at pCa 4.0 and at pCa 5.6, αfs was 
significantly lower in Sp-NO treated fibers compared to time controls. Degraded Sp-NO did 
not affect αfs at (sub)maximal activation (n = 7, data not shown).  
 
Effect of Sp-NO on ktr 
ktr was measured to study cross-bridge cycling kinetics. A representative trace is shown in 
fig. 4A and grouped data in fig. 4B. This latter figure clearly shows the Ca2+ dependency of 
the ktr. Exposure to Sp-NO significantly reduced ktr during submaximal, but not during 
maximal Ca2+ activation. Degraded Sp-NO did not significantly affect ktr at pCa 5.6 or pCa 
4.0 (96 ± 2% and 106 ± 6% of initial value respectively, n = 7).  
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Figure 3. Effect of Sp-NO on the ratio of stiffness at (sub)maximal activation to maximal rigor activation (αfs) 
in permeabilized rabbit psoas fibers. Filled bars, timed control; open bars Sp-NO. The αfs was reduced in fibers 
exposed to 1.0 mM Sp-NO for 10 minutes. The effect of Sp-NO was more pronounced during submaximal 
activation. Results are presented as means ± SE. *P<0.05 compared to pre exposure  
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Figure 4. Effect of Sp-NO on the rate of force redevelopment (ktr) in permeabilized rabbit psoas single fibers. 
A representative original trace. Upper trace, ktr at pCa 4.0, lower trace, ktr at pCa 5.6 B Group means ± SE. Filled 
bars, time control; open bars, Sp-NO treated fibers. 1.0 mM Sp-NO reduced ktr only at submaximal activation. 
*P<0.05 compared to pre exposure.  
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DISCUSSION 
The present study demonstrates that in permeabilized rabbit psoas fibers, Sp-NO reduces 
force generation at submaximal Ca2+ activation, reduces the fraction of strongly bound cross-
bridges (αfs) and slows cross-bridge cycling kinetics (reflected by a slower ktr during 
submaximal activation). The effect of Sp-NO on force generation is consistent with a number 
of previous studies using different preparations and different NO donors (13,19,26,29). 
Similarly, the more pronounced effects of Sp-NO on force generation at submaximal Ca2+ 
activation are in general agreement with previous studies (1,26). Together, these results 
indicate a NO-induced reduction in the Ca2+ sensitivity of cross-bridge recruitment. The effect 
of NO on cross-bridge cycling kinetics is more controversial, with one study indicating no 
effect (1), while another study reported a significant slowing (13). The results of the present 
study indicate that the effect of Sp-NO on ktr was relatively modest and was limited to 
submaximal Ca2+ activation. Thus, these observations may partially reconcile the 
discrepancies in these previous observations. 
Sp-NO, a nucleophilic type of NO donor with the general structure [XN(O)NO]-, 
spontaneously releases NO (21). The rate of NO release is only dependent on pH, temperature 
and the nucleophilic residue (23), and it is therefore easy to control. The rate of release of NO 
from Sp-NO is approximately 30 times lower compared to the frequently used NO donor 
diethylamine NONO-ate (DEA-NO) (21). Therefore, a higher concentration of Sp-NO is 
required to obtain similar biological effects (15). It is important to consider that the effects of 
NO donors can be independent of the release of NO. In the present study, these potential 
independent effects were controlled by demonstrating that degraded Sp-NO did not affect the 
mechanical properties of psoas fibers. The absence of an effect of degraded SP-NO is 
consistent with a previous report demonstrating no effect of degraded Sp-NO on smooth 
muscle mechanical properties (15). This previous study also showed that OxyHb abolished 
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the depressant effects of Sp-NO on smooth muscle force generation, indicating that NO 
release mediates the effects of Sp-NO (15). Similarly, the results of the present study in 
skeletal muscle supported these findings as OxyHb abolished the effects of Sp-NO on 
submaximal force generation.   
In the present study, chemiluminescence measurements NOx were used to approximate 
changes in NO concentration induced by Sp-NO at varying concentrations (100, 500 and 1000 
µM). As noted above, the chemiluminescence method is not specific for free NO, but detects 
other oxidative products of NO as well (e.g., NO2 and NO3 - NOx) (22). However, these 
chemiluminescence measurements did validate that NOx concentration increased as Sp-NO 
concentration increased, strongly indicating that NO concentration also increased. In addition, 
it was shown that the reduction in force generation at submaximal Ca2+ activation (pCa 5.6) 
was dependent on Sp-NO concentration. At 1000 µM Sp-NO, the concentration inducing the 
greatest reduction in force, NOx concentration was 892 µM, and it is likely that the NO 
concentration was even less. However, it is difficult to determine the physiological relevance 
of the Sp-NO concentration used in the present study, since the local concentrations of NO in 
skeletal muscle fibers remains unknown. Although NO release has been measured from intact 
skeletal muscle tissue in vitro (2), no data are available concerning the NO concentrations that 
exist within subcellular compartments. This is important since within muscle fibers NOS 
expression is not uniform (19,20), suggesting that localized areas of higher NO concentration 
may exist.  
In the present study, we found that Sp-NO reduced the ratio of stiffness during Ca2+ 
activation to maximal rigor activation (αfs) indicating an effect on the number of cross-
bridges in the strongly bound state (12,17,18). The parallel changes in αfs and force induced 
by Sp-NO indicate that NO influences cross-bridge recruitment rather than the force 
generated per cross-bridge.  
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Brenner and colleagues presented an analytical framework based on the Huxley two-
state model of cross-bridge cycling (with an rate constant for cross-bridge attachment, fapp, 
and another for cross-bridge detachment, gapp) that showed the relationship between the 
number of strongly bound cross-bridges (αfs) and cross-bridge cycling kinetics at any given 
level of Ca2+ activation (Eq. 1)  (4,5,7).  
αfs = fapp / (fapp + gapp)  Eq. 1 
Brenner and colleagues utilized measurements of ktr to derive the components of cross-bridge 
cycling kinetics (Eq. 2).  
ktr = fapp + gapp     Eq. 2 
 The results of the present study demonstrated that Sp-NO reduces ktr at submaximal 
(pCa 5.6) but not maximal (pCa 4.0) Ca2+ activation. These results are consistent with the 
effects of Sp-NO on force and αfs and suggest an influence on cross-bridge recruitment (fapp) 
at submaximal Ca2+ activation.  The effects of NO donors on ktr in single skeletal muscle 
fibers have been previously studied with varying outcomes (1,13). Galler et al (13) found that 
S-nitroso-N-acetylpenicillamide (SNAP) slowed ktr whereas Andrade et al (1) found no effect 
of S-nitroso-N-acetylcysteine (SNAC) on ktr. It should be noted that both studies evaluated ktr 
during maximal activation. Moreover, the methods used to determine ktr in both studies did 
not include sarcomere length control and restretching fibers to original length, both of which 
might affect ktr (7). In addition, Andrade et al (1) evaluated the effect of SNAC on only a very 
small number of intact fibers (n = 3).   
A key issue is the potential site of action of NO. The results of the present study are 
not consistent with a direct effect of NO on the force generated per cross-bridge, since Sp-NO 
did not influence fiber mechanics at maximum Ca2+ activation (pCa 4.0). However, the Sp-
NO induced reduction in force αfs and ktr during submaximal Ca2+ activation indicate a 
decrease in the Ca2+ sensitivity of cross-bridge recruitment, which could result from a number 
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of underlying mechanisms including altered Ca2+ binding to troponin C (TnC). Binding of 
Ca2+ to TnC induces a conformational change of the troponin complex resulting in an increase 
in the availability of myosin-binding sites on actin (30). However, to date there is no direct 
evidence that NO affects Ca2+ binding to TnC. TnC (and TnI) contain cysteine residues, 
which two are known to be susceptible to reactive oxidants (10,27). Biochemical studies 
showed that disulfide cross-linking of these residues decreases Ca2+ sensitivity of TnC (25). 
In fact, after disulfide cross-linking of cysteine residues, the troponin complex was no longer 
able to regulate actomyosin ATPase activity in a Ca2+ dependent matter. Although no direct 
biochemical evidence exists that NO is able to alter troponin function, this is likely to occur 
when NO modifies the cysteine residues. Such a modification would be consistent with the 
results of the present study. First, the dependence of both force and ktr on Ca2+ is mediated 
through TnC and thin filament regulation (9,28). Second, force and ktr can be dissociated by 
modifying TnC characteristics (9,28). Alternatively, the depressant effect of NO on force and 
ktr could be mediated through modification of hyperreactive thiols SH-1 and SH-2 on the 
myosin head (26). However, the absence of an effect of Sp-NO during maximum Ca2+ would 
be inconsistent with such a mechanism.  
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Abstract 
Recent evidence indicates that hypoxia enhances generation of oxidants. Little is known about 
the role of free radicals in contractility of the rat diaphragm during hypoxia. We hypothesized 
that antioxidants improve contractility of the hypoxic rat diaphragm and that xanthine oxidase 
(XO) is an important source for free radicals in the hypoxic diaphragm. The effects of N-
Acetylcysteine (NAC, 18 mM), Tiron (10 mM) and the XO inhibitor allopurinol (250 µM) 
were studied on isometric and isotonic force generation during hypoxia (Po2 ~ 7 kPa). NAC 
and Tiron decreased maximal force generation, slowed shortening velocity and decreased 
power output. Fatigue rate was decreased in the presence of either NAC or Tiron. Allopurinol 
did not alter contractility or fatigability of the diaphragm. During hyperoxia (Po2 ~85 kPa), 
neither NAC nor allopurinol affected contractility or fatigability of the diaphragm. Thus, free 
radicals play a significant role in diaphragm contractility during hypoxia. Whether 
antioxidants exert a beneficial or harmful effect on muscle performance depends on the 
contraction pattern of the muscle. Free radicals generated by XO do not play a role in 
diaphragm contractility during either hypoxia or hyperoxia.  
 
Introduction 
Free radicals are important modulators of respiratory muscle function (2;18;29). Scavenging 
free radicals in the unfatigued rat diaphragm impairs in vitro force generation (29), indicating 
that free radicals are essential for optimal contractile function. However, oxidative stress, a 
dysbalance between oxidants and antioxidants in favor of the former, impairs skeletal muscle 
contractility (20). Recently, data from our own laboratory showed that markers for free radical 
generation inversely correlate with in vitro force generation of the diaphragm in an animal 
model for pulmonary emphysema (13). Fatiguing contractions enhance generation of free 
radicals in the rat diaphragm muscle (19) and overproduction of free radicals during 
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contractile activity is associated with the development of respiratory muscle fatigue (30). 
Scavenging free radicals during strenuous contractions reduces fatigability of the rat 
diaphragm in vitro (18).  
 Hypoxia, which is a common feature in several diseases including chronic obstructive 
pulmonary disease (COPD), has been found to accelerate skeletal muscle fatigue in vitro 
(31;38) although in some other studies hypoxia did not affect in vitro fatigability (10;31). It 
has been shown that hypoxia enhances generation of free radicals in rat cardiac tissue (26). 
Mohanraj et al (21) found that free radical scavengers such as N-Acetylcysteine (NAC) and 
Tiron, improve in vitro force generation of the rat diaphragm under hypoxic conditions.  
 To date no study has evaluated the effect of free radical scavengers on shortening 
velocity or power output in striated muscle during hypoxia. This could be important because 
isotonic contractile properties better reflect diaphragm muscle performance in vivo. In 
addition, there is no a priori reason to believe why force and velocity should be affected to the 
same extend, since the underlying cellular mechanisms are different. Morrison et al (24) 
showed that inhibiting synthesis of the nitric oxide (NO) does not affect maximal force, but 
reduces maximal shortening velocity (Vmax) and maximal power output of the rat diaphragm 
in vitro. Based on previous studies (8,26) showing elevated oxidant production in hypoxic 
tissues, the first hypothesis of the present study is that free radical scavengers increase Vmax 
and maximal power output of the rat diaphragm during severe hypoxia. The effects of 
scavengers will be more pronounced during fatiguing contractions, when generation of free 
radicals is further increased. In order to test this hypothesis, we determined the effects of 
NAC and Tiron on isometric and isotonic contractile properties of the hypoxic rat diaphragm 
in vitro.  
Cellular sources for free radicals during hypoxia have not been identified yet. During 
normoxia the mitochondrial electron transport chain is an important source for free radicals 
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(5). Xanthine oxidase (XO) can generate superoxide in the presence of (hypo)-xanthine, a 
chemical reaction that is largely triggered and controlled by substrate availability (41). 
Strenuous contractile activity, especially in the presence of hypoxia may favor ATP 
degradation in skeletal muscle, resulting in accumulation of hypoxanthine (12), which in turn 
may enhance generation of free radicals by XO (41). Recently, Heunks et al (15) we found 
that allopurinol (a competitive XO inhibitor) prevents exercise-induced oxidative stress in 
patients with severe COPD. It is conceivable that this was at least partly the result of blocking 
XO in skeletal muscle. These and other studies (41) suggest that XO may be involved in 
generation of free radicals in skeletal muscle during hypoxia, which in turn may affect 
contractility. The second hypothesis of the present study is that free radicals generated by XO 
play a prominent role in hypoxia-induced impairment in force generation of the diaphragm.  
 
Methods 
Study design  
The role of free radicals in contractile performance of the hypoxic rat diaphragm in vitro was 
assessed. In addition, the contribution of XO derived free radicals on diaphragm contractility 
during hypoxia was investigated. Accordingly, the effects of two chemically distinct 
antioxidants, NAC and Tiron, and of the XO blocker allopurinol, were tested on contractility 
and fatigability of the hypoxic rat diaphragm in vitro. Three control groups were studied: 
hyperoxia control, hyperoxia + NAC and hyperoxia + allopurinol. The study was approved by 
the Animal Ethics Committee, University of Nijmegen.  
 
General procedures 
Adult male outbred Wistar rats aged 12-16 weeks and with a mean weight of 306 ± 6 (SE) g 
were used. The animals were housed at a specific pathogen free unit and fed ad libitum. The 
rats were anesthetized with pentobarbital sodium (70 mg/kg bodyweight, ip). Diaphragm 
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bundles were prepared as described previously (36;37). Briefly, a tracheotomy was 
performed, and a polyethylene cannula was inserted. The animals were mechanically 
ventilated with 100% O2. The diaphragm and adherent lower ribs were quickly excised after a 
combined laparotomy and thoracotomy, and were immediately submersed in cooled 
oxygenated (95% O2, 5% CO2) Krebs solution at ~pH 7.4. This Krebs solution consisted of 
137 mM NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 1 mM KH2PO4, 24 mM NaHCO3, 7 
mM glucose and 25 µM d-tubocurarine (Sigma Chemicals, Bornem, Belgium).  
 From the central costal region of the right and the left hemidiaphragm one rectangular 
bundle was dissected parallel to the long axis of the muscle fibers. Silk sutures were tied 
firmly to both ends. The strips were mounted vertically in separate tissue baths containing 
Krebs solution, maintained at 26 °C, and perfused with a 95% O2 and 5% CO2 mixture. In 
general, the bundle excised from the right hemidiaphragm was used for isotonic contractile 
properties and the bundle from the left hemidiaphragm was used in the repetitive twitch 
experiments (see below). Totally, 81 rats were used in the present studies.  
 
Isotonic contractile properties 
The insertion of the muscle bundle at the costal margin was attached to a metal clamp 
mounted in series with a micromanipulator at the base of the tissue bath. The suture attached 
to the central tendon was connected to the lever arm of a dual-mode length-force servo control 
system (Cambridge Technologies, model 308B) using a steel hook.  
The Cambridge system was controlled using Poly-5 based software (Inspektor 
Research Systems, Amsterdam, The Netherlands) running on a Pentium PC. Length and force 
could be controlled independently, allowing the Cambridge system to operate either in the 
isometric or isotonic mode respectively. Length and force outputs were digitized using a data 
acquisition board (DASH 1602, Keithley, Taunton, USA) at a sampling frequency of 2.0 kHz. 
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 The muscle was stimulated directly using platinum plate electrodes placed on either 
side of the muscle bundle. Rectangular current pulses (0.5 ms) were generated by a stimulator 
(IDS, University of Nijmegen) activated by a personal computer. To ensure supramaximal 
stimulation, strips were stimulated 1.25 times the current needed for maximal activation 
(~200-250 mA). Muscle preload force was adjusted using the micromanipulator until optimal 
fiber length (L0) for maximal twitch force (Pt) was achieved.  
 The Cambridge system was first set for length control (isometric mode). After 15 min 
of thermo-equilibration, both Pt and maximal tetanic force at 100 Hz (Po) were determined 
twice with a 2 min. interval between subsequent stimulations. Next, Krebs solution and gas 
mixture were changed to appropriate experimental conditions (see below for experimental 
groups). After 60 min of drug equilibration measurements of Pt and Po were repeated. 
Subsequently, the Cambridge system was set for force control (isotonic mode). The muscle 
was stimulated at 100 Hz (330 ms train duration) while force was clamped at different levels 
ranging from 1-100% of Po. Two min intervened between each force level clamp. Muscle 
shortening velocity at each clamp level was calculated as the change in muscle length during a 
30 ms period and expressed as muscle lengths per s (L0/s).  
 To determine isotonic fatigue, the load clamp level was set for maximum power output 
(assumed a priori to be ~33.3% Po in all groups), and the muscle was stimulated at 100 Hz 
(330 ms train duration) every 2 s. Stimulation continued until no muscle shortening could be 
observed, and this was defined as the isotonic endurance time.  
 
Repetitive twitch experiments 
Previous studies demonstrated that free radicals exert time dependent effects on skeletal 
muscle contractility (2). As this may also be the case for antioxidants, we tested the effects of 
antioxidants on Pt for a 90 min period. The origin of the muscle was tied to a glass hook fixed 
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to the bottom of the tissue bath. The central tendon end was connected to an isometric force 
transducer (Sensotec, model 31/1437-10, Columbus, OH) mounted on a micrometer. Two 
large platinum electrodes were placed parallel to the bundles. Stimuli were applied with a 
pulse-duration of 0.2 ms and duration of 400 ms and were delivered by a stimulator (ID-
electronics, University of Nijmegen, Nijmegen, The Netherlands) activated by a personal 
computer. Data acquisition and storage of the amplified signal were performed via a DASH 
1602 interface on a personal computer (Twist-trigger software, ID electronics). The strip was 
placed at L0, and after 15 min thermo-equilibration period, baseline Po and Pt were 
determined. After changing gas mixture and Krebs solution to appropriate experimental 
condition (see below) Pt was measured at 2 min interval for 90 min in three different 
experimental groups, namely, hypoxia control (n = 9), hypoxia + NAC (n = 8) and hypoxia + 
allopurinol (n = 9).  The pH of the Krebs solution was measured at regular intervals and 
maintained between 7.35 and 7.45.  
 
Gas tension analysis 
In pilot experiments gas tension and pH of the Krebs solution was measured at regular 
intervals. After 15 min thermo-equilibration, gas mixture in ‘hypoxic groups’ was switched to 
5% CO2 and 95% N2.  As shown in Fig 1, this resulted in a rapid decline in O2 tension of the 
Krebs solution (n = 8). In the hyperoxic groups, gas mixture was maintained at 95% O2 and 
5% CO2. In these groups, PO2 of the Krebs solution did not change significantly throughout 
the experiments. In both groups, pH was maintained between 7.35 and 7.45.  
To verify experimental conditions in the present studies, pH, PCO2 and PO2 of the 
Krebs solutions were measured after completion of the contractile experiments (isotonic or 
repetitive twitch). 
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Figure 1. Pilot experiments were performed to determine the change in PO2 of the Krebs solution in the 
hypoxic groups (n = 8). After 15 min of thermo-equilibration, the hyperoxic gas mixture was substituted by a 
hypoxic gas mixture.  
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Effects of free radical scavengers and xanthine oxidase inhibition on rat diaphragm 
isotonic contractile properties during hypoxia 
The effects of NAC (FLUIMUCIL, Zambon, Amersfoort, The Netherlands) and Tiron (4,5-
dihydroxy-1,3 benzenedisulfonic acid, Sigma-Aldrich, Zwijndrecht, The Netherlands) were 
determined on contractile properties under hypoxic conditions. The final concentration of 
NAC was 18 mM and of Tiron was 10 mM. These concentrations have been shown to 
increase in vitro force generation of the rat diaphragm under hypoxic conditions (21). 
Allopurinol and its metabolite oxypurinol are well-known competitive XO-inhibitors. In 
patients with COPD, we recently showed that plasma concentration of 13 µM allopurinol and 
60 µM oxypurinol effectively inhibits exercise-induced free radical generation (15). In a pilot 
study, diaphragm muscle bundles were incubated in Krebs solution containing 13 µM 
allopurinol and 60 µM oxypurinol for 60 min under hypoxic conditions and subsequently 
contractile properties of the bundles were determined. No significant differences were 
observed in force-velocity characteristics, force-power characteristics or isotonic fatigability 
between hypoxia control and allopurinol/oxypurinol treated bundles (n = 6 each group, data 
not shown). Therefore, allopurinol (Sigma Chemicals, St Louis, MO) concentration in the 
tissue baths was set on 250 µM to ensure complete blocking of XO. The effects of 
antioxidants and allopurinol on contractility during hypoxia were compared with contractility 
in standard Krebs solution, under hypoxic conditions. To assess the effects of hypoxia on rat 
diaphragm contractility similar measurements were performed under hyperoxic conditions. In 
addition, the effects of free radical scavenging and XO inhibition were studied under 
hyperoxic conditions. Accordingly, seven experimental groups were studies: Hypoxia control 
(n = 8), hypoxia + NAC (n = 9) and hypoxia + Tiron (n = 7), hypoxia + allopurinol (n = 9), 
hyperoxia control (n = 10), hyperoxia + NAC (n = 9) and hyperoxia + allopurinol (n = 11). 
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The diaphragm bundles were randomly allocated to the treatment groups. After thermo-
equilibration period, baseline contractile properties (Pt and Po) were determined under 
hyperoxic conditions (95% O2, 5% CO2). Subsequently, perfusion of the tissue baths was 
either maintained with the hyperoxic gas mixture or switched to a gas mixture containing 5% 
CO2 and 95% N2 (hypoxia). At the same time, Krebs solution was substituted by the 
experimental Krebs solutions (i.e. control, NAC, Tiron or allopurinol). After 60 min of gas 
and drug equilibration, contractile measurements were performed as described above. The 
repetitive twitch protocol started immediately after changing gas mixture and introduction of 
experimental solutions.  
 
Purine measurements 
To determine the effects of strenuous contractions and of XO blocking on ATP degradation 
products during hypoxia hypoxanthine and xanthine concentration were determined in the rat 
diaphragm. The allopurinol concentration in the diaphragm muscle bundles was also 
measured. The remaining of the muscular diaphragm from the rats in hypoxic groups was 
used to determine baseline (hypo)xanthine concentration in the diaphragm. The bundles used 
for contractile properties were after completion of the experiments saved for later 
(hypo)xanthine and allopurinol measurements. The muscle sample was thoroughly rinsed with 
saline (0.9%), blotted dry and transferred to liquid nitrogen, and stored at –80°C until later 
biochemical analysis.  
 
Data treatment and statistics  
After completion of the force measurements muscle bundle length was measured with a 
micrometer and bundles were blotted dry, central tendon and ribs were removed and muscle 
weight was determined. Cross-sectional area was calculated by dividing diaphragm strip 
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weight (in g) by strip length (cm) times specific density (1.056). Force is expressed per cross-
sectional area (in N/cm2).  
 Muscle shortening velocity at each clamp level was calculated as the change in muscle 
length during a 30 ms period and expressed as muscle lengths per s (L0/s). To eliminate the 
effect of muscle compliance, the time window for shortening velocity measurements was set 
to begin 10 ms following the first detectable change in length. Since Po was significantly 
different between experimental groups after 60 min drug equilibration, force-velocity 
characteristics are plotted with respect to P/Po. The data were fitted to the Hill equation (16): 
(P + a)(V + b) = (Po + a)b 
where P is force, Po is maximum isometric force, V is velocity of shortening and a and b are 
constants with dimension of force and velocity respectively. From this equation a/Po can be 
derived. a/Po represents the curvature of the force-velocity relationship, the value of which 
declines with increasing curvature. The constants b and a were calculated using a computer 
program (Fig.P for Windows v2.7; Fig.P Software Corporation, Durham, NC) that fitted the 
data to the Hill equation. Power (force [N/cm2] times shortening velocity [L0/s]) was 
calculated for each load clamp release and plotted with respect to load.   
Differences in single baseline contractile properties, bundle dimensions and gas 
pressure between the experimental groups were analyzed using one-way ANOVA and, if 
appropriate, Student-Newman-Keuls (SNK) post hoc testing. Parameters requiring repeated 
measures over time (i.e. force-velocity, force-power, fatigue) were estimated by using 
repeated measurement models, if appropriate, SNK post hoc testing. Statistical analysis was 
performed using the SPSS package, v 9.0 (Chicago, IL). Data are expressed as means ± SE. 
Comparisons were considered significant at p ≤ 0.05.  
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Results 
Verification of tissue bath hypoxia and strip dimensions 
Perfusion of the tissue baths with the hypoxic gas mixture significantly reduced pO2 from 
84.8 ± 0.9 kPa to ~6.8 ± 0.2 kPa. pH which was continuously measured during all 
experiments, and was 7.36 ± 0.01 in hyperoxia and 7.37 ± 0.01 in the hypoxic groups. In 
addition, Pco2 was not significantly different between hyperoxia and hypoxia (4.8 ± 0.2 kPa 
and 4.8 ± 0.1 kPa, respectively). No significant differences were found in PO2, PCO2 and pH 
among hypoxic and hyperoxic groups.  
Diaphragm muscle bundle dimensions did not significantly differ between 
experimental groups (P > 0.05, One-way ANOVA). Average muscle strip weight was 32.8 ± 
0.8 mg and strip length at L0 was 18.44 ± 0.21 mm. 
 
Isotonic studies 
Baseline contractile properties 
HYPOXIA. Baseline Pt and Po were not significantly different between the experimental 
groups (P > 0.05) and averaged 9.3 ± 0.4 N/cm2 and 24.6 ± 0.5 N/cm2 respectively. Sixty 
minutes of hypoxia impaired Pt (Fig. 2A) and to a lesser degree Po (Fig 3A). NAC tended to 
decrease Pt, whereas Tiron tended to increase Pt (Fig 2A, p = 0.07 and p = 0.06 respectively, 
one-way ANOVA). However, in muscle bundles incubated with either NAC or Tiron, Po was 
significantly lower compared to hypoxia control (Fig 3A). 250 µM allopurinol did not 
significantly affect Pt or Po compared to hypoxia control (Fig 2B and 3B).  
 HYPEROXIA. After 60 minutes Pt and Po as percentage of initial value were 
significantly higher under hyperoxic compared to hypoxic conditions (Fig 2 and 3; p < 0.01). 
Neither NAC, nor allopurinol affected Pt or Po under hyperoxic conditions (Fig 2B and 3B).  
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Figure 2. Rat diaphragm twitch tension (Pt) after 60 min in experimental Krebs solution (see methods), 
expressed as percentage of initial value. A: Hypoxic conditions (Po2 ~6.8 kPa). Pt tended to be lower in bundles 
incubated with NAC (p = 0.06, n = 9), and elevated with incubation in Tiron (p = 0.06, n = 7) compared to 
hypoxia alone (n = 8). B: Under hyperoxic conditions (Po2 ~85 kPa) NAC (n = 9) antioxidant treatment or 
allopurinol (n = 11) did not affect Pt compared to hyperoxia alone (n = 10).  
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Figure 3. Diaphragm maximal tetanic tension (Po) after 60 min in experimental Krebs solution, expressed as 
percentage of baseline value. Numbers of bundles are shown in legend of fig. 2. A: Both NAC and Tiron 
decreased Po during hypoxia. Allopurinol did not affect Po under hypoxic conditions. * P < 0.05 compared to 
hypoxia. B: Under hyperoxic conditions, neither NAC, nor allopurinol significantly affected Po compared to 
hyperoxia.  
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Isotonic contractile properties and fatigability 
HYPOXIA. NAC and Tiron both significantly slowed shortening velocity over a wide range 
of loads (Fig. 4A). The curvature of the force-velocity relationship is described by a/Po. Tiron 
altered the curvature of force velocity characteristics (a/Po = 0.23 ± 0.03 in hypoxia control 
vs. 0.37 ± 0.08 in hypoxia + Tiron, P<0.05). Allopurinol did not affect shortening velocity 
(Fig. 4A), neither a/Po (0.22 ± 0.3 and 0.21 ± 0.02 in hypoxia control and hypoxia + 
allopurinol respectively, P > 0.05). Both NAC and Tiron significantly depressed power output 
over a wide range of loads (Fig 5A) Maximal power output during hypoxia was 91 ± 8 N/cm2 
x Lo/s, 63 ± 2 N/cm2 x Lo/s and 47 ± 5 N/cm2 x Lo/s in control, NAC and Tiron respectively, 
p < 0.000). However, allopurinol did not affect force-power characteristics under hypoxic 
conditions (Fig 5A; maximal power output 96 ± 6 N/cm2 x Lo/s; p > 0.05 compared to 
hypoxia control).  
HYPEROXIA. Force-velocity characteristics were not significantly different between 
hyperoxia control and hypoxia control neither was Vmax (5.2 ± 0.5 L0/s vs. 5.0 ± 0.4 L0/s in 
hyperoxia control and hypoxia control, respectively, p > 0.05). The curvature of the force-
velocity relationship was not significantly altered by hypoxia (0.18 ± 0.01 vs. 0.23 ± 0.03 in 
hyperoxia control and hypoxia control, respectively). Consequently, force power 
characteristics were not significantly different between hyperoxia and hypoxia (maximal 
power output 113 ± 9 N/cm2 * L0/s and 91 ± 8 N/cm2 * L0/s in hyperoxia control and hypoxia 
control, respectively, p > 0.05). Neither NAC, nor allopurinol significantly affected Vmax, 
force-velocity characteristics (Fig. 4B), force-power characteristics or maximal power output 
(Fig. 5B) under hyperoxic conditions.  
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Figure 4. Normalized force-velocity relationships in the diaphragm after 60 min incubation in experimental 
Krebs solution. A: Both NAC and Tiron significantly depressed the force-velocity relationship of the diaphragm 
during hypoxia. * P < 0.05 compared to hypoxia, repeated measurements ANOVA). Allopurinol did not affect 
velocity of shortening. B. Normalized force-velocity characteristics were not significantly different between 
hypoxia control and hyperoxia control (A + B). Under hyperoxic conditions, experimental Krebs solutions did 
not affect shortening velocity.  
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Figure 5. Normalized force-power characteristics of the diaphragm after 60 min incubation with experimental 
Krebs solution. A: Both NAC and Tiron depressed power output over a wide range of applied loads under 
hypoxic conditions. * P < 0.05 compared to hypoxia control, repeated measurements ANOVA. Allopurinol did 
not affect power generation in the diaphragm during hypoxia. B: Normalized force-power characteristics were 
not significantly different between hyperoxia control and hypoxia control (Fig. A + B). In addition, neither NAC 
nor allopurinol affected power generation of the diaphragm under hyperoxic conditions.  
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Isotonic fatigue 
HYPOXIA. Repetitive isotonic contractions resulted in a rapid decline in power output of the 
rat diaphragm under hypoxic conditions (Fig. 6A). Tiron reduced the rate of decline in power 
output under hypoxic conditions (P<0.05, Fig 6A). NAC tended to decrease fatigue rate (p = 
0.07, Fig. 6A). Both NAC and Tiron significantly prolonged isotonic endurance compared to 
hypoxia control (p < 0.000; Fig 7A). Allopurinol did significantly not affect fatigability under 
hypoxic conditions (Fig. 6A and 7A).  
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Figure 6. Power production during repetitive isotonic contractions in the rat diaphragm. A: NAC and Tiron 
reduced fatigue rate of the diaphragm in comparison to hypoxia control (* P < 0.05 compared to hypoxia control, 
repeated measurements ANOVA). Allopurinol did not affect the fatigability of the diaphragm during hypoxia. B. 
Fatigue rate was significantly higher in hypoxia control than in hyperoxia control (P < 0.05). NAC nor 
allopurinol affected fatigability of the diaphragm under hyperoxic conditions.  
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HYPEROXIA. Power output of the diaphragm muscle significantly declined faster in 
hypoxia control compared to hyperoxia control (p < 0.000, repeated measurement analysis). 
Isotonic endurance was 156 ± 15 s and 59 ± 3 s in hyperoxia control and hypoxia control 
respectively (p < 0.000, Fig 7). Neither NAC, nor allopurinol significantly affected the rate of 
decline of power output or isotonic endurance of the diaphragm muscle under hyperoxic 
conditions (Fig 6B and 7B).  
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Figure 7. Mean isotonic fatigue endurance for experimental groups under hypoxic and hyperoxic conditions. 
Endurance time was defined as the time point at which the muscle was no longer able to shorten. A: Both NAC 
and Tiron significantly increased endurance time during hypoxia (* P < 0.05 compared to hypoxia control). 
Allopurinol did not affect endurance time under hypoxic conditions. B. Hypoxia reduced endurance time until 
~50% of endurance time in hyperoxia (P < 0.05 compared to hyperoxia control). Endurance time was not 
significantly different between hypoxia control or hyperoxia + NAC or hyperoxia + allopurinol.  
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Repetitive twitch studies 
To ascertain the antioxidants or allopurinol did not exert differential effects in time, the effect 
of NAC and allopurinol on Pt was studied under hypoxic conditions for a 90 min period, a 
time window that corresponds with the total duration of the isotonic protocol (incubation time 
+ time needed for all contractile experiments). As shown in fig. 8, the ‘direction of effect’ did 
not change during this period. In correspondence with data shown above (Fig. 2), in NAC 
treated muscle bundles (n = 8) Pt was significantly lower compared to hypoxia control (n = 
9), but allopurinol (n = 9) did not affect Pt.  
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Figure 8. In the repetitive twitch studies, diaphragm twitch force was measured every 2 min for 90 min to 
study time dependent effects of allopurinol or the free radical scavenger NAC. Repeated measurements ANOVA 
revealed that the rate of decline in force was not different between hypoxia control and hypoxia-allopurinol. 
However, the rate of decline in NAC treated fibers was significantly faster. * P < 0.05 compared to hypoxia 
control. 
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Effects of allopurinol on ATP degradation under hypoxic conditions 
Allopurinol was present in the muscle bundles from the hypoxia + allopurinol group, 
indicating adequate uptake from the Krebs solution (table 1). In hypoxia control, strenuous 
contractile activity resulted in elevated levels of xanthine (P < 0.05). Both inosine and 
hypoxanthine were significantly increased and xanthine was decreased after contractile 
experiments in the hypoxia + allopurinol group, which is in agreement with blocking XO 
activity of the muscle (table 1).  
  
Table 1: Allopurinol and adenine nucleotides in rat diaphragm muscle bundles  
 Hypoxia control Hypoxia + allopurinol 
 Rest Fatigue Rest Fatigue 
Allopurinol, µM 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.75 ± 0.01* 
Inosine, µM 4.90 ± 0.76 5.56 ± 0.44 3.68 ± 0.44 6.76 ± 0.36* 
Hypoxanthine, µM 1.62 ± 0.27 1.85 ± 0.11 1.65 ± 0.25 2.33 ± 0.10* 
Xanthine, µM 0.34 ± 0.02 0.48 ± 0.05* 0.24 ± 0.04 0.04 ± 0.00* 
 
Values are mean ± SE. Rest values were obtained from the remaining of the rat diaphragm after excising bundles 
for contractile properties. Fatigue values were obtained from measurements in strips used after completion of the 
contractile experiments. * P < 0.05 compared to respective rest value.  
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Discussion 
The present study demonstrated that severe hypoxia impairs force generation of the rat 
diaphragm muscle, but does not affect velocity of shortening. The antioxidants NAC and 
Tiron impaired force generation, slowed velocity of shortening, and reduced fatigability of the 
diaphragm during hypoxia, indicating that free radicals play a role in cross-bridge recruitment 
and cross-bridge cycling kinetics under hypoxic conditions. Antioxidants had opposite effects 
in the unfatigued and fatigued muscle indicating that the contraction pattern determines 
whether the effects of antioxidants during hypoxia are beneficial or harmful. The fact that 
allopurinol did not affect contractile function or fatigability of the diaphragm during hypoxia, 
indicate that free radicals generated by XO are not directly involved in excitation-contraction 
coupling under hypoxic conditions. Under hyperoxic conditions, NAC and allopurinol did not 
affect isometric or isotonic contractility of the diaphragm, indicating that in our model free 
radicals do not affect muscle performance during hyperoxia.  
 
Allopurinol, NAC and Tiron 
Allopurinol was used to block XO activity in the rat diaphragm. The major pharmacological 
actions of allopurinol are mediated by its major metabolite oxypurinol. Both are structural 
analogues of the purine bases hypoxanthine and xanthine and competitively bind to XO. 
Thereby they inhibit the conversion of hypoxanthine to xanthine and xanthine to uric acid and 
thus generation of superoxide. Moorhouse et al (23) reported that allopurinol in 
concentrations >250µM may have direct hydroxyl scavenging properties. Therefore, in the 
present study allopurinol concentration in the Krebs solution was 250 µM. This concentration 
was sufficient to block XO activity, as indicated by the increase in hypoxanthine 
concentration, and the reduction in xanthine concentration in allopurinol treated bundles 
during hypoxia.  
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NAC is an antioxidant drug commonly used in clinical practice. Two possible 
antioxidant mechanisms have been proposed for this thiol-containing agent. Firstly, NAC may 
have direct free radical scavenging properties. Free radicals may react with NAC resulting in 
the formation of NAC disulphide (3;22). Although this mechanism of action is of limited 
relevance in vivo due to the high first pass effect of NAC (25), it might be important in in 
vitro studies. Secondly, NAC may also exert its antioxidant effects indirectly by facilitating 
biosynthesis of GSH. The concentration of NAC in the present study was 18 mM and was 
similar to previous studies using this agent in the rat diaphragm (21). To ensure that the 
effects of NAC on muscle contractility were the result of its antioxidant properties, similar 
experiments were conducted with Tiron, a chemically distinct free radical scavenger. Tiron is 
an intracellular superoxide scavenger and metal chelator and has been shown to effectively 
scavenge free radicals in the contracting rat diaphragm (34).  
 
Hypoxia and muscle function 
We have discussed the severity of hypoxia, as used in the present study in a recent paper (36). 
Briefly, a reduction in PO2 in the Krebs solution from ~85 kPa to 7 kPa should be considered 
as severe hypoxia, since oxygenation of diaphragm muscle bundles is dependent solely on 
diffusion of O2 into the core region of the bundles. Hypoxia impairs force generation and 
increases fatigability of the diaphragm in vitro (10;31;32;36;38). The present studies confirm 
these effects of hypoxia on isometric contractility. After 60 min both Pt and Po were 
significantly lower in hypoxia compared to hyperoxia, indicating that hypoxia impaired cross-
bridge recruitment or reduced force per cross-bridge. This study also shows that hypoxia does 
not significantly affect force velocity relationship, indicating that hypoxia does not have 
major effects on cross-bridge cycling rate of the diaphragm. It has been shown previously that 
variation in maximum force has little effect on normalized force-velocity relationship (9;17). 
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This is not surprising because there is no a priori reason why force and velocity should be 
reduced to the same extent, since the underlying cellular mechanisms are different. The 
effects of hypoxia on velocity of shortening and power output in the rat diaphragm have not 
been investigated previously. However, studies on fatigued and hypoxic muscle demonstrated 
that the changes in intracellular milieu under these conditions are remarkably similar (11). It 
has been shown that in intact muscle fibers, in the early stages of fatigue, isometric force 
declines significantly with little effect on maximal shortening velocity (39). This is in line 
with the results of the present study. It has been proposed that changes in intracellular ionic 
phosphate (Pi) and Ca2+ concentration, as occurs in the early stages of fatigue affect isometric 
force generation, but have little or no effect on shortening velocity (for review see ref (1)). It 
has been shown that shortening velocity correlates with myosin ATPase activity (4). 
Apparently, ATPase activity was not reduced in the hypoxic diaphragm during non fatiguing 
contractions. The curvature of the force velocity relationship (derived from a/Po) was not 
altered by hypoxia, indicating that hypoxia did not affect efficacy of contraction in the 
unfatigued muscle. 
However, hypoxia had detrimental effects on isotonic fatigue rate, as indicated by 
progressive decline in power output during the fatigue protocol (Fig 6A). Power is the product 
of force and velocity of shortening. Since force was clamped at 33.3% of Po, force generation 
was constant during the entire fatigue protocol. The reduction in power is the result of 
reduction in shortening velocity. As mentioned, shortening velocity is correlated with myosin 
ATPase activity (4), thus it is likely that ATPase activity decreased during fatigue. Several 
studies suggest that elevated concentration of ADP inhibit the rate of cross-bridge detachment 
and consequently maximal shortening velocity (for review see (1)). The increase in inosine 
and xanthine in diaphragm muscle bundles after fatiguing contractions is consistent with such 
a hypothesis. Since hypoxia will slow ATP regeneration, ADP accumulation will occur 
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sooner under hypoxic than hyperoxic conditions. Consequently, fatigue rate will be higher 
during hypoxia, as is shown in the present study. Although we did not measure ATP 
degradation products after fatiguing contractions under hyperoxic conditions, it is likely that 
the response will be similar as under hypoxia, since both groups of bundles fatigued to the 
same level, i.e. inability of the muscle to shorten at 33.3% of Po.  
  
Free radicals in skeletal muscle during hypoxia 
Several studies demonstrated that hypoxia enhances generation of oxidants (8) and these free 
radicals might act as second messengers in the adaptive response to hypoxia (6;26). For 
instance, Park et al (26) showed that in a perfused rat heart model, 10 minutes of hypoxia (Po2 
~0.4 kPa) resulted in a significant increase in markers for generation of free radicals such as 
lipid-peroxides, carbonyls and oxidized glutathione. Generation of free radicals in cultured 
cardiac myocytes starts within several minutes after initiation of hypoxia and the rate of 
generation is more pronounced in severe hypoxia (8). No direct evidence exists for elevated 
generation of free radials in the diaphragm during hypoxia.  
In the present study, the effects of NAC and Tiron on contractility of the rat diaphragm 
were tested during hypoxia. Surprisingly, Tiron increased Pt, whereas NAC tended to 
decrease Pt (P < 0.05 and P < 0.07 respectively, one-way ANOVA, SNK post hoc testing). 
We do not have a clear explanation for this discrepancy. However, both antioxidants 
significantly reduced Po indicating a reduction in the number of available cross-bridges, or a 
reduction in force per cross-bridge. The reduction in velocity of shortening induced by both 
NAC and Tiron indicate that oxidants play a role in cross-bridge cycling. In addition, the 
normalized force-velocity relationship in the Tiron treated bundles was less curved (lower 
a/Po) compared to hypoxia alone, indicating that Tiron impaired efficacy of contraction (40). 
Power is the product of force and velocity and is considered as a more physiological 
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estimation of muscle performance in vivo than either force or velocity alone. Since both NAC 
and Tiron reduced power generation over a wide range of loads, it could be expected that 
antioxidants will impair performance of the hypoxic unfatigued muscle in vivo. Based on 
previous studies, showing that hypoxia enhances generation of oxidants (26), we hypothesized 
that this would contribute to impaired contractile performance of the diaphragm under 
hypoxic conditions. Our findings partly refute this hypothesis. NAC and Tiron impaired 
contractile performance of the unfatigued diaphragm. It could be argued that the degree of 
hypoxia was not sufficient to enhance generation of free radicals. However, as discussed 
previously the degree of hypoxia should be considered as severe (36). Nevertheless, the 
amount of oxidants generated depends on the severity of hypoxia (8), thus further reducing 
Po2, might have changed the response of antioxidants on contractility in the present study. 
However, the clinical and physiological relevance of such experiments would be limited. The 
study by Mohandraj et al (21) supports these speculations. In their study both NAC (18 mM) 
and Tiron (10 mM) increased Pt and Po in the hypoxic/anoxic rat diaphragm (Po2 < 0.08 kPa). 
Since the concentration of NAC and Tiron used was similar between their and the present 
study, and differences cannot be explained by time dependent effects of NAC (fig. 8), it is 
likely that difference in Po2 contributed to the differences in outcome. Indeed, in their study 
hypoxia decreased maximal force until ~25% of initial value (table 1, ref (21)), whereas in the 
present study Po decreased until ~90% of baseline value. Another explanation for rejection of 
our hypothesis is that the relatively high concentration of the antioxidants shifted the redox 
balance from slightly oxidized too far to the reduced state, which will also compromise 
muscle performance. Reid et al (28) proposed a model of force production as a function of the 
cellular redox balance. Both oxidant- and reductant stress will impair muscle performance. 
Such a model would fit well with the data of the current study. Adding free radical scavengers 
to the tissue bath placed the unfatigued muscle in a reduced state, which compromised muscle 
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performance. This study is the first to demonstrate that antioxidants modulate isotonic fatigue 
in skeletal muscle. During isotonic fatiguing contractions, when generation of free radicals is 
enhanced (19;29), these antioxidants exerted beneficial effects on muscle performance, as 
indicated by reduced fatigue rate and increased endurance time. As mentioned above, the 
reduction in power is the result of reduction in shortening velocity. Therefore, these 
antioxidants modulate cross-bridge cycling. 
Under hyperoxic conditions, NAC did not affect isometric or isotonic contractility of 
the diaphragm. These findings are in apparent contrast with previous studies (18;33), showing 
that NAC attenuates diaphragm fatigability under hyperoxic conditions. However, in those 
studies (18;33) the effects of NAC on isometric fatigability were assessed. In contrast, in the 
present study, the effect of NAC on isotonic fatigability (force clamped at 33% Po) was 
determined. Thus, different physiological parameters were studied. As discussed above these 
parameters (i.e. force and velocity) are not dependent, thus these previous and the present 
study are not necessarily conflicting, and suggest that under hyperoxic conditions free radicals 
affect cross-bridge recruitment or force per cross-bridge, but not cross-bridge cycling kinetics.  
 
XO inhibition and skeletal muscle function 
We hypothesized that XO is a prominent source for free radicals in the diaphragm under 
hypoxic conditions. Although, xanthine concentration in the diaphragm bundle was 
significantly increased after strenuous contractions, blocking XO activity did not alter 
contractile properties at rest or during fatiguing contractions. Thus, our original hypothesis 
must be rejected. Allopurinol effectively blocked XO, as indicated by accumulation of 
hypoxanthine and a sharp decrease in xanthine concentration in bundles incubated in 
allopurinol. Apparently, free radicals generated by XO do not affect contractility in the rat 
diaphragm. Our findings are in line with a recent study by Supinski et al (35). Oxypurinol 
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administration before inspiratory resistive breathing in rats failed to prolong task endurance 
and did not prevent lipid peroxidation in the diaphragm. This indicates that XO dependent 
pathways do not affect diaphragm contractility in vivo. Chandler and Schumacker (6) recently 
proposed that the hypoxia induced reduction in mitochondrial cytochrome oxidase activity, 
results in an increase in the mitochondrial redox state, which in turn accelerates free radical 
formation during hypoxia. Whether free radicals generated via this pathway affect excitation 
contraction coupling under hypoxic conditions remains to be investigated.  
 
Clinical relevance 
Respiratory muscle dysfunction frequently occurs in patients with severe COPD (27). Free 
radicals may be involved in the pathogenesis of respiratory muscle dysfunction in these 
patients (14). Firstly, in patients with COPD, especially emphysema, the altered geometry of 
the thorax, puts the diaphragm on a disadvantageous position of the length tension curve (7) 
thereby increasing load on the diaphragm. It has been shown that elevated loading enhances 
generation of free radicals in skeletal muscle (19). Secondly, it has been shown that hypoxia 
enhances generation of free radicals in muscle (26). Since hypoxia frequently occurs in severe 
COPD, investigating the role of free radicals in contractile performance of the diaphragm is 
important. In addition, identifying the pathways for free radical generation is important in 
order to effectively inhibit generation of free radicals from specific pathways.  
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Abstract 
Loading of skeletal muscles is associated with increased generation of oxidants, which in turn 
may impair muscle contractility. We investigated if the load on the hamster diaphragm 
imposed by pulmonary emphysema induces oxidative stress, as indicated by glutathione 
oxidation and if the degree of glutathione oxidation is correlated with contractility of the 
diaphragm. In addition, the effect of 12 weeks of treadmill exercise training on contractility 
and glutathione content in the normal (NH) and emphysematous hamster (EH) diaphragm was 
investigated. Training started six months after elastase instillation. After the training period 
glutathione content and in vitro contractility of the diaphragm were determined. Twitch force 
(Pt) and maximal tetanic force (Po) were significantly reduced (by ~30% and ~15% 
respectively) in EH compared to NH. In sedentary hamsters the GSSG/GSH ratio was 
significantly elevated in the EH compared to the NH diaphragm. A significant inverse 
correlation was found between GSSG/GSH ratio and Pt in the diaphragm (P<0.01). Training 
improved Po and reduced fatigability of the EH diaphragm, but did not alter its glutathione 
the content. In conclusion, (1) emphysema induces oxidative stress in the diaphragm, (2) 
training improves the contractile properties of the EH diaphragm, (3) this improvement is not 
accompanied by changes in glutathione redox status.  
 
Introduction 
Skeletal muscles generate reactive oxygen species (ROS) at rest and generation is increased 
during contractile activity (17;27). ROS are required for optimal contractile function (27). 
However, overproduction of ROS, so-called oxidative stress, is associated with impaired force 
generation (6;28). Overproduction of ROS by skeletal muscle during fatiguing contractions 
may lead to a nonpathologic form of oxidative stress (1). Indeed, in the rat diaphragm an 
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inverse correlation exists between superoxide anion release during fatiguing contractions and 
the final stress developed (28).  
Antioxidant defenses protect skeletal muscles from deleterious effects of ROS. 
Reduced glutathione (GSH) is probably the most important antioxidant in skeletal muscle. 
Intracellular glutathione metabolism is regulated by complex pathways (21). GSH serves as 
an antioxidant by reacting directly with free radicals and by providing substrate for 
glutathione peroxidase (GPX). Both direct and enzymatic oxidation of GSH results in the 
formation of oxidized glutathione (GSSG), which is reconverted to GSH by glutathione 
reductase (GR). Thus, tissue glutathione status depends on the direct interaction of GSH with 
oxidants, the activity of the GPX and GR redox cycle and by the ability of tissues to 
synthesize GSH. Elevated glutathione oxidation is considered as a marker for oxidative stress 
(5). For instance, it has been shown that acute loading of the respiratory muscles by 
inspiratory resistive breathing increases glutathione oxidation in the rat diaphragm (34).  
In contrast to acute loading, little is known about the effects of chronic loading on 
ROS generation in the diaphragm. However, this may be of major relevance to patients with 
chronic obstructive pulmonary disease (COPD). Respiratory muscle dysfunction frequently 
occurs in patients with COPD (25). Pulmonary hyperinflation, which is one of the key 
features of COPD (10), puts the diaphragm on a disadvantageous position of the length-
tension curve and thereby chronically increases the load on the diaphragm.  
The first hypothesis of the present study was that impaired contractility of the 
diaphragm due to pulmonary emphysema is accompanied by elevated glutathione oxidation in 
the diaphragm. We tested this hypothesis in the emphysematous hamster (EH), which is a 
frequently used animal model to study the effects of pulmonary hyperinflation on diaphragm 
function and morphology (12;20;36).   
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During general exercise training-sessions the diaphragm faces an elevated load due to 
increased ventilation. Previous research in healthy rodents revealed that training-induced 
elevation in oxidative capacity of the diaphragm is accompanied by increased antioxidant 
enzyme activity (23;26). This indicates that the antioxidant screen of the diaphragm adapts to 
the elevated oxygen consumption rate. However, it is unknown if training affects glutathione 
status of the diaphragm. Only one study has been published on the effects of training on 
contractility of the EH diaphragm (11). In that study general exercise training did not affect in 
vitro contractility of the diaphragm. In contrast to our EH model, in the study by Farkas and 
Roussos (11) pulmonary emphysema did not impair in vitro contractility of the diaphragm. 
This difference in baseline contractility of the diaphragm may affect the course of training 
responses. In a separate study the same authors reported that training did not increase oxidant 
capacity of the EH diaphragm as expressed by citrate synthase activity (12). To our 
knowledge the effects of training on antioxidant status in the EH diaphragm have not been 
studied yet.  
The second hypothesis of the present study was that training improves contractility of 
the EH diaphragm which is accompanied by a reduction in glutathione oxidation at rest. In 
order to answer this question EH were trained on a motor driven treadmill for 12 weeks. 
Subsequently the degree of glutathione oxidation and in vitro contractility of the diaphragm 
were assessed. 
 
Methods 
Animals, induction of emphysema and study design 
All experiments were conducted on male Syrian hamsters. Animals were housed in a specific 
pathogen free area (SPF unit), with controlled day and night cycle and were fed ad libitum. 
Hamsters were studied for the following reasons. First, antioxidant enzyme activities in 
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human are more similar to hamsters compared to rats (9). Secondly, the emphysematous 
hamster is a frequently used animal model to study the effects of pulmonary emphysema on 
diaphragm contractility and morphology. The hamster model has several advantageous. The 
pathological lesions in the lung induced elastase instillation have been studied in detail (31) 
and are quite similar to patients with emphysema. Furthermore, lung function changes in the 
EH resemble changes in patients with emphysema: increased pulmonary compliance, 
functional residual capacity, residual volume and total lung capacity. In the present study 
hamsters at 40 weeks of age were intratracheally instilled with either porcine pancreas 
elastase (24 U/100 g bodyweight, (EPC, Owensville, MI) in 0.50 ml 0.9% NaCl/100 g 
bodyweight) or an equal volume of 0.9% saline, as was described in detail previously (36). 
Six months after instillation 15 emphysematous hamsters and 15 normal hamsters were 
trained (EH-Tr and NH-Tr respectively) on a motor driven treadmill. Sedentary normal and 
emphysematous hamsters were used as controls (n=17 each group, NH-Sed and EH-Sed 
respectively). These studies were approved by the Animal Ethical Committee, University of 
Nijmegen. 
 
Training 
Day and night cycle was reversed in order to train the hamsters during their naturally most 
active period of the day. Training started 6 months after instillation. In the week preceding the 
start of training, NH-Tr and EH-Tr were acclimatized to the treadmill by walking at low speed 
for 15 minutes a day (5° inclination). An electrical grid in the rear of each running 
compartment was used to encourage running. The animals were exercised 5 days/week for a 
12 week period. In the first week of the training-program running speed was 11.4 m/min for 
40 minutes per day. In the following 5 weeks running speed and duration were gradually 
increased up to 20 m/min for 60 min per day. An attempt to further increase running speed 
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was abandoned since EH were not able to maintain this speed. Thus, from the 6th until the 12th 
week both NH and EH ran 20 m/min, 60 min/per day at 5° inclination for 5 days a week. 
Subsequent experiments were performed 24 – 36 hours after the last training session.  
 
General procedures and tissue treatment 
The hamsters were anesthetized with pentobarbital sodium (Nembutal, 70 mg/kg ip). A 
tracheotomy was performed, and a polyethylene cannula was inserted. The animals were 
mechanically ventilated with 100% O2. The diaphragm and adherent ribs were quickly 
excised after combined laparotomy and thoracotomy and they were immediately submersed in 
cooled oxygenated Krebs solution at pH ~7.40. This Krebs solution consisted of 137 mM 
NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 1 mM KH2PO4, 24 mM NaHCO3, 7 mM 
glucose and 25 µM d-tubocurarine (Sigma Chemicals, Bornem, Belgium). The right middle 
costal hemidiaphragm was used for in vitro contractile measurements. The remaining of the 
right costal hemidiaphragm was used for citrate synthase (CS) activity measurement. From 
the left hemidiaphragm ribs and connective tissue was removed and the remaining was 
quickly frozen in liquid N2 and stored at –80°C for later glutathione measurements. 
Meanwhile, the posterior-inferior area of the liver and the intact soleus muscles were removed 
from the animal and also quickly frozen in liquid N2 and stored at –80°C for glutathione 
measurements. There is no good peripheral counterpart in terms of fiber type composition of 
the diaphragm. The soleus muscle (80% type I fibers (37)) was chosen arbitrarily as a control 
muscle for the diaphragm, to investigate whether any changes in glutathione concentration of 
the diaphragm were the result of a systemic response.  
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Measurement of contractile properties 
From the middle lateral costal region of the right hemidiaphragm two rectangular strips were 
dissected parallel to the long axis of the muscle fibers. Silk sutures were tied firmly to both 
ends of the strip. The strips were suspended in two tissue baths containing Krebs solution, 
maintained at 37°C, pH 7.35-7.45 and perfused with a mixture of 95% O2 and 5% CO2. The 
central tendon end of each strip was connected to an isometric force transducer (Model 
31/1437-10; Sensotec, Columbus, OH) mounted on a micrometer. Two large platinum 
stimulation electrodes were placed parallel to the muscle strips. Stimuli were applied with a 
pulse duration of 0.2 ms and a train duration of 250 ms and were delivered by a stimulator 
(ID-electronics; University of Nijmegen, The Netherlands) activated by a personal computer. 
To ensure supramaximal stimulation, the strips were stimulated at approximately 20% above 
the voltage at which maximal forces were obtained. (~6V applied through the stimulating 
electrodes). Data acquisition and storage of the amplified signal were done with a Dash-16 
interface (Twist-trigger software, ID-electronics, University of Nijmegen) on a personal 
computer. Both strips were placed at their optimal length (L0), defined as the length at which 
peak twitch tension was obtained. The following protocols were performed in either both or 
one of the strips: 
Twitch characteristics. In each strip two twitches were recorded to determine maximal 
twitch tension (Pt), contraction time (CT), and half relaxation time (½ RT). 
Maximal tetanic force. Both bundles were stimulated twice at 160 Hz to obtain a 
plateau in force generation. The maximal force was defined as the maximal tetanic force (Po).   
Force-frequency characteristics. Randomly one of the bundles was selected for 
studying force-frequency characteristics. The bundle was stimulated with 2 min intervals at 
the following frequencies: 15, 25, 50, 80 and 120 Hz. Both the absolute force and the 
percentage of Po were calculated.  
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Fatigability. To avoid impairment in force generation at the start of the fatigue 
protocol due to measuring force-frequency characteristics, in vitro fatigability was studied in 
the strip not used in force-frequency experiments. The strip was stimulated once every 2 s. at 
25 Hz, 330 ms train duration for 120 s. After the completion of these measurements the length 
of each strip was measured twice by using a micrometer (model 560-128, Mitutuoyo, 
Veenendaal, The Netherlands), and the strips were weighed. The CSA was calculated by 
dividing diaphragm strip weight (g) by strip length (cm) times specific density (1.056). Forces 
were expressed per CSA (N/cm2), and the Pt/Po ratio was calculated for each muscle strip.  
 
Verification of emphysema 
After the diaphragm was removed, the trachea was exposed and an endotracheal canula was 
inserted and held in place with silk sutures. Subsequently, the lungs were inflated with 0.9% 
saline to a pressure of 25 cmH2O. Fluid displacement was assessed as an estimation of lung 
volume.  
 
Biochemical measurements 
Glutathione. GSSG and total glutathione (T-Glu) were measured enzymatically, basically as 
described by Anderson (2). GSH concentration was calculated by [T-Glu] – 2*[GSSG]. Since 
validation experiments revealed that prolonged storage of tissue samples results in artificial 
glutathione-oxidation, samples were analyzed within 1 week after excision from the animals. 
In short, the tissues were thawed, minced and subsequently homogenized in phosphate 
buffered saline. The samples were diluted ten times in 1.3% 5-sulphosalicylic acid (SSA) (in 
10 mM HCl) in order to prevent oxidation. For measurement of T-Glu, to 50 µL of the 
samples, 100 µL of a 5,5`-dithiobis-2-nitrobenzoic acid / NADPH solution (final 
concentration 0.2 and 0.16 µM respectively) and 50 µL GSSG reductase (final concentration 
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1 U/mL) were added. All reagents were dissolved in 145 mM phosphate buffer (pH 7.4) in 
order to neutralize the acid. 5-Thio-nitrobenzoic acid was determined at 405 nm in a 
microplate reader.  
GSSG was measured after treatment of 100 µL of the SSA/HCl samples with 5 µL of 
2-vinylpyridine for 60 min. Subsequently, 50 µL was processed as described above for T-Glu.  
Citrate synthase. Citrate synthase (CS) activity was measured in the remains of the 
right hemidiaphragm after two muscle strips were excised. Frozen muscles were thawed in 
ice-cooled buffer containing 250 mM sucrose, 2 mM EDTA and 10 mM Tris-HCl (pH 7.4). In 
this buffer muscle homogenates (5% w/v) were prepared. CS activity was measured at 25°C 
as described by Shepherd and Garland (30) and was expressed as µmol coenzyme A 
formed/min/g tissue.  
 
Data analysis 
Single data (i.e. Pt, Po, GSSG, CS) were compared among groups using one-way analysis of 
variance (ANOVA). If appropriate Student Newman Keuls post hoc tests were performed. 
Repeated measurements analysis of variance was used for comparing force–frequency 
characteristics and fatigability. The bivariate Pearson correlation coefficient was calculated to 
test for significant correlations between glutathione oxidation and force generation. All tests 
were performed by using the SPSS/PC+ package version 8.0 (Chicago, IL) Results were 
considered significant at P<0.05. All data are expressed as means ± SE. 
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Table 1. Effects of elastase instillation and training on biophysical characteristics 
 Normal hamster Emphysematous hamster 
 Control Training Control Training 
 (n=17) (n=15) (n=17) (n=14) 
     
Body weight pre Tr (g) 147 ± 4 166 ± 3 131 ± 4* 138 ± 3* 
Body weight post Tr (g) 146 ± 4 153 ± 3 129 ± 3* 131 ± 5* 
Lung volume (ml) 9.8 ± 0.3 10.9 ± 0.4 13.2 ± 0.5* 15.0 ± 0.9*, ✝ 
 
Values are means ± SE. Tr, training. * Significantly difference due to elastase treatment (P<0.05). ✝ Significantly 
different due to training (P<0.05).  
 
Results 
Animal Characteristics 
One of the EH did not complete the training-program due to serious limb injury. The 
remaining 29 hamsters successfully completed all training sessions. After several days of 
treadmill exercise electrical stimulation to encourage running was needed only sporadically. 
At the end of each training-session EH were severely fatigued as indicated by tachypnea and 
lethargy. Some EH were evidently cyanotic and wheezing was audible after the training 
session. Instillation with elastase had profound effects on bodyweight and lung volume of 
hamsters (table 1). Elastase treatment resulted in severe pulmonary emphysema, as indicated 
by ~35% increase in lung volume. Exercise training further increased lung volume in EH.  
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In vitro contractile properties of the diaphragm 
Pulmonary emphysema significantly reduced Pt, Po and L0 of the diaphragm strips compared 
with NH-Sed (Table 2). Pt and Po were ~30% and ~15% lower in EH-Sed compared to NH-
Sed respectively. In the EH-Sed normalized force frequency responses were significantly 
impaired at frequencies up to 60 Hz compared to NH-Sed (Fig. 1). This indicates that due to 
elastase treatment besides a downward shift also a rightward shift of the force-frequency 
curve occurred. Further, fatigability of the EH-Sed was significantly higher in comparison to 
the NH-Sed diaphragm (Fig. 2).  
 
Table 2. Effects of elastase instillation and training on diaphragm properties 
 Normal hamster Emphysematous hamster 
 Control Training Control Training 
 (n = 17) (n = 15) (n = 17) (n = 14) 
     
L0 (mm) 15.5 ± 0.4 15.5 ± 0.3 12.6 ± 0.3
* 13.0 ± 0.2*  
CT (ms) 27.8 ± 0.2 28.2 ± 0.3 26.6 ± 0.3* 27.4 ± 0.3# 
½ RT (ms) 26.4 ± 0.5 26.1 ± 0.5 26.3 ± 0.7 27.1 ± 0.9 
Pt (N/cm2) 7.14 ± 0.26 7.30 ± 0.17 4.93 ± 0.28* 5.62 ± 0.24* 
Po (N/cm2) 25.92 ± 1.10 26.33 ± 0.79 22.11 ± 1.34* 25.62 ± 0.98# 
Pt/Po ratio 0.28 ± 0.01 0.28 ± 0.01 0.23 ± 0.00* 0.22 ± 0.01* 
 
Values are means ± SE; n, no. of hamsters. L0, optimal diaphragm length. CT, twitch contraction time. ½ RT, 
twitch half relaxation time. Pt, twitch tension. Po, maximal tetanic tension. * Significant difference due to 
elastase instillation (P<0.05). # Significant difference due to training (P<0.05).  
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General exercise training did not significantly change Pt in NH or EH, but 
significantly increased CT in EH. Maximal force generating capacity of the EH diaphragm 
was increased by ~15% due to training (P<0.05, Table 2). In fact, training abolished the 
detrimental effects of emphysema on Po. In addition, training did not affect the shape of the 
normalized force frequency curve in NH or EH. Training had a small but significant 
beneficial effect on fatigability of the EH diaphragm.  
 
 
 
Figure 1. Normalized force frequency characteristics in the emphysematous and normal hamster diaphragm 
(mean ± SE). NH: normal hamsters, EH: emphysematous hamsters, Sed: sedentary, Tr: trained. *Significant 
difference due to emphysema (P<0.05, repeated measurements ANOVA, Student Newman Keuls (SNK) post 
hoc testing). 
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Figure 2. Fatigability of the diaphragm (means ± SE). For clarification of abbreviations see fig. 1. *Significant 
difference between NH-Sed and EH-Sed, †significant difference between EH-Sed and all other groups (P<0.05, 
repeated measurements ANOVA, SNK post hoc testing).  
 
Tissue glutathione measurements  
 Emphysema did not affect glutathione levels in the diaphragm (Table 3). Although GSSG 
concentration in the EH-Sed was ~34% higher compared to NH-Sed, this did not reach 
statistical significance (P=0.18, ANOVA). However, GSSG/GSH ratio was significantly 
higher in the EH diaphragm compared to NH diaphragm (9.1 ± 0.8% vs. 5.9 ± 0.6% 
respectively, Fig. 3A).  
  Endurance training did not significantly affect GSH or GSSG levels in the diaphragm 
of NH or EH. Also, GSSG/GSH ratio in the diaphragm was not affected by training (7.8 ± 
0.7% vs. 10.5 ± 1.1% in NH-Tr and EH-Tr respectively).  
 Neither emphysema, nor training had significant effects on GSH or GSSG levels or 
GSSG/GSH ratio in soleus muscle or liver (Table 3, Fig 3B,C). T-Glu, GSH and GSSG levels 
were significantly higher in the diaphragm compared to soleus muscle for all groups. 
Furthermore, liver glutathione content was significantly higher compared to diaphragm and 
soleus muscle in all groups.  
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Table 3. Effects of elastase instillation and training on tissue glutathione content, expressed as 
µmol/g tissue 
 Normal hamster Emphysematous hamster 
 Control Training Control Training 
 (n = 16) (n = 14) (n = 17) (n = 14) 
     
 Diaphragm 
T-Glu (µmol/g) 1.13 ± 0.06 1.21 ± 0.08 1.11 ± 0.07 1.01 ± 0.08 
GSH (µmol/g) 1.00 ± 0.05 1.05 ± 0.07 0.95 ± 0.07 0.84 ± 0.06 
GSSG (µmol/g) 0.062 ± 0.009 0.080 ± 0.008 0.083 ± 0.006 0.091 ± 0.013 
     
 Soleus muscle 
T-Glu (µmol/g) 0.55 ± 0.06 0.60 ± 0.06 0.54 ± 0.09 0.57 ± 0.05 
GSH (µmol/g) 0.48 ± 0.05 0.51 ± 0.04 0.47 ± 0.08 0.46 ± 0.04 
GSSG (µmol/g) 0.036 ± 0.005 0.043 ± 0.008 0.031 ± 0.005 0.054 ± 0.006 
     
 Liver 
T-Glu (µmol/g) 7.44 ± 0.61 7.23 ± 0.69 6.38 ± 0.34 5.88 ± 0.51 
GSH (µmol/g) 6.93 ± 0.59 6.67 ± 0.62 5.85 ± 0.32 5.35 ± 0.50 
GSSG (µmol/g) 0.26 ± 0.02 0.28 ± 0.04 0.27 ± 0.02 0.26 ± 0.03 
 
Values represent means ± SE. n, no of hamsters. T-Glu, total glutathione. GSH, reduced glutathione. GSSG, 
oxidized glutathione. ANOVA did not show differences in absolute glutathione content due to elastase 
instillation or training.  
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Figure 3. Degree of glutathione oxidation expressed as the GSSG/GSH ratio in the diaphragm (I), soleus 
muscle (II) and liver (III). Values are means ± SE. GSSG: oxidized glutathione, GSH: reduced glutathione, other 
abbreviations see fig. 1. *Significant higher compared to NH, †Significantly higher compared to all other groups 
(P<0.05, ANOVA, SNK post hoc testing).   
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Correlation between force generation and glutathione oxidation 
To test the first hypothesis of the present study further correlations were made between 
glutathione oxidation and in vitro force generation of the diaphragm. If oxidative stress 
impairs contractility of the diaphragm, an inverse correlation should be present between 
markers for these variables. Indeed, we found a significant inverse correlation between the 
ratio of GSSG/GSH and Pt (Pearson correlation coefficient = -0.48, P<0.01, Fig. 4A). No 
correlation exits between the ratio of GSSG/GSH and Po (Pearson correlation coefficient = -
0.26, P>0.05, Fig. 4B).  
Figure 4. Correlation between twitch tension (Pt) and GSSG/GSH ratio (A) and between max. tension (Po) and 
GSSG/GSH ratio (B) in the diaphragm. A significant correlation was found between Pt and GSSG/GSH ratio 
(Pearson’s correlation = -0.48, P<0.01). No significant correlation was found between Po and GSSG/GSH ratio 
(Pearson correlation coefficient = -0.26, P>0.05).  
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Oxidative capacity of the diaphragm 
CS activity was used as marker of oxidative capacity of the diaphragm. No significant 
differences in CS activity were observed between NH-Sed and EH-Sed (1.24 ± 0.12 vs. 0.98 ± 
0.11 respectively, P>0.05)).  
 General exercise training did not affect CS activity in the NH diaphragm (1.24 ± 0.12 
vs. 1.02 ± 0.60, respectively, P>0.05). However, in the EH training increased oxidative 
capacity of the diaphragm (0.98 ± 0.11 vs. 1.35 ± 0.14 in EH-Sed and EH-Tr respectively, 
P<0.05, Student T test).  
 
Discussion 
The results of our experiments show that in hamsters the load on the respiratory muscles 
imposed by pulmonary emphysema impairs in vitro contractility of the diaphragm, which is 
accompanied by increased generation of ROS as indicated by elevated glutathione oxidation 
in the diaphragm. In fact, a significant inverse correlation exists between the ratio of 
GSSG/GSH and Pt in the diaphragm. Second, general exercise training improves maximal 
force generating capacity of the diaphragm in EH. However, contrary to our expectation, 
exercise training did not affect glutathione redox status of the diaphragm in EH.  
 
Effects of emphysema on diaphragm force generation and glutathione content 
Reduction in diaphragm muscle strip length and impairment in in vitro contractility after 
treatment with elastase has been reported previously by others and by studies from own lab 
(19;20;36), although some other groups did not find changes in in vitro contractility (11;33). 
Possible explanations for reduction in contractility due to emphysema have been discussed 
previously (20), being alterations in the contractile protein composition, changes in 
noncontractile proteins (sarcoplasmic, stromal and mitocondrial), changes in the intrinsic 
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characteristics of muscle fibers or disturbances in calcium uptake and release. Changes in 
fiber type frequency or cross sectional area (CSA) may also contribute. Data on fiber type 
composition in the EH diaphragm are conflicting. It has been shown that the relative 
contribution of type I fibers is increased in the EH diaphragm (12), whereas other studies 
reported hypertrophy of type II fibers in the EH diaphragm (20). We did not find any effect of 
emphysema on diaphragm muscle fiber frequency or CSA (36). Thus, in our animal model of 
emphysema, it is unlikely that changes in diaphragm morphology fully explain impaired in 
vitro force generation. It is likely that other factors contributed to the negative effects of 
emphysema on contractility, like oxidative stress.  
The GSSG/GSH ratio is frequently used as a marker for oxidative stress. The latter is 
defined as a disturbance between the pro oxidant and antioxidant balance, in favor of the 
former. The GSSG/GSH ratio is a good indicator of oxidative stress (5) and is considered as 
an important regulator of the function of enzymes, receptors, transporters and transcription 
factors (14). Accurate measurement of the GSH/GSSG ratio is difficult due to GSH 
autoxidation. Since GSSG is only present in minimal amounts in comparison to GSH, a small 
GSH autoxidation during sample processing can give erroneously high GSSG levels. In order 
to prevent GSH autoxidation GSH trapping agents such as N-Ethylmaleimide and 2-vinyl 
pyridine have been used. Although HPLC is assumed to be the state of the art technique for 
measurement of GSH and GSSG, it has been shown that, at least in solid tissue, an enzymatic 
assay as used in the present study is a valid alternative to the much more time consuming 
HPLC technique (13).    
In the present study the GSSG/GSH ratio in the diaphragm was significantly higher in 
EH-Sed compared to NH-Sed. This indicates that, even at rest, the EH diaphragm is in a more 
oxidized state compared to the NH diaphragm. In vitro studies using rat diaphragm showed 
that oxidants accumulate intracellular and contribute directly to the loss of contractile function 
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which occurs in muscular fatigue (27). Other studies have confirmed the association between 
increased generation of ROS and muscular fatigue (17), but the present study is the first 
investigating the oxidant status of the EH diaphragm. In other models for loading of the 
respiratory muscles, such as inspiratory resistive breathing, in vitro force generation is also 
impaired and glutathione-oxidation increased (4;34). In these latter studies the GSSG/GSH 
ratio in the rat diaphragm increased up to ~28%, whereas in the present study this ratio was 
~9% in the EH. Probably, these differences in the degree of glutathione oxidation are the 
result of differences in the duration and severity of loading. In inspiratory resistive breathing a 
strenuous load is acutely applied, resulting in ventilatory failure and apnea within ~30 min., 
whereas in the EH a less severe load is applied continuously for a prolonged period of time. 
Indeed, when inspiratory resistive breathing was discontinued prior to the development of 
apnea (7) or when the loading was applied by tracheal banding for 4 – 12 days (32) changes in 
diaphragm glutathione content were less severe (7). The association between oxidant status 
and force generation is also demonstrated by the significant correlation between the 
GSSG/GSH ratio and Pt in the diaphragm in the present study (Fig. 4A), although no such 
correlation existed for GSSG/GSH ratio and Po (Fig 4B). It has been recognized previously 
that submaximal force is more sensitive to oxidative stress than maximal force. For instance, 
prolonged exposure of mouse skeletal muscle fibers to H2O2 reduced maximal force 
generation by 23%, whereas submaximal force was reduced by 79% (3). Reduction in 
(sub)maximal force generation by oxidants could arise from  modification of different steps in 
excitation-contraction coupling process, including oxidation of hyperreactive thiols on the 
myosin head (24), modification of intracellular sulphydryl groups on Ca2+ release channels (8) 
and reduced Ca2+ sensitivity (3). The present study was not designed to identify the target for 
elevated generation of oxidants. However, since besides a downward shift, also a rightward 
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shift of the force-frequency curve occurred (Fig. 1), it is likely that oxidants have effects on 
non-contractile proteins as well.  
The liver plays a prominent role in GSH homeostasis and hepatic export of GSH is the 
major source for plasma glutathione (22). Thus theoretically, it is possible that emphysema 
altered GSH status of the liver. However, this did not occur in the present study, indicating 
that the liver could fulfill the glutathione demands of the other tissues. 
Soleus muscle glutathione content and GSSG/GSH ratio were not affected by 
emphysema. This indicates that the alterations in GSSG/GSH ratio in the diaphragm were not 
the result of a systemic inflammatory response, following elastase instillation. Although EH 
had significantly lower bodyweight compared to NH, it is unlikely that a catabolic response 
attributed to changes in glutathione status in the diaphragm, since no such changes were 
observed in the limb skeletal muscles. Thus, changes in diaphragm GSSG/GSH ratio in EH 
are most likely the direct result of the increased loading.   
 CS activity in the diaphragm tended to be lower in the EH-Sed compared to NH-Sed. 
This is in apparent contrast to other studies (12;20), in which CS activity was increased. 
However, our findings are in line with the increased fatigue rate of the EH compared to NH 
diaphragm found in the present study. The degree of hyperinflation due to elastase treatment 
was less severe in the present study compared to previously published studies (i.e. (20)). This 
may have contributed to the lack of response of CS activity in the diaphragm due to 
hyperinflation. 
 
Effects of training on diaphragm contractility and glutathione status 
The beneficial effects of exercise training on contractility of the EH diaphragm are in 
apparent contrast to previous studies by Farkas and Roussos (11). These differences in 
outcome are probably the result of differences in experimental set-up. As mentioned earlier, in 
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the study by Farkas and Roussos (11) elastase instillation did not affect contractility of the 
diaphragm at optimal fiber length, indicating the absence of respiratory muscle dysfunction in 
their hamster model. Possibly, the load on the respiratory muscles of the EH was higher in our 
study. It has been postulated that the threshold for obtaining a training effect is much higher in 
the diaphragm compared to limb skeletal muscle (16). Due to the absence of respiratory 
muscle dysfunction, it is possible that this threshold was not exceeded in the study by Farkas 
and Roussos (11) and thus no effect of training on contractility was achieved. Second, in the 
present study training started 6 months after instillation with elastase, whereas Farkas and 
Roussos started training 3 weeks after instillation (11). It has been demonstrated that changes 
in lung volume occur up to 26 weeks after instillation with elastase (31). Thus, part of the 
differences in outcome between their and our data may be explained by differences in the 
experimental set-up.  
Training reduced fatigability of the EH diaphragm, which is in accordance with 
training-induced elevation in CS activity of the EH diaphragm. In contrast, contractility of the 
NH diaphragm was not affected by endurance exercise training. This is probably due to the 
fact that the training stimulus was not strenuous enough for the NH diaphragm. This is in line 
with our expectations since the training program was designed for EH. Indeed, increasing 
running speed beyond 20 m/min was abandoned because the EH could not sustain this speed. 
In contrast to the NH, the EH appeared severely fatigued at the end of each training-session.   
Training-induced elevation in CS activity in the diaphragm of EH increases oxygen 
flux through the mitochondria which may favor generation of ROS. In spite of the effects of 
training on contractility and oxidative capacity of the EH diaphragm, training did not affect 
glutathione status of the diaphragm at rest. No other studies have been published regarding the 
effects of exercise training on glutathione status in the (EH) diaphragm. In addition, scarce 
literature is available concerning the effects of exercise training on glutathione status of limb 
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skeletal muscles. In line with our observations, training did not affect total glutathione level of 
highly oxidative rat limb skeletal muscles such as the red gastrocnemius (29) and the soleus 
muscle (18). However, the absence of a response on muscle glutathione status after training 
does not necessarily imply that antioxidant capacity was unaffected. Sen et al (29) found that 
GPX activity increased in response to training, whereas glutathione content was unaltered. 
Upregulation of antioxidant enzyme activity was reported in other studies as well. Superoxide 
dismutase (SOD) activity of the diaphragm increased after 10 weeks of endurance training in 
rats (26) and mice (23). Also, in rats GPX activity of the diaphragm was increased after 
training (23;26). Moreover, a significant correlation existed between GPX and CS activity 
(26). Thus, it is conceivable that endurance training increases enzymatic antioxidant capacity 
of skeletal muscles, including the diaphragm, without affecting glutathione status at rest. This 
suggests that after training the diaphragm is better equipped to sustain increased generation of 
oxidants, for instance induced by an acute bout of exercise. 
 
Clinical Relevance 
Pulmonary hyperinflation, which is a key feature of COPD, has detrimental effects on 
diaphragm function (10). This is of importance, since a significant correlation exists between 
respiratory muscle strength and exercise tolerance in COPD (15). Thus strategies to improve 
respiratory muscle function in COPD are of major clinical importance. The present study 
shows that pulmonary hyperinflation is associated with oxidative stress in the diaphragm and 
that a significant correlation exists between in vitro contractility and oxidant status of the 
diaphragm. Based on these findings we speculate that in patients with COPD the diaphragm is 
continuously exposed to oxidant stress. This implies that treatment with antioxidants might be 
able to improve respiratory muscle function. Indeed it has been demonstrated that 
administration of the antioxidant N-Acetylcysteine, a precursor of glutathione, to healthy 
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subjects prior to inspiratory resistive breathing attenuates the fall in transdiaphragmatic 
pressure and increases task endurance (35). However, no such studies have been performed in 
patients with COPD. Furthermore, we showed that endurance training reversed the 
detrimental effects of hyperinflation on contractility of the diaphragm, indicating that in 
patients with COPD exercise training may improve diaphragm function and thus exercise 
tolerance 
 
Summary 
In conclusion, elastase-induced pulmonary emphysema impairs in vitro contractility of the 
hamster diaphragm, which is accompanied by alterations in the redox status of the diaphragm. 
The significant inverse correlation between submaximal force generation and the ratio of 
GSSG/GSH suggests an important role of oxidative stress in impaired force generation in the 
diaphragm of EH. Endurance training did not affect glutathione status of the diaphragm, but 
reversed the detrimental effects of emphysema on maximal force generating capacity of the 
diaphragm.   
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Abstract 
In the present study we hypothesized that exhaustive exercise in patients with Chronic 
Obstructive Pulmonary Disease (COPD) results in glutathione-oxidation and lipid-
peroxidation and that xanthine oxidase (XO) contributes to free radical generation during 
exercise. COPD patients performed incremental cycle ergometry until exhaustion with (n=8) 
or without (n=8) prior treatment with allopurinol, a XO inhibitor. Reduced (GSH) and 
oxidized glutathione (GSSG) and lipid-peroxides (malondialdehyde, MDA) were measured in 
arterial blood. In non-treated COPD patients maximal exercise (Wmax ~75 Watt) resulted in a 
significant increase in the GSSG/GSH ratio (4.6 ± 0.9% at rest vs. 9.3 ± 1.7% after exercise). 
In non-treated patients MDA increased from 0.68 ± 0.08 nmol/ml at rest up to 1.32 ± 0.13 
nmol/ml 60 minutes after cessation of exercise. In contrast, in patients treated with allopurinol 
GSSG/GSH ratio did not increase in response to exercise (5.0 ± 1.2% pre exercise vs. 4.6 ± 
1.1% after exercise). Plasma lipid-peroxide formation was also inhibited by allopurinol pre 
treatment (0.72 ± 0.15 nmol/ml pre exercise vs. 0.64 ± 0.09 nmol/ml 60 minutes after 
exercise). We conclude that strenuous exercise in COPD patients results in blood glutathione-
oxidation and lipid-peroxidation. This can be inhibited by treatment with allopurinol, 
indicating that XO is an important source for free radical generation during exercise in COPD.  
 
 
Introduction 
Strenuous physical exercise results in increased generation of free radicals (FR), which is 
associated with skeletal muscle fatigue. Indeed, it has been demonstrated that heavy exercise 
in healthy subjects results in blood glutathione-oxidation (8;30), which is a marker of 
oxidative stress. Moreover, strenuous exercise is associated with lipid-peroxidation (16;33), 
which is considered a marker for FR-induced tissue damage. Reid et al (29) showed that FR 
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are involved in the development of limb skeletal muscle fatigue in healthy subjects. Exercise-
induced blood glutathione-oxidation also occurs in patients with severe chronic obstructive 
pulmonary disease (COPD) (36). 
 Healthy subjects performing a maximal incremental exercise test are limited by their 
cardio circulatory system. In patients with moderate to severe COPD, the threshold of fatigue 
during exercise is reduced. When the Forced Expiratory Volume in the first second (FEV1) is 
below ~50% of predicted value, maximal exercise is ventilatory limited. This results in an 
inability to eliminate adequately carbon dioxide (CO2). The ventilatory limitation is a result of 
the inability of the respiratory muscles to maintain a sufficient level of ventilation in order to 
assure normal alveolar ventilation. Besides ventilatory limitation, peripheral skeletal muscle 
weakness also contributes to exercise limitation in COPD (9). In very severe COPD, arterial 
hypoxemia may occur during exercise as a result of diffusion limitation at the alveolar-
capillary membrane due to loss of lung tissue.  
Generally, it is assumed that the mitochondria are an important source of FR, since 
~2% of all oxygen reduced by the mitochondria escapes the respiratory chain to yield 
superoxide anion (10). When the oxygen flux through mitochondria increases, as for example 
during exercise, it is expected that FR generation will increase. Surprisingly, the degree of 
blood glutathione-oxidation after exhaustive physical exercise is rather similar between 
healthy well-trained subjects (30) and patients with severe COPD (36), while oxygen 
consumption at maximal exercise (Vo2max) is much lower in patients with COPD compared 
to healthy subjects.  
Therefore, we investigated if other sources of FR are involved in exercise-induced FR 
generation in patients with COPD. During exhaustive physical exercise, ATP degradation 
occurs as indicated by the release of hypoxanthine from skeletal muscles (12). The ubiquitous 
enzyme xanthine oxidase (XO), which is also present in human skeletal muscles (14), can 
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generate superoxide radical in the presence of hypoxanthine and oxygen (19). In the present 
studies, we tested the following hypotheses:  
 1: Exhaustive physical exercise in patients with severe COPD results in plasma lipid-
peroxidation. Previous studies have revealed that strenuous exercise in COPD results in blood 
glutathione-oxidation (36) indicating exercise-induced oxidative stress. It is unknown if this is 
accompanied by tissue damage. In order to establish FR-induced tissue damage we measured 
plasma concentrations of lipid-peroxides, before and after an incremental cycle ergometer test 
in eight patients with COPD.  
 2: XO is an important source of exercise-induced FR generation in patients with 
severe COPD. In order to study the contribution of XO we treated patients with allopurinol, a 
clinically used inhibitor of XO, before incremental cycle-ergometry in another group of eight 
COPD patients.  
 
Methods 
Subjects 
Sixteen patients with COPD were recruited from our outpatient clinic. General characteristics 
and pulmonary function data are shown in table 1. All patients had severe pulmonary 
obstruction, with little reversibility in forced expiratory volume in the first second (FEV1) 
after ß2-agonist inhalation (<15% of predicted value). Pulmonary hyperinflation was present 
as indicated by increased total lung capacity (TLC). Furthermore, carbon monoxide diffusion 
capacity (DLCO) was severely reduced. The severity of COPD did not differ between the 
group receiving no allopurinol (n=8), and the group with pre treatment with allopurinol (n=8). 
Patients using supplemental antioxidants or suffering from exercise-limiting diseases besides 
COPD were excluded. The study was conducted according to the Declaration of Helsinki and 
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was approved by the Ethical Committee of our hospital. Informed written consent was 
obtained from all patients. 
 
Table 1. Patient characteristics and pulmonary function in control and allopurinol treated 
COPD patients 
   
 Control Allopurinol 
   
   
N 8 8 
Male 5 8 
Age (yr) 64 ± 3 63 ± 4 
FEV1 (L) 1.06 ± 0.13 1.16 ± 0.13 
FEV1 (% pred.) 36 ± 3  35 ± 4 
FEV1/VC (% pred.) 46 ± 5 48 ± 6 
TLC (% pred.) 115 ± 7 111 ± 8 
DLco (% pred.) 34 ± 7 45 ± 10 
   
 
Values represent means ± SE. FEV1, forced expiratory volume in the first second; VC, vital capacity; TLC, total 
lung capacity; DLco, diffusion capacity for carbon monoxide 
 
Procedures 
Patients were alternately (in order of entrance in the study) divided into control or allopurinol 
treated group. Patients in the treated group received two tablets of 300 mg allopurinol 
(Zyloric, Genfarma bv, The Netherlands). The first tablet was taken 24 hours before cycle 
ergometry and the second one-hour before cycle ergometry. We administered allopurinol for a 
very short period, since treatment during several days results in gradual accumulation of 
oxypurinol (24); high concentrations of oxypurinol may result in direct FR scavenging, 
Xanthine oxidase and oxidative stress in COPD 162 
independent of XO inhibition (See discussion). Patients took the second tablet 1 hour before 
ergometry, since peak plasma concentration of allopurinol occurs one hour after oral ingestion 
(24). Plasma for determination of allopurinol and its metabolite oxypurinol concentration was 
collected before ergometry to verify patient compliance. All treated patients took the tablets 
as indicated by adequate plasma concentration of allopurinol and oxypurinol ([mean] 13.0 ± 
[SE] 2.8 µmol/L and 60.0 ± 4.4 µmol/L, respectively). The physician supervising the exercise 
test (HTMF) was blinded for treatment groups. The laboratories, performing the biochemical 
measurements were blinded for treatment group and the order in which samples were 
collected.  
 A cannula was inserted into the brachial artery under local anesthesia to obtain blood, 
which was collected 1 minute before the start of cycle ergometry (‘Pre exercise’), at maximal 
exercise (‘Max exercise’) and three minutes after maximum load (Post exercise). Recovery 
samples were obtained 60 minutes after discontinuation of exercise (Recovery). 
  
Pulmonary function testing and cycle ergometry 
Spirometry and DLCO were performed before cycle ergometry. The patients cycled on an 
electrically braked cycle ergometer (Lode, Groningen, The Netherlands) at a pedaling rate of 
60 revolutions per minute, breathing room air. The work rate was increased each minute by 
10% of estimated maximal workload (Wmax) until exhaustion (4). Minute ventilation (VE), 
oxygen consumption (Vo2) and carbon dioxide production was measured every 30 seconds by 
a breath-by-breath ergospirometry unit (Vmax, Sensormedics, Bilthoven, The Netherlands). 
Electrocardiography was conducted throughout the test. After the cycle ergometry patients 
recovered for 60 minutes. During this period, patients were allowed to drink water.  
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Biochemistry 
Blood for determination of hemoglobin, hematocrit and leukocytes was collected in 
vacutainers containing ethylenediaminetetraacetic acid (EDTA) and analyzed immediately 
according to standard laboratory assays. To determine creatine kinase (CK), uric acid and 
glucose, blood was collected in dry vacutainers and analyzed immediately in serum according 
to standard laboratory assays. For the measurement of lactate and pyruvate, 2.0 ml blood was 
collected in tubes containing 2 ml perchloric acid. The tubes were immediately centrifuged 
and the clear supernatant was stored at -80°C until analysis (which in all cases was performed 
within 1 week). Measurements were routine enzymatic laboratory assays. Blood for blood gas 
was collected into heparinized syringes and immediately analyzed. 
 Reduced glutathione (GSH) was measured according to Brigelius et al (2). Shortly, 0.5 
ml blood was immediately added to 0.5 ml chilled 30% trichloric acetic acid solution 
containing 2 mM EDTA. The samples were immediately centrifuged and the clear supernatant 
was stored at -80°C until later analysis. Oxidized glutathione (GSSG) was determined 
according to Viña et al (35). 0.5 ml blood was immediately added to 0.5 ml 12% perchloric 
acid containing 40 mM N-ethylmaleimide and 0.2 M bathophenathrolinedisulphonic acid. 
Samples were immediately centrifuged and the clear supernatant was stored at -80°C for 
subsequent analysis.  
Plasma lipid-peroxides were determined by measuring malondialdehyde (MDA) 
formation according to Wong et al (37). Two ml blood was collected in EDTA vacutainers 
and immediately centrifuged and the supernatant was stored at -80°C until later analysis. 
Samples were thawed and subsequently hydrolyzed by boiling in dilute phosphoric acid. 
MDA, one of the hydrolysis products, was reacted with TBA to form MDA-TBA adduct. 
Plasma proteins were precipitated with methanol and removed from the reaction mixture by 
centrifugation. The protein free extract was fractionated by HPLC on a column of octadecyl 
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silica gel, to separate the MDA-TBA adduct from interfering chromogens. The adduct was 
eluted from the column with methanol/phosphate buffer and quantified 
spectrophotometrically at 532 nm.  
 Blood for analysis of allopurinol and its active metabolite oxypurinol was collected in 
heparinized vacutainers, immediately centrifuged and the clear supernatant was stored at -80° 
until later HPLC analysis.  
 
ATP degradation during exercise 
In view of the data collected in this study (see results) we also investigated the effects of 
exercise on ATP degradation in patients with COPD. To this end, plasma levels of xanthine 
and hypoxanthine were measured by HPLC in another group of COPD patients before and 30 
minutes after exercise. Sixteen patients with COPD performed incremental cycle ergometry 
with (n=8) or without (n=8) prior treatment with allopurinol. The experimental set-up 
(exercise testing and allopurinol administration) was similar as described in procedures. 
 
Statistical analysis  
Data were analyzed with SPSS/PC+, version 8.0. (SPSS Inc. Chicago, IL). The results were 
expressed as means ± SE. Variables within groups were compared with non-parametric 
related sample test according to Wilcoxon. To compare independent variables between groups 
(i.e. lung function) the Mann-Whitney U test was applied. Significance was set at the 0.05 
level.  
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Results 
Allopurinol effects on resting free radical generation in patients with severe COPD 
 
Glutathione-oxidation and lipid-peroxidation. Blood GSH and GSSG concentrations are 
summarized in fig. 1. Due to a technical problem the glutathione samples of one allopurinol 
treated patient were lost. Thus, the samples of 8 control COPD and 7 allopurinol treated 
COPD patients were analyzed. No significant differences were observed in blood GSH and 
GSSG status between control and allopurinol treated patients at rest. Allopurinol treatment did 
not affect the GSSG/GSH ratio at rest (4.6 ± 0.9% in control patients vs. 5.0 ± 1.2% in 
allopurinol treated COPD patients). In addition, no differences were observed in plasma MDA 
between control and allopurinol treated patients (n=8 in each group) (Fig. 2A).  
 
Allopurinol effects on exercise-induced oxidative stress in patients with severe COPD 
Glutathione-oxidation. Fig. 1 shows that incremental cycle-ergometry until Wmax decreased 
blood GSH concentration immediately after exercise in control COPD patients. In contrast, in 
allopurinol treated patients GSH was not affected by exercise. In control patients blood GSSG 
significantly increased up to ~170% of pre exercise value, immediately after maximum 
exercise. GSSG approached pre exercise concentration during the recovery period. In 
contrast, in allopurinol treated patients GSSG did not increase after incremental exercise. The 
degree of oxidative stress is frequently expressed as the GSSG/GSH ratio. Allopurinol 
treatment prevented the elevation in blood GSSG/GSH ratio that occurred immediately after 
exercise in control patients (4.6 ± 0.9% pre exercise vs. 9.3 ± 1.7% post exercise in control 
patients (P<0.05) and 5.0 ± 1.2% pre exercise vs. 4.6 ± 1.1 post exercise in allopurinol treated 
patients).  
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Figure 1. Changes in reduced (A) and oxidized (B) glutathione (GSH and GSSG, respectively) in arterial blood 
of control- and allopurinol treated COPD patients. Blood was collected at rest, 3 minutes after incremental cycle 
ergometry (post exercise) and 60 minutes after incremental cycle ergometry (recovery). In control patients, GSH 
was significantly reduced and GSSG was significantly elevated post exercise, whereas in allopurinol treated 
patients exercise did not affect blood GSH and GSSG status. Values are means ± SE.  
*P<0.05 vs. pre exercise.  
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Figure 2. Changes in malondialdehyde (MDA) concentration as indicator of free radical induced lipid-
peroxidation in control- and allopurinol treated COPD patients. Plasma was collected at rest, 3 minutes after 
incremental cycle ergometry (post exercise) and 60 minutes after incremental cycle ergometry (recovery). Fig. 
2A shows groups means ± SE. In control patients exercise significantly elevated MDA post exercise and a 
further elevation was observed at recovery. In allopurinol treated patients exercise did not affect MDA.  
*P<0.05 vs. pre exercise. Individual MDA responses are shown in B for control patients and in C for allopurinol 
treated COPD patients. 
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Lipid-peroxidation. Fig. 2 shows that exhaustive exercise in patients with severe COPD was 
accompanied by increased lipid-peroxidation in plasma. In control patients, MDA 
significantly increased immediately after exercise (0.68 ± 0.08 µmol/L  up to 1.08 ± 0.12 
µmol/L, P<0.05). Lipid-peroxides further increased until 1.32 ± 0.13 µmol/L 60 minutes after 
exercise (P < 0.05). In allopurinol treated patients, however, exercise was not accompanied by 
an elevation of plasma lipid-peroxides. The increase in MDA (Fig. 2B) and the effect of 
allopurinol treatment on inhibition of exercise-induced lipid-peroxidation (Fig 2C) were very 
consistent. 
 
Table 2: Physiological responses in control and allopurinol treated patients before and after 
incremental cycle ergometry 
   
 Control Allopurinol 
     
 Pre exercise Max exercise Pre exercise Max exercise 
     
Wmax (% pred)  55 ± 8  53 ± 10 
Heart rate (bpm) 92 ± 4 128 ± 7* 88 ± 5 130 ± 7* 
VE (L/min) 14 ± 1 37 ± 4* 16 ± 1 42 ± 6* 
Vo2 (L/min) 0.27 ± 0.0 0.96 ± 0.13* 0.34 ± 0.01† 1.09 ± 0.12* 
Vco2 (L/min) 0.25 ± 0.04 0.97 ± 0.2* 0.30 ± 0.01 1.10 ± 0.16* 
     
(A-a) Do2 4.3 ± 0.4 5.9 ± 0.5* 4.4 ± 0.6 6.2 ± 0.8* 
Lactate (mM) 0.9 ± 0.1 6.1 ± 1.5* 1.0 ± 0.1 4.7 ± 0.9* 
Pyruvate (µM) 59 ± 10 77 ± 22 59 ± 8 72 ± 8 
 
Values are means ± SE. *P<0.05 vs. pre exercise value, †P<0.05 vs. pre exercise in control patients. Wmax, 
maximal workload; VE, Minute ventilation; Vo2, oxygen consumption; Vco2, carbon dioxide production; (A-a) 
Do2, arterio-alveolar oxygen tension difference 
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Physiological responses and routine biochemical parameters during and after exercise in 
COPD patients  
Physiological responses to exercise are shown in table 2. Exercise endurance was not 
significantly different between control and allopurinol treated patients (6.0 ± 0.6 versus 5.6 ± 
0.5 minutes, respectively). Wmax was 74 ± 16 and 79 ± 17 Watt, respectively. There was no 
cardiovascular limitation since the patients did not reach their predicted maximum heart rate. 
A small but significant (p<0.05) difference in baseline VO2 was observed between control and 
allopurinol treated patients, but Vo2max did not differ significantly between these two groups. 
Table 3 shows arterial blood gases at rest and at maximum exercise in both groups of 
patients. In both groups exhaustive exercise significantly lowered pH. However, PaO2 
significantly decreased and PaCO2 significantly increased only in allopurinol treated patients 
(P<0.05). 
 
Table 3. Effects of incremental exercise on arterial blood gases before and after exercise in 
control and allopurinol treated COPD patients 
   
 Control Allopurinol 
     
 Pre exercise Max exercise Pre exercise Max exercise 
     
     
pH 7.39 ± 0.01 7.33 ± 0.02* 7.41 ± 0.01 7.32 ± 0.01* 
PaO2 (kPa) 10.2 ± 0.5 9.0 ± 0.7 10.7 ± 0.6 8.5 ± 0.7* 
PaCO2 (kPa) 5.3 ± 0.2 5.5 ± 0.3 5.1 ± 0.2 5.9 ± 0.4* 
BE (mM) 0.0 ± 0.5 -3.7 ± 1.1* 0.1 ± 0.5 -3.0 ± 0.6* 
     
 
All values are means ± SE; *P<0.05 vs. pre exercise level. PaO2, arterial oxygen tension; PaCO2, arterial carbon 
dioxide tension; BE, base excess 
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Routine hematological data before and immediately after exercise are presented in 
table 4. A small but significant increase in hematocrit and hemoglobin was observed after 
exercise in both groups. Plasma CK was not affected by either exercise or allopurinol 
treatment. Plasma glucose concentration did not change during exercise, in either group (data 
not shown).  
 
Table 4. Hematological measurements in blood before and after exercise in control and 
allopurinol treated COPD patients 
   
 Control Allopurinol 
     
 Pre exercise Post exercise Pre exercise Post exercise 
     
     
Hemoglobin (mM) 9.1 ± 0.1 9.4 ± 0.1* 9.1 ± 0.3 9.4 ± 0.3* 
Hematocrit (vol%) 0.45 ± 0.01 0.46 ± 0.01* 0.43 ± 0.01 0.45 ± 0.01* 
Leucocytes (*109/L) 8.0 ± 0.9 9.6 ± 1.2* 8.1 ± 0.4 9.9 ± 0.6* 
     
 
All values are means ± SE; *P<0.05 vs. pre exercise 
 
Effects of exercise on ATP degradation products 
In the subsequent study patient characteristics and exercise physiological data did not differ 
significantly from the patients in the study described above (data not shown). Figure 3 shows 
the plasma levels of hypoxanthine and xanthine. Elevated pre exercise level of xanthine in 
allopurinol treated patients compared to control COPD patients indicate that XO was 
effectively inhibited by allopurinol. Furthermore, in control COPD patients exercise results in 
elevated levels of hypoxanthine and xanthine, although only the latter reached statistical 
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significance (P<0.05). This indicates that ATP degradation occurred because of exercise. 
Significant elevation of hypoxanthine and xanthine was also observed in allopurinol treated 
COPD patients (P<0.05). 
 
 
 
 
 
Figure 3. Changes in plasma hypoxanthine and xanthine concentration in control COPD and allopurinol treated 
COPD patients. Pre exercise xanthine was significantly higher in allopurinol treated patients compared to control 
patients. Values are means ± SE. *P<0.05 vs. pre exercise, † P<0.05 vs. control 30 min post exercise, ‡ P<0.05 vs. 
control pre exercise.    
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Discussion 
These experiments demonstrate that exhaustive physical exercise in patients with severe 
COPD results in FR mediated tissue damage, as indicated by plasma lipid-peroxidation. 
Moreover, this study is the first to show that exercise-induced oxidative stress can be 
prevented by XO inhibition. Treatment with 300 mg allopurinol twice before incremental 
cycle-ergometry prevented both blood glutathione-oxidation and plasma lipid-peroxidation. 
These findings indicate that patients with severe COPD performing strenuous exercise are 
exposed to oxidative stress resulting in tissue damage, which can be inhibited by blocking 
XO. Finally, this paper reports data showing that ATP degradation occurs in patients with 
COPD performing strenuous exercise. 
 
Oxidative stress during exercise.  
GSH is a ubiquitous endogenous antioxidant. FR can be reduced by GSH, mainly through the 
conversion of GSH into GSSG by the selenium containing enzyme glutathione-peroxidase 
(21). When GSSG accumulates intracellular, cells will export GSSG (32). Therefore blood 
reflects the glutathione status of less accessible tissues such as skeletal muscle (26), and 
increased levels of GSSG or increased GSSG/GSH ratio in blood can be considered as signs 
of oxidative stress (15). It has been demonstrated in rats that glutathione-oxidation occurs in 
contracting skeletal muscles (34). Therefore, exercise-induced elevation in blood GSSG may 
be, at least partially a result of export of GSSG from contracting skeletal muscles.  
Blood GSH and GSSG concentrations at rest in the present study are in agreement 
with observations in healthy subjects (30) and previous studies in patients with COPD (36). 
Also, GSSG and GSSG/GSH ratio immediately after exercise in our study resembles data 
from previous studies in healthy subjects and patients with COPD (30;36). In the present 
study, a small but significant GSH depletion occurred immediately after discontinuation of 
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exercise in control COPD patients. GSH depletion after exercise might be due to inhibition of 
GSH synthesis, for instance because of adrenergic stimulation (7). Significant blood GSH 
depletion after exercise has been reported previously in healthy subjects (30), although in this 
latter study the depletion was more severe and persisted up to 60 minutes after discontinuation 
of exercise. As mentioned before, exercise-induced oxidative stress decreases skeletal muscle 
glutathione concentration in animals (31). Under these circumstances, the liver releases GSH 
into the blood to provide contracting muscles with GSH (31). From our study it appears that 
the liver in patients with COPD can fulfill glutathione demands of peripheral tissues more 
adequately than in healthy subjects, since the degree of blood GSH depletion after exercise 
was less severe compared to healthy subjects. This may be due to the duration of oxidative 
stress. In the study by Sastre et al (30) using healthy subjects exercise duration was 12 
minutes, while in our study exercise lasted only 6.4 ± 0.6 minutes. Furthermore, limb skeletal 
muscle mass of patients with COPD is reduced compared to healthy subjects (1). Therefore, it 
may be argued that the GSH demand during exercise was lower in comparison to healthy 
subjects. 
We used plasma lipid-peroxidation as a marker for FR-induced tissue damage. Free 
radicals can initiate lipid-peroxidation resulting in free radical chain reactions (11). Therefore, 
lipid-peroxidation is frequently used as a marker of FR-induced tissue damage, although 
results should be interpreted with caution, since it is technically complicated to determine 
lipid-peroxidation reliably (11). We used a specific, sensitive and reproducible HPLC method, 
which allows a good separation between the MDA-TBA adduct and interfering substances 
(37). Furthermore, the effects of exercise on MDA were very consistent in control patients 
(Fig. 2B). Exercise-induced lipid-peroxidation in plasma of healthy subjects has been 
demonstrated in several studies (16;33). In addition, expired pentane, which is another marker 
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of lipid-peroxidation, was reported to be increased after cycle-ergometry in healthy subjects 
(5).  
 
XO inhibition and exercise-induced oxidative stress 
Exercise-induced oxidative stress was prevented by treatment with allopurinol. In our study, 
both exercise-induced glutathione-oxidation and elevation of lipid-peroxides were prevented 
by allopurinol treatment. This strongly suggests that XO is involved in exercise-induced 
generation of FR. XO generates FR in the presence of oxygen and hypoxanthine or xanthine, 
which are ATP degradation products (18). The role of XO in ischemia-reperfusion injury is 
well recognized (18). For instance, treating isolated rat hearts with allopurinol prior to 20 
minutes of ischemia and subsequent 40 minutes of reperfusion inhibited generation of H2O2 
by the myocardium and attenuated loss in ventricular function (3). Similar results were 
obtained in limb skeletal muscle (20).  
Elevated generation of FR by XO during exercise may be attributed to increased XO 
activity. Indeed, it has been shown that immunoreactivity of XO in skeletal muscles is 
increased after eccentric exercise (14). In this latter study, XO was mainly present in skeletal 
muscle endothelium. This is in line with the observation that allopurinol treatment in mice 
attenuated exercise-induced skeletal muscle damage, especially in the endothelial cells (6). 
However, it is unlikely that increased XO expression could account for the elevated 
generation of FR during exercise, since elevated enzyme expression is unlikely to occur 
within the time span of the present study. Interestingly, it has been proposed that generation of 
FR by XO is not enzyme- but rather substrate-limited (38). This implies that when ATP 
degradation products accumulate, XO may generate FR. This fits well with data from the 
present study demonstrating elevation of ATP degradation products after exercise; this was 
accompanied elevation of markers of FR, which was inhibited by allopurinol treatment. 
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Release of xanthine and hypoxanthine from skeletal muscles after exercise has been shown 
previously in healthy subjects (12;17). Moreover, uric acid release from active skeletal 
muscles has been shown, indicating XO activity (13).  
XO activity has been demonstrated in human tissues such as liver, small intestine heart 
and skeletal muscle (14;25). Using in vivo models, it is impossible to identify the source of 
XO for increased FR generation. However, we speculate that XO in skeletal muscles may 
play an important role, since ATP degradation products are elevated in skeletal muscles after 
exercise, providing substrate for XO to generate FR. Furthermore, allopurinol administration 
to mice attenuated exercise-induced morphological skeletal muscle damage (6). 
Our data on the effects of allopurinol on exercise-induced oxidative stress are in line 
with data in horses (22), showing that allopurinol treatment prevented exercise-induced blood 
glutathione-oxidation and lipid-peroxidation. Viña et al (36) found that oxygen 
supplementation attenuates exercise-induced oxidative stress in patients with COPD. This fits 
well with our reasoning of XO as a source for FR generation during exercise, since oxygen 
supplementation is likely to reduce metabolic stress to tissues and therefore may reduce ATP 
degradation.  
 
Allopurinol pharmacology 
Allopurinol (1 H-pyrazolo (3,4-d) pyrimidin-4-ol) is an oxypurine base (MW 136.11) and is 
clinically used for treatment of hyperuricaemia. The major pharmacological actions of 
allopurinol are mediated by its major metabolite oxypurinol. Both are structural analogues of 
the purine bases hypoxanthine and xanthine and competitively bind to XO. Thereby they 
inhibit the XO mediated conversion of hypoxanthine to xanthine and xanthine to uric acid and 
thus generation of FR. Controversy exists regarding the role of allopurinol as a direct 
hydroxyl radical scavenger. Moorhouse et al (23) reported that allopurinol and oxypurinol 
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have direct hydroxyl scavenging properties in vitro. However, in this latter study the 
concentration of both allopurinol and oxypurinol were above 250 µM. Alternatively, 
experiments by Zimmerman et al (39) revealed that allopurinol and oxypurinol at 
concentration of 12.0 µM and 12.9 µM respectively, do not enhance FR scavenging properties 
of plasma. In our study plasma concentration of allopurinol was similar to the study by 
Zimmerman et al, although oxypurinol was somewhat higher. Therefore, it is conceivable that 
the effects of allopurinol treatment in our study are the result of XO inhibition and not the 
result of its direct antioxidant properties considering the low plasma concentrations in our 
patients. However, XO was blocked sufficiently as indicated by higher pre exercise levels of 
xanthine in allopurinol treated patients compared to untreated patients (Fig. 3).  
 After oral administration, allopurinol is well absorpted from the gastrointestinal tract. 
Peak plasma concentration of allopurinol and oxypurinol are reached after ~1 and ~3 hours 
respectively (24). Half-life time after oral administration of allopurinol and oxypurinol are > 1 
hour and ~20 hours, respectively. Allopurinol is usually well tolerated by patients. The most 
common side effects are hypersensitivity reactions. However, none of our patients reported 
any side effects.  
 
Clinical relevance 
Overproduction of FR is associated with skeletal muscle fatigue. In vitro studies by Reid et al 
(28) demonstrated that contracting rat diaphragm generates superoxide anion radical. 
Moreover, an inverse relationship exists between superoxide release and contractile function 
during a fatigue protocol (28). In healthy subjects infusion with high dose N-acetylcysteine 
attenuated limb skeletal muscle fatigue (29). This and many other studies suggest that 
oxidative stress is associated with limb and respiratory skeletal muscle fatigue. However, 
these studies do not identify the source of FR. This may be important to effectively inhibit FR 
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generation. An additional concern in studies using healthy subjects is how these findings can 
be extrapolated to patients with ventilatory exercise limitation. Unlike healthy subjects, 
patients with severe COPD become fatigued at low external workload, for instance during 
daily life activities, which therefore may result in frequent exposure to oxidative stress. In 
these patients, an association exists between exercise capacity and limb- and respiratory 
skeletal muscle force (9). Therefore, effective inhibitors of FR generation might be of clinical 
relevance to patients with exercise limiting diseases such as COPD. There are no reasons to 
argue that the effects of allopurinol found in the present study are specific to patients with 
COPD. The key issue is that the degree of exercise is severe enough to induce ATP 
degradation in order to provide substrates for XO. Since this occurs at low external workload 
in patients with severe COPD, these patients will be exposed to oxidative stress more 
frequently compared to healthy subjects.  
In both groups of COPD patients arterial PO2 decreased during exercise while PCO2 
increased. This phenomenon is an indication of a ventilatory limitation and frequently occurs 
in patients with a degree of airflow limitation as in our patients. We did not empower the 
study to detect physiological or functional differences between the two groups (See 
perspectives). 
In conclusion, this study demonstrates that strenuous exercise in patients with COPD 
results in exercise-induced oxidative stress, which is accompanied by tissue damage. Besides, 
this study is the first to demonstrate that XO contributes to FR generation during exercise in 
humans, in this case in patients with COPD.  
 
Perspectives 
Our observation that allopurinol inhibits exercise-induced oxidative stress may have 
important implications. Identifying the source for elevated generation of FR during exercise in 
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humans may stimulate research into the effects of application of specific inhibitors for FR 
generation. Using these specific inhibitors it is possible to attenuate the damaging effects of 
FR, while the physiological functions for instance in microbiological defense, remain 
unaffected. In our opinion, future research should focus on the development of agents 
affecting specific pathways resulting in FR formation.  
An interesting question arising from the present study is if allopurinol treatment 
affects physical performance. Basically, this question should be divided into two separate 
questions. Firstly, does short-term allopurinol administration alter physical exercise 
performance? Our data indicate that allopurinol prevents accumulation of GSSG. In vitro 
studies revealed that intracellular accumulation of oxidants directly contribute to the loss of 
contractile function during fatigue (27). Thus, it is possible that allopurinol reduces fatigue 
rate in skeletal muscles. This may be relevant to patients with COPD and to healthy athletes 
performing competitive exercise. Secondly, does long-term allopurinol administration alter 
physical exercise performance? Peripheral and limb skeletal muscle dysfunction frequently 
occurs in COPD and is associated with impaired exercise tolerance (9). Our data demonstrate 
that strenuous exercise results in lipid-peroxidation, possibly originating from contracting 
skeletal muscles. Since daily life activities can be exhaustive for these patients, it is 
conceivable that they are exposed to lipid-peroxidation frequently. This may contribute to 
skeletal muscle dysfunction. Therefore, long-term allopurinol administration may partly 
prevent such dysfunction. Controlled studies are needed to establish the effect allopurinol 
administration on exercise performance.  
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Abstract 
Mechanisms for elevated generation of free radicals during exercise are poorly understood. In 
the present study, we hypothesized that markers for tissue metabolic stress (hypoxanthine, 
lactate, pH) are related to the degree of exercise-induced free radical generation, estimated by 
blood oxidized glutathione (GSSG) levels. Nineteen patients with chronic obstructive 
pulmonary disease (COPD; FEV1 36 ± 4%) performed incremental cycle ergometry until 
exhaustion (Wmax). GSSG, lipid-peroxides [malondialdehyde (MDA)], hypoxanthine, lactic 
acid and pH were measured at rest and after Wmax (73 ± 8 W). Exercise significantly 
increased GSSG up to 143 % of resting value, and MDA up to 114 % of resting value. After 
exercise, a significant correlation was found between blood GSSG and markers for tissue 
metabolic stress (hypoxanthine: r = 0.57, p < 0.01, lactic acid: r = 0.68, p < 0.01, and pH: r = - 
0.52, p < 0.05). No significant correlation was found between GSSG at Wmax and maximal 
oxygen consumption rate (r = 0.41, p > 0.05). Plasma MDA at Wmax was not significantly 
correlated with these markers for metabolic stress (p > 0.05), neither with maximal oxygen 
consumption rate (p > 0.05). In conclusion, the degree of exercise-induced free radical 
generation in COPD is correlated with markers for tissue metabolic stress, but not with 
oxygen consumption rate.  
 
Introduction 
In healthy well-trained subjects and patients with severe chronic obstructive pulmonary 
disease (COPD), strenuous exercise is associated with elevated generation of free radicals as 
indicated by an increase in glutathione oxidation in blood (21,32,40) and skeletal muscle (7). 
Furthermore, exhaustive exercise is associated with increased levels of plasma lipid-peroxides 
(21,22), indicating free radical-induced tissue damage.  
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The mitochondrial respiratory chain has been considered as a prominent source for 
free radicals, since ~2% of all O2 reduced by the mitochondria escapes the respiratory chain to 
yield superoxide anion (14). It was assumed that when O2 flux through the mitochondria 
increases, as occurs during exercise, generation of free radicals would increase. As discussed 
recently (20), however, the degree of blood glutathione oxidation at maximal exercise is 
similar between healthy well-trained subjects and patients with severe COPD, albeit a lower 
oxygen consumption rate (VO2) in COPD, suggesting a lack of correlation between 
glutathione oxidation and Vo2 at maximal exercise.  
Recent data indicate that elevated free radical generation during exercise may be due, 
at least in part, to increased xanthine oxidase activity (21,38). ATP degradation products, such 
as hypoxanthine or xanthine, are requisite substrates for xanthine oxidase. Thus, it is expected 
that a correlation exists between exercise-induced free radical generation and the degree of 
metabolic stress in tissues, for instance reflected by levels of ATP degradation products. 
Understanding pathways for generation of free radicals is of potential clinical importance, 
since overproduction of free radicals is associated with skeletal muscle dysfunction (31), 
which is recognized as a major problem and determinant of exercise intolerance in COPD (3).  
In the present study, we investigated how biochemical and physiological variables of 
exercise are related to free radical generation during exercise in patients with severe COPD. 
Based on previous findings (21,38) we hypothesized that the degree of metabolic stress is the 
most important predictor of exercise-induced free radical generation in these patients. The 
following specific hypotheses were tested:   
1) The degree of exercise-induced free radical generation correlates with markers for 
tissue metabolic stress. In general, the metabolic stress of physical activity can be gauged by 
fluxes generated within the exercising muscles in reactions involving metabolic or mechanical 
pathways (8). Accumulation of metabolites can be used to quantify metabolic stress (8). 
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Therefore, plasma hypoxanthine, blood lactate and pH were measured at rest and after 
exercise. Reduced (GSH) and oxidized glutathione (GSSG) were measured before and after 
exercise to assess exercise-induced free radical generation. Plasma lipid-peroxides, expressed 
as malondialdehyde (MDA), were measured to assess free radical mediated tissue damage.  
2) The degree of exercise-induced oxidative stress is neither correlated with absolute 
maximal workload (Wmax), nor with VO2max, or with severity of COPD. To this end, all 
patients had routine lung function testing before exercise. VO2 and VCO2 were continuously 
measured before and during exercise. The correlations between these physiological 
parameters and the degree of glutathione oxidation and lipid-peroxidation at Wmax were 
calculated.  
 
Methods 
Subjects 
Nineteen patients with COPD according to ATS criteria (2) were recruited from our outpatient 
clinic. Patient characteristics and pulmonary function data are shown in table 1. Pulmonary 
hyperinflation was present as indicated by increased total lung capacity and residual volume. 
Furthermore, carbon monoxide diffusion capacity was severely reduced. Patients using 
supplemental antioxidants or suffering from exercise-limiting diseases besides COPD were 
excluded. None of the patients included were using long-term oxygen therapy. The study was 
conducted according to the Declaration of Helsinki and was approved by the Ethical 
Committee of our hospital. Informed written consent was obtained from all patients. 
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Table 1. Patient characteristics 
 COPD patients 
N 19 
Male 14 
Age, yr 58 ± 2 
Body mass index, kg/m2 23.9 ± 1.1 
FEV1, L 1.13 ± 0.14 
FEV1, % pred 36 ± 4 
FEV1/VC, % pred 40 ± 2 
TLC, % pred 111 ± 3 
RV, % pred 160 ± 8 
Dlco, % pred 47 ± 4 
PI max, % pred 89 ± 8 
PE max, % pred 71 ± 5 
 
All values are means ± SE. Dlco = lung diffusion capacity to carbon monoxide; PI max = maximal inspiratory 
pressure; PE max = maximal expiratory pressure.  
 
Pulmonary function, respiratory muscle function and cycle ergometry 
Spirometry, carbon monoxide diffusion capacity and respiratory muscle function testing were 
performed before cycle ergometry. Maximal sniff inspiratory and expiratory esophageal 
pressure (PI max and PE max, respectively) was measured with a balloon catheter, which was 
connected to a pressure transducer (Validyne, DP103-32, Northridge, CA). Maximal sniff 
maneuvers from residual volume were performed in sitting position until the highest pressure 
was achieved. Subsequently, a cannula was inserted into the brachial artery under local 
anesthesia to obtain blood, which was collected 1 min prior to exercise (‘rest’), at Wmax 
(‘maximum exercise’) and 15 min after discontinuation of exercise (‘recovery’).   
The patients cycled on an electrically braked cycle ergometer (Lode, Groningen, The 
Netherlands) a pedaling rate of 60-rpm breathing room air. The work rate was increased each 
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minute by 10% of estimated Wmax until exhaustion (9,11). Minute ventilation, O2 
consumption, and CO2 production was averaged every 30 s by a breath-by-breath 
ergospirometry unit (Vmax, Sensormedics, Bilthoven, The Netherlands). Electrocardiography 
was conducted throughout the test.  
 
Biochemistry 
Blood for determination of hemoglobin, hematocrit and leukocytes was collected in 
vacutainers containing ethylenediaminetetraacetic acid and analyzed immediately according 
to standard laboratory assays. For the measurement of lactate and pyruvate, 2.0 ml blood was 
collected in tubes containing 2 ml perchloric acid. The tubes were immediately centrifuged 
and the clear supernatant was stored at -80°C until analysis (within 1 week). Measurements 
were performed according to Maughan (24). Blood for blood gas was collected into 
heparinized syringes and immediately analyzed. 
 Reduced glutathione (GSH) was measured according (39). Shortly, 0.5 ml blood was 
immediately added to 0.5 ml chilled 30% trichloric acetic acid solution containing 2 mM 
ethylenediaminetetraacetic acid. The samples were immediately centrifuged and the clear 
supernatant was stored at -80°C until later analysis. Oxidized glutathione (GSSG) was 
determined according to Viña et al (39), and as described previously (21).  
Plasma lipid-peroxides were determined by measuring malondialdehyde (MDA) 
formation according to Wong et al (41) and as described previously (21). Blood for analysis 
of purines was collected at rest and 15 min after discontinuation of exercise, since previous 
studies have shown that at this time point, peak plasma hypoxanthine concentration occurs 
(23). Blood was collected in heparinized vacutainers, immediately centrifuged and the clear 
supernatant was stored at -80° until later HPLC analysis.  
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Data analysis 
Paired T test was used to compare pre- and post exercise values (i.e. glutathione, PO2, VO2). 
The bivariate Pearson correlation coefficient was calculated to test for significant correlations 
between markers for free radical generation (glutathione and MDA) and physiological and 
biochemical data. All tests were performed using the SPSS/PC+, version 10.0.5 (SPSS, 
Chicago, IL). Results were considered significant at P < 0.05. All data are expressed as means 
± SE.  
 
Results 
Exercise tolerance was severely reduced in patients with severe COPD. Wmax was 51 ± 5% 
of predicted value. As shown in table 2, at Wmax patients were ventilatory limited, as 
indicated by high maximal ventilation (40 times FEV1) and the increase in PaCO2 at Wmax. 
Despite of these changes in blood gases, the maximal exercise level was sufficient to raise 
lactic acid from 1.0 ± 0.1 mM at rest to 6.3 ± 0.1 at Wmax (P<0.05).  
 Despite the low Wmax, exercise resulted in purine degradation as indicated by a 
significantly elevated plasma concentration of hypoxanthine 15 min after discontinuation of 
exercise (Table 3). 
Incremental cycle ergometry in patients with severe COPD increased generation of 
free radicals, as indicated by significant glutathione oxidation in blood (Figure 1A, B) and 
elevated lipid-peroxides in plasma (Figure 1C). GSSG concentration increased up to 143% of 
the resting value. Plasma lipid-peroxides (expressed as MDA), and increased up to 114% of 
resting value.  
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Table 2: exercise study parameters in patients with severe COPD 
 Pre exercise Maximum exercise 
Wmax, W  73 ± 8 
Heart rate, beats/min 93 ± 4 137 ± 5* 
MVV, L/min  45 ± 6 
VE, L/min 14 ± 1 41 ± 4* 
VE / MVV, % 35 ± 3 95 ± 4 
Vo2, L/min 0.28 ± 0.02 1.03 ± 0.09* 
Vco2, L/min 0.23 ± 0.01 0.99 ± 0.09* 
(A-a)Do2 4.8 ± 0.3 6.4 ± 0.3* 
Lactate, mM 1.0 ± 0.1 6.3 ± 0.1* 
Pyruvate, µM 75 ± 7 124 ± 11* 
PH 7.42 ± 0.01 7.35 ± 0.01* 
PaO2, kPa 10.3 ± 0.3 8.6 ± 0.3* 
PaCO2, kPa 4.7 ± 0.2 5.6 ± 0.1* 
Hemoglobin, mM 9.1 ± 0.1 9.6 ± 0.1* 
Hematocrit, vol% 0.43± 0.01 0.46 ± 0.01* 
Leucocytes, *109/l 8.5 ± 0.4 10.3 ± 0.5* 
 
Values are means ± SE. MVV = maximal voluntary ventilation; VE = minute ventilation; Vo2 = oxygen 
consumption rate; Vco2 = carbon dioxide production rate; (A-a)Do2 = alveolar – arterial oxygen tension 
difference. * P < 0.05 compared to pre exercise. 
 
 Linear regression analysis showed a good correlation between GSSG at Wmax and 
markers for metabolic stress, such as hypoxanthine at Wmax + 15 min (r = 0.57, p < 0.01), 
lactic acid (r = 0.68, p < 0.005) and pH at Wmax (r = -0.52, p < 0.05; Figure 2). In contrast, 
no significant correlations were found between MDA at Wmax and hypoxanthine at Wmax + 
15 (r = 0.32, P = 0.18), lactic acid (r = 0.29, P = 0.24) and pH at Wmax (r = -0.32, P = 0.18). 
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Table 3. Exercise-induced changes in plasma purine metabolites in COPD 
 Pre exercise Wmax + 15 min 
   
Inosine, µM 1.76 ± 0.28 1.57 ± 0.24 
Hypoxanthine, µM 2.71 ± 0.33 8.26 ± 1.68* 
Xanthine, µM 3.63 ± 0.38 3.68 ± 0.37 
 
Values represent means ± SE. *P < 0.05 compared to pre exercise 
 
 
No significant correlations between GSSG at Wmax and Vo2max were observed (Figure 
3A) or arterial O2 saturation at Wmax (r = 0.30, P > 0.05). Neither did the severity of COPD, 
determined by lung function, significantly correlate with GSSG at Wmax (Figure 3B). In 
addition, no significant correlations were found between GSSG at Wmax and carbon 
monoxide diffusion capacity (r = -0.03, P > 0.05) nor between GSSG at Wmax and total lung 
capacity (r = -0.01, P > 0.05). A significant correlation was found between GSSG at Wmax 
and Wmax (Figure 3C). No significant correlation was found between GSSG or MDA at 
Wmax and leukocyte count at Wmax (r = 0.35 and r = 0.32 respectively). Furthermore, MDA 
at Wmax was not significantly correlated with either Vo2max (r = 0.24, P = 0.33), Wmax (r = 
0.24, p = 0.33) and FEV1 (r = 0.32, P = 0.18).  
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Figure 1. Exercise-induced changes in reduced (GSH, A), oxidized glutathione (GSSG, B) in arterial blood and 
plasma lipid-peroxides [malondialdehyde] (MDA, C) in patients with severe chronic obstructive pulmonary 
disease. Blood was collected at rest and immediately after maximal exercise (Wmax). Exercise was associated 
with significantly elevated GSSG and MDA concentrations. * P < 0.01 vs. pre exercise.  
Free radicals and metabolic stress in COPD 191 
 
 
 
 
 
 
 
 
 
 
Figure 2. Linear regression analysis shows significant correlation between oxidized glutathione (GSSG) in 
arterial blood at maximal exercise (Wmax) and markers for metabolic stress. A, hypoxanthine at Wmax + 15 
minutes (r = 0.57, p < 0.01); B, lactic acid at Wmax (r = 0.68, p < 0.005); and C, pH at Wmax (r = - 0.52, p < 
0.05).  
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Figure 3. Linear regression analysis between oxidized glutathione (GSSG) at Wmax versus A, maximal 
oxygen consumption rate (Vo2max, r = 0.41, p = 0.10); B, forced expiratory volume in first second (FEV1, r = 
0.28, p > 0.05) and C, Wmax (r = 0.51, p < 0.05). 
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Discussion 
Previous studies from our laboratory have shown that strenuous exercise in patients with 
COPD is associated with elevated blood glutathione oxidation and plasma lipid-peroxidation 
(21). The present study shows that elevated blood GSSG concentration after exercise, in these 
patients is significantly correlated with biochemical markers for tissue metabolic stress, 
including hypoxanthine, lactic acid and acidosis. In addition, this study shows that exercise-
induced elevation in blood GSSG concentration is not correlated with Vo2max, or with severity 
of COPD. Contrary to our expectations, a significant correlation was found between blood 
glutathione oxidation and maximal workload.  
 In contrast to GSSG, MDA concentration at Wmax, a marker for free radical mediated 
tissue damage, does not correlate with the degree of tissue metabolic stress in patients with 
severe COPD.  
 
O2 consumption and free radical generation during exercise 
Elevated O2 consumption has been assumed to play a prominent role in the generation of free 
radicals during exercise. Studies by Chance et al (6) showed that ~2% of O2 consumed in 
mitochondria in state 3, the resting state, was not reduced to H2O, but yielded reactive oxygen 
species. Consequently, mitochondrial respiration was proposed as a source for free radicals 
during exercise (1,13,22,33,35), since with exercise O2 flux through the mitochondria is 
increased. However, as discussed recently (38), it has been shown that the amount of free 
radical generation of mitochondria in state 3, that is, when they are actively using O2, is 
negligible. Therefore, we expressed our doubts about the assumption that mitochondria are a 
prominent source for generation of free radicals during exercise. This is supported by the 
observation that the degree of exercise-induced glutathione oxidation of the blood is similar 
between healthy well-trained subjects and patients with severe COPD (20), although Vo2max is 
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significantly lower in the latter group. The lack of correlation between GSSG and Vo2 found 
in the present study (Figure 3A) supports our skepticism, and is in line with previous studies 
in patients with COPD, showing that O2 supplementation (Fio2 0.24 – 0.26) during exercise, 
which increases Vo2max, actually attenuates exercise-induced blood glutathione oxidation (40). 
The lack of correlation between GSSG at Wmax and arterial O2 saturation at Wmax does not 
necessarily conflict with this hypothesis. Oxygen availability in peripheral muscle does not 
only depend on arterial O2 saturation, but on hemoglobin concentration, muscle blood flow 
and too much lesser extend to arterial Po2 as well (3). In addition, studies in rats have shown 
that O2 supplementation (Fio2 = 1.0) during inspiratory resistive breathing does not increase 
GSSG concentration of the diaphragm at the end of loading (37). Together, these data support 
our hypothesis other pathways besides increased O2 consumption, play a prominent role in 
exercise-induced free radical generation. 
  
Metabolic stress and free radical generation during exercise 
GSH is a ubiquitous antioxidant that is regulated by complex intracellular pathways (28). 
When generation of free radicals is enhanced, intracellular GSSG increases. It has been shown 
that muscle cells export GSSG when subjected to oxidative stress (34). Studies in rats have 
shown that glutathione oxidation occurs in contracting skeletal muscles (36). Thus, increased 
levels of GSSG in blood after exercise originate, at least partly, from contracting skeletal 
muscles.  
 Plasma lipid-peroxides were used as a marker for free radical induced tissue damage. 
Lipid-peroxidation can be initiated by any free radical that has sufficient reactivity to abstract 
a hydrogen atom from a fatty acid (15). Elevated content of lipid-peroxides in membranes 
alters membrane function and may eventually result in cell death. Although lipid-peroxides 
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are frequently used as markers for free radical-induced tissue damage, these data should be 
interpreted with caution. We have addressed this problem in a previous paper (21). 
In the present study, three different, but related markers for metabolic stress were 
measured (i.e. hypoxanthine, lactic acid and pH). It should be noted that in our patients, 
exercise-induced reduction in arterial pH is the result of combined respiratory and metabolic 
acidosis. Thus, pH should be used with caution as a marker for metabolic stress. However, all 
these three markers for metabolic stress (hypoxanthine, lactic acid and pH) significantly 
correlated with blood GSSG at Wmax (Figure 2). Therefore, our data support the hypothesis 
that the more severe the metabolic stress, the higher the concentration of free radicals 
generated during exercise in these patients. This is in line with previous studies in healthy 
subjects, showing that exhaustive exercise results in blood glutathione oxidation (32,35) and 
lipid-peroxidation (22,25), but when exercise is not exhaustive, blood glutathione oxidation 
and lipid-peroxidation do not occur or do so to a lesser extend (5,25,26). This correlation 
between the degree of metabolic stress and GSSG concentration at Wmax can be explained in 
at least two ways.  
On one hand, systemic factors associated with or resulting from metabolic stress, such 
as acidosis, hypoxemia and hypercapnia could impair the antioxidant screen, for instance by 
modulating (re)synthesis or transport of GSH. Indeed, α-adrenergic stimulation has been 
shown to inhibit glutathione metabolism in hepatocytes (10), the primary side for GSH 
synthesis. However, in our patients exercise was not associated with reduced blood GSH 
levels at maximal exercise, indicating that the liver could meet the GSH demands of 
peripheral tissues. In addition, inspiratory resistive breathing in rats resulted in elevated 
glutathione oxidation in contracting skeletal muscles, but not in resting skeletal muscles, 
despite severe arterial hypoxemia and hypercapnia (36). This indicates that systemic effects 
are not a major modulator of glutathione metabolism during exercise. Gibson et al (12) have 
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shown that in rat small intestine 60 min of ischemia decreases GSH content, without affecting 
GSSG in the small intestine or plasma, suggesting that ischemia may inhibit GSH synthesis, 
but does not affect GSSG concentration. Together, it is unlikely that alterations in glutathione 
synthesis or transport explain the elevation in blood GSSG concentration after exercise in the 
present study. Therefore, a more likely explanation is that metabolic stress enhances the 
generation of free radicals.  
A significant correlation was found between Wmax and blood GSSG concentration at 
Wmax (Figure 3C). This partially refutes our second hypothesis since we expected that as 
long as exercise was exhaustive, generation of free radicals would occur, irrespective of the 
absolute Wmax. To understand this unexpected finding we calculated the correlation between 
plasma hypoxanthine after exercise and absolute Wmax. This revealed a significant 
correlation (r = 0.88, P < 0.000), and might explain this unexpected finding.  
 In contrast to GSSG, plasma lipid-peroxide concentration at Wmax did not 
significantly correlate with markers for metabolic stress. This may be due to fact that only one 
oxygen centered free radical can result in the conversion of hundreds of fatty acid side chains 
into lipid hydroperoxides (15). The length of propagation depends on many factors, including 
the lipid-protein ratio in a membrane, the fatty acid composition, the O2 concentration and the 
presence within the membrane of chain breaking antioxidants, such as vitamin E (15). In 
addition, the time point for withdrawing plasma for the measurement of lipid-peroxides may 
not be adequate. It has been shown that plasma lipid-peroxides have been shown to increase 
up to 60 min after exercise (21).  
 
Pathway for generation of free radicals during exercise 
Xanthine oxidase has been proposed as a possible source for generation of free radicals 
(27,38). Little is known about the role for xanthine oxidase in the generation of free radicals 
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during exercise in humans, although activity has been demonstrated in various human tissues, 
including liver, small intestine, heart and skeletal muscle (17,29). Recent data have shown 
that strenuous exercise increases xanthine oxidase activity in rat plasma (38). The expression 
of xanthine oxidase in skeletal muscle of COPD patients has not been investigated. 
Hypoxanthine is a requisite substrate for xanthine oxidase. Generation of free radicals by 
xanthine oxidase is triggered and controlled by substrate availability (42). The present study 
shows that strenuous exercise in severe COPD results in over 300% increase in plasma 
hypoxanthine concentration. To the best of our knowledge, no other groups have studied 
purine degradation during exercise in COPD. The significant correlation between plasma 
hypoxanthine concentration and blood GSSG concentration after maximal exercise (Figure 
2A), is in line with our previous study, showing that blocking xanthine oxidase, inhibits 
exercise-induced blood glutathione oxidation and plasma lipid-peroxidation in severe COPD 
(21) and in healthy subjects (38). Exercise-induced elevation in hypoxanthine provides the 
requisite substrates for xanthine oxidase to generate superoxide. Thus, during exercise the 
accumulation of hypoxanthine might favor generation of free radicals by xanthine oxidase. 
This reasoning is supported by the observations that in severe COPD, O2 administration 
during exercise has beneficial effects on muscle metabolism, as indicated by lower inorganic 
phosphate to phosphocreatine ratio at Wmax (30), and that O2 administration attenuates 
exercise-induced blood glutathione oxidation in patients with severe COPD (40).  
The present study was not designed to identify the organ responsible for elevated 
GSSG and MDA concentration after exercise. Contracting skeletal muscle may play a role. 
Hypoxanthine accumulates in contracting skeletal muscles at the onset of fatigue induced by 
cycle ergometry (4). In addition, in healthy young subjects, it has been shown that during and 
12 min after incremental cycle ergometry contracting skeletal muscles release hypoxanthine 
(16). Measuring femoral arterial and venous uric acid concentration during and after cycle 
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ergometry revealed that skeletal muscles do not release uric acid (16), which would be 
expected if xanthine oxidase mediated, hypoxanthine degradation occurred during exercise. 
However, this does not necessarily mean that there was no uric acid formation in these 
muscles. First, calculating arterial-venous concentration differences may not be a very 
sensitive method for a metabolite physiologically present in very low concentrations and 
secondly, it has been shown that uric acid may act as an intracellular free radical scavenger, 
resulting in the formation of uric acid oxidation products, including allantoin. Indeed, skeletal 
muscle allantoin concentration has been found to increase immediately after incremental cycle 
ergometry in healthy subjects (18). Alternatively, xanthine oxidase activity is relatively high 
in the liver (29), and animal studies have shown that the liver releases GSSG during exercise 
(38).  
 
Clinical relevance 
It is becoming increasingly clear that both in healthy young subjects and in patients with 
COPD, exhaustive physical activity is associated with oxidative stress. In healthy subjects, 
this will occur only during high load exercise. However, in patients with severe COPD, daily 
life activities can be regarded as strenuous physical activity. Thus, these patients are subjected 
to oxidative stress easily. Repetitive bursts of oxidative stress and nutritional depletion, as 
occurs in a subgroup of COPD patients, may impair the antioxidant screen, which in turn will 
promote free radical mediated tissue damage. It has been demonstrated in the emphysematous 
hamster, an animal model for COPD, that the degree of glutathione oxidation of the 
diaphragm is significantly correlated with in vitro force generation of the diaphragm (19).  
However, it should be kept in mind that physical exercise also exerts beneficial effects 
to the musculoskeletal system. Free radicals are known to play a role in cell physiology, for 
instance in cell signaling and gene regulation. This could be part of an adaptive response to 
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exercise. Exploring mechanisms for generation of free radicals during exercise may add to the 
understanding of the role of free radicals in the pathophysiology of muscle (dys) function as 
occurs in patients with COPD (3).  
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Abstract 
Strenuous exercise is associated with elevated generation of free radicals and free radical 
mediated tissue damage. Oxidative stress may play a causal role in the development of 
skeletal muscle fatigue. In the present study we hypothesized, that pulmonary rehabilitation 
attenuates exercise-induced oxidative in patients with COPD. Patients (n = 7) performed 
incremental cycle ergometry until maximal load (Wmax) before and after a 12-week 
pulmonary rehabilitation program. Reduced (GSH) and oxidized (GSSG) glutathione and 
lipid-peroxides (malondialdehyde [MDA]) were measured in arterial blood before and after 
exercise testing. Before pulmonary rehabilitation, blood GSSG was significantly elevated 
after exercise (60 ± 5 µM at rest and 101 ± 14 µM at Wmax, p < 0.05). In addition, exercise 
increased plasma lipid-peroxidation (0.65 ± 0.02 µM at rest and 0.76 ± 0.02 µM at Wmax, p < 
0.005). In contrast, after pulmonary rehabilitation, maximal exercise was not associated 
elevated blood GSSG (68 ± 15 µM at rest vs. 79 ± 12 µM at Wmax, p > 0.05). Although 
plasma lipid-peroxides were significantly elevated at Wmax after pulmonary rehabilitation 
(0.69 ± 0.04 µM at rest vs. 0.75 ± 0.04 µM at Wmax, p = 0.03), the response tended to be 
lower in comparison to pre rehabilitation values (increase before rehabilitation was 16% vs. 
8% after rehabilitation, p = 0.10). We conclude that pulmonary rehabilitation attenuates 
exercise-induced oxidative stress.  
 
 
Introduction 
Strenuous exercise is associated with elevated generation of free radicals in healthy subjects 
(19) and in patients with COPD (11,27). Moreover, several studies indicated that exercise is 
associated with free radical mediated tissue damage as indicated by elevated plasma lipid 
peroxides after exercise (11,19). These studies have shown that exercise-induced free radical 
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generation and tissue damage in COPD occur at low absolute workload. The precise role of 
free radicals in muscle function is still subject of research, but oxidative stress (a dysbalance 
between free radicals and antioxidants) plays a causal role in the development of skeletal 
muscle fatigue in humans (18). The physiological significance of free radical mediated tissue 
damage is uncertain, but uncontrolled repetitive muscle damage might impair muscle 
performance.  
 Exercise training has marked effects on biochemical and physiological characteristics 
of skeletal muscle. Oxidative capacity of the vastus lateralis muscle increases after cycle 
ergometry training in healthy subjects (22). Limited data are available regarding the effects of 
exercise training on skeletal muscle antioxidant defenses. Hellsten et al (7) showed that seven 
weeks of sprint cycle training increased vastus lateralis muscle glutathione peroxidase and 
glutathione reductase, but not superoxide dismutase activity in healthy subjects. Alternatively, 
eight weeks of aerobic cycle training did not affect glutathione peroxidase or superoxide 
dismutase activity of vastus lateralis muscle in healthy subjects (24). In a preliminary study, 
Vi!a and colleagues (28) have shown that exercise training in healthy subjects attenuates 
exercise-induced blood glutathione oxidation. 
To date no study has evaluated the effect of exercise training on exercise-induced free 
radical generation in patients with COPD. The present study was designed to investigate the 
effects of pulmonary rehabilitation on exercise-induced free radical generation in COPD. 
Based on the findings in studies in animals and healthy subjects, we hypothesized that 
pulmonary rehabilitation attenuates exercise-induced free radical generation and free radical 
mediated tissue damage in these patients. Recently, it was shown that for a given level of 
effort, expressed as ratio of lactate / pyruvate, the degree of glutathione oxidation is higher in 
untrained compared to trained subjects (28). In the present study we investigated whether this 
is also the case in COPD patients.  
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Methods 
Subjects 
Seven (6 male) patients with COPD according to ATS / ERS (20) criteria were recruited from 
our outpatient clinic. Subjects were stable at the time of entering the study and at least 6 
weeks before exercise testing. None of these patients had exercise limiting diseases besides 
COPD. The study was conducted according to the declaration of Helsinki and was approved 
by the ethical committee of our hospital. Informed written consent was obtained from all 
patients.  
 
Pulmonary function, exercise testing and pulmonary rehabilitation 
Spirometry was performed before the first cycle ergometry test. Before cycle ergometry, a 
cannula was inserted into the brachial artery under local anesthesia to obtain blood, which was 
collected immediately before exercise (‘rest’), and at maximal exercise (‘Wmax’). Initially, 
we planned to withdrawn blood at after pulmonary rehabilitation at the workload 
corresponding to Wmax before pulmonary rehabilitation. However, Wmax did not 
significantly increase after pulmonary rehabilitation (see results). Therefore, no blood was 
obtained at this time point. Patients cycle on an electrically braked cycle ergometer (Lode, 
Groningen, The Netherlands), at a pedaling rate of 60-rpm breathing room air. Workload was 
increased each minute by 10% of estimated Wmax until voluntary exhaustion (3). The time 
from start of exercise until exhaustion was defined as exercise endurance. Increases in 
workload during ergometry were similar before and after pulmonary rehabilitation.  
 A general hospital based 12-week exercise-training program has been developed 
consisting of dynamic and isometric strength training exercises, and training of specific daily 
life activities. Patients performed whole body exercise and exercise by different muscle 
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groups of upper and lower extremities. Because of the reduced ventilatory reserve, interval 
training and bouts of exercise of short duration were used. Training sessions were held 5 days 
per week and were supervised by a physiotherapist. Hemoglobin O2 saturation was monitored 
with a pulse oxymeter using a finger probe. Supplemental O2 was supplied if necessary to 
keep O2 saturation above 90%. Training exercises were started at low workloads, which were 
gradually increased during the first week. Afterwards, exercise training was performed at the 
highest intensity that could be tolerated. Apart from this, patients joined activities that were 
held once or twice a week and included indoor games, swimming, sauna and outdoor 
activities, such as walking and cycling.  
 
Biochemical methods 
For the measurement of lactate and pyruvate, 2.0 ml blood was collected in tubes containing 2 
ml perchloric acid. The tubes were immediately centrifuged and the clear supernatant was 
stored at -80°C until analysis (within 1 week). Measurements were routine enzymatic 
laboratory assays. Blood for blood gas was collected into heparinized syringes and 
immediately analyzed. 
 Reduced glutathione (GSH) was measured according to previously published methods 
(26). Shortly, 0.5 ml blood was immediately added to 0.5 ml chilled 30% trichloric acetic acid 
solution containing 2 mM EDTA. The samples were immediately centrifuged and the clear 
supernatant was stored at -80°C until later analysis. Oxidized glutathione (GSSG) was 
determined according to Viña et al (26), and as described previously (11).  
Plasma lipid-peroxides were determined by measuring malondialdehyde (MDA) 
formation according to Wong et al (29) and as described previously (11).  
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Data analysis 
Paired T test was used to compare pre- and post exercise values (i.e. GSH, GSSG, MDA). All 
tests were performed using the SPSS/PC+, version 10.0.5 (SPSS, Chicago, IL). Results were 
considered significant at P < 0.05. All data are expressed as means ± SE.  
 
Results 
Patient characteristics at entering the study are shown in table 1. In general, patients had 
severe COPD as indicated by severe irreversible airflow obstruction, pulmonary 
hyperinflation and reduced diffusion capacity for carbon monoxide. In addition, these patients 
were severely limited in exercise performance. Wmax was only 65 ± 9% of predicted value 
before rehabilitation.  
 
Table 1. Patient characteristics at entering the study 
  
Age, yrs 59 ± 4 
Bodyweight, Kg 65 ± 4 
Length, cm 173 ± 4 
FEV1, L/min 1.29 ± 0.14 
FEV1 after ß2 agonist, L/min 1.39 ± 0.16 
FEV1, % pred. 40 ± 3 
TLC, % pred. 108 ± 5 
RV, % pred. 140 ± 9 
Kco, % pred. 41 ± 7 
 
Values are means ± SE. FEV1: forced expiratory volume in first second; TLC: total lung capacity; RV: residual 
volume; Kco: carbon monoxide diffusion capacity.
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 Before pulmonary rehabilitation, exercise was associated significant increase in both 
blood GSH and GSSG (Fig. 1A, B). The GSSG/GSH ratio increased from 7 ± 1 % at rest up 
to 11 ± 1 % at Wmax (p < 0.05). In addition, exercise resulted in an ~16% increase in plasma 
lipid peroxides (Fig 1C).  
 Blood GSH was significantly lower after- compared to pre pulmonary rehabilitation 
(Fig. 1A). However, exercise was still associated with a significant increase in blood GSH. In 
contrast, exercise after pulmonary rehabilitation was not associated with significant blood 
glutathione oxidation (Fig. 1B). Exercise after pulmonary rehabilitation was associated with 
an 8% increase in MDA levels (p < 0.05, compared to resting value, Fig. 1C). This response, 
although attenuated, was not significantly different from the response before pulmonary 
rehabilitation (p = 0.10).   
Physiological and biochemical responses before and after pulmonary rehabilitation are 
shown in table 2. Before pulmonary rehabilitation, exercise capacity was severely reduced. 
Wmax was 60 ± 9% of predicted value. The high maximal ventilation and the increase in 
Paco2 indicate that these patients were ventilatory limited. Nevertheless, patients performed 
strenuous exercise as indicated by the significant increase in lactate at Wmax. Pulmonary 
rehabilitation did not significantly alter Wmax, neither exercise endurance (6.7 ± 0.7 vs. 7.2 ± 
1.2 min pre and after pulmonary rehabilitation respectively, p > 0.05).  
 The slope of the line that relates the oxidation of glutathione and the lactate / pyruvate 
ratio was reduced after pulmonary rehabilitation. In fact, before pulmonary rehabilitation a 
significant correlation existed between the ratio of lactate / pyruvate and the GSSG / GSH 
ratio (Fig. 2; r = 0.75, p < 0.01). However, no correlation was observed between lactate / 
pyruvate ratio and the GSSG / GSH ratio after pulmonary rehabilitation (Fig. 2; r = -0.14, p > 
0.05).  
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Figure 1. Exercise-induced changes in reduced (GSH, A), oxidized glutathione (GSSG, B) in arterial blood and 
plasma lipid-peroxides [malondialdehyde] (MDA, C) in patients with severe COPD before and after pulmonary 
rehabilitation. Blood was collected at rest and immediately after maximal exercise (Wmax). A. Exercise resulted 
in significant elevation in blood GSH both before and after pulmonary rehabilitation (*). Pulmonary 
rehabilitation, reduced resting GSH level (#), but did not significantly affect GSH at Wmax. B. Maximal 
exercise resulted in elevated blood glutathione oxidation only before pulmonary rehabilitation (*). Resting 
GSSG concentration was not affected by pulmonary rehabilitation. C. Exercise was associated with elevated 
MDA concentration both before and after pulmonary rehabilitation (P < 0.005 and P = 0.03 respectively).    
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Table 2. Physiological parameters during exercise testing before and after pulmonary 
rehabilitation.  
 
 Pre rehabilitation (n = 7) Post rehabilitation (n = 7) 
 Rest Wmax Rest Wmax 
Wmax, W  85 ± 14  94 ± 21 
VE, L/min 14 ± 1 45 ± 6* 15 ± 1 48 ± 8* 
Vo2, ml/min 0.28 ± 0.03 1.11 ± 0.14* 0.31 ± 0.02 1.15 ± 0.18* 
Heart rate, bpm 88 ± 5 142 ± 13* 88 ± 3 143 ± 12* 
Lactate, mM 1.0 ± 0.2 5.7 ± 0.7* 1.2 ± 0.2 7.1 ± 1.3* 
Pyruvate, mM 84 ± 14 133 ± 19* 56 ± 11 59 ± 16# 
PH 7.41 ± 0.01 7.33 ± 0.02* 7.42 ± 0.01 7.31 ± 0.03* 
PaO2, kPa 9.9 ± 0.8 8.9 ± 0.7* 9.9 ± 0.6 8.4 ± 0.7*# 
PaCO2, kPa 4.8 ± 0.2 5.6 ± 0.3* 5.0 ± 0.2 5.6 ± 0.3 
Sat O2, % 94 ± 1 90 ± 1* 94 ± 1 89 ± 2* 
 
Values are means ± SE. Wmax: maximal workload; VE: minute ventilation; Vo2:oxygen consumption rate; PaO2: 
arterial oxygen tension; PaCO2: arterial carbon dioxide tension: sat O2: blood oxygen saturation. *P < 0.05 
compared to rest value. # p < 0.05 compared to pre rehabilitation 
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Figure 2. Relationship between blood glutathione oxidation and lactate / pyruvate in patients with COPD 
before (solid squares) and after pulmonary rehabilitation (circles). Before pulmonary rehabilitation a significant 
correlation exists between GSSG / GSH ratio and lactate / pyruvate (r = 0.75, P < 0.01). No such correlation was 
found after pulmonary rehabilitation (r = -0.14, P > 0.05).  
 
 
Discussion 
The present study is the first to show that in patients with severe COPD, pulmonary 
rehabilitation attenuates exercise-induced blood glutathione oxidation. This indicates that the 
degree of oxidative stress induced by strenuous exercise, is attenuated by pulmonary 
rehabilitation. In fact, before rehabilitation a significant positive correlation existed between 
glutathione oxidation and lactate / pyruvate ratio. This correlation was lost after pulmonary 
rehabilitation and indicates that an increase in the level of effort (as reflected by lactate / 
pyruvate ratio) did not increase blood glutathione oxidation. Thus, training protects against 
exercise-induced blood glutathione oxidation. However, pulmonary rehabilitation did not 
attenuate exercise-induced lipid-peroxidation in this study. 
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Methodological issues 
GSH serves as an antioxidant by its direct reaction with free radicals and by serving as a 
substrate for glutathione peroxidase. Both direct and enzymatic oxidation of GSH results in 
the formation of GSSG, which can be reduced to GSH. An elevation of GSSG, or the ratio of 
GSSG / GSH is frequently used as a marker for enhanced generation of free radicals (21). 
Lipid-peroxidation is used as a marker for free radical mediated tissue damage (6). The attack 
of one free radical can oxidize multiple fatty acid side chains to lipid-peroxides (‘chain 
reaction’), damaging membrane proteins, making the membrane leaky, and eventually causing 
complete membrane breakdown (‘tissue damage’) (6).  
 Since the number of patients included in this study is relatively small, conclusions 
should be drawn cautiously. However, the glutathione and MDA data at rest and at Wmax are 
consistent with previous observations from our laboratory (10,11,27). The absence of a 
training effect on physiological responses after pulmonary rehabilitation may be due to the 
small number of patients included in this study. In addition, Wmax and arterial lactate at 
Wmax may not be adequate parameters to evaluate effectiveness of rehabilitation (2). When 
designing this study, we planned to obtain blood during the post rehabilitation incremental 
exercise test at the workload corresponding to Wmax before rehabilitation for analysis of 
glutathione and lactate (see methods). However, this appeared to be unfeasible, since Wmax 
before rehabilitation and Wmax after rehabilitation were too close.  
 
Pulmonary rehabilitation effects on exercise-induced oxidative stress  
Limited data are available on the effects of endurance training on the antioxidant screen. 
Strenuous exercise training is associated with repetitive exposure to free radicals. Thus, 
exercise training may be a stimulus to improve the antioxidant screen, as training is a stimulus 
to increase oxidative capacity of skeletal muscle (22). However, as mentioned in the 
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introduction, the effects of exercise training on skeletal muscle antioxidant enzyme activity 
are conflicting (7,24). In animal models, exercise training increased activity of antioxidant 
enzymes such as superoxide dismutase and glutathione peroxidase (12,13,16,17), but not 
catalase (17). The effects of exercise training on skeletal muscle GSH content are less 
consistent. Exercise training increases GSH content of peripheral skeletal muscle in rats 
(12,13). In contrast, 12 weeks of treadmill running did not affect GSH content of normal or 
emphysematous hamster diaphragm or soleus muscle (8). In the present study, we studied the 
effect of pulmonary rehabilitation on the antioxidant screen, when the antioxidant screen was 
‘stressed’, namely immediately after maximal exercise. Indeed, this study shows that after 
pulmonary rehabilitation strenuous exercise was associated with less blood glutathione 
oxidation. In fact, figure 2 shows that after training, the degree of exercise-induced oxidative 
stress is independent from the metabolic stress that skeletal muscles face. Whether this is the 
result of elevated antioxidant enzyme activity, elevation in non-enzymatic antioxidants or 
reduced generation of free radicals is uncertain. However, pulmonary rehabilitation did not 
prevent exercise-induced lipid-peroxidation. This could result from the fact that lipid-
peroxidation is a chain reaction. Thus, a relatively small number of free radicals could result 
in significant lipid-peroxidation. Lipid-peroxidation can be terminated by chain breaking 
antioxidants, such as alpha-tocopherol (15). Indeed, Meyandi et al (14) showed that 48 days 
of vitamin E supplementation to healthy subjects attenuates exercise-induced elevation in 
urinary MDA. Moreover, elevation (p = 0.09) in skeletal muscle lipid conjugated denies was 
prevented by vitamin supplementation in these subjects (14). Similarly, vitamin E 
supplementation attenuates exercise-induced elevation in plasma MDA, but also of cytosolic 
enzymes such as ß-glucuronidase in healthy subjects (23).  
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Clinical relevance 
The precise role of free radicals in skeletal muscle function is still subject of investigation. 
However, convincing data exist showing that overproduction of free radicals plays a role in 
the development of muscle fatigue in humans (18). In addition, elevated generation of free 
radicals is associated with tissue damage as indicated by elevated lipid-peroxides in plasma 
and skeletal muscle i.e (11,14,23). Strategies aiming at attenuating exercise-induced oxidative 
stress may improve skeletal muscle function. The benefits could be twofold.  Firstly, several 
studies have shown that overproduction of free radicals impairs excitation-contraction 
coupling in skeletal muscle i.e. (1), for review see (9). Thus, attenuation of exercise-induced 
free radicals generation may improve skeletal muscle contractility. The present study shows 
that exercise training attenuates exercise-induced oxidative stress. Whether this improves 
muscle performance remains to be investigated. Promising in vivo data were obtained using 
the antioxidant N-acetylcysteine. Pretreatment with N-acetylcysteine attenuates fatigability of 
peripheral (18) and respiratory (25) muscle in healthy subjects. Secondly, the present and 
previous studies (11,14,23) showed that exercise-induced oxidative stress results in tissue 
damage. This could be of special interest to patients with COPD. These patients become 
easily exhausted during daily life activities, which may result elevated generation of free 
radicals and resulting tissue damage. Peripheral and respiratory muscle dysfunction frequently 
occurs in severe COPD and is associated with impaired exercise tolerance (5). If free radical 
mediated tissue damage contributes to muscle dysfunction in COPD remains to be 
investigated. The present study shows that pulmonary rehabilitation is not en effective 
strategy to attenuate lipid-peroxidation. Malnourishment frequently occurs in patients with 
COPD and is associated with lower values for respiratory and peripheral muscle strength 
compared to non-depleted COPD patients (4). If these patients are antioxidant depleted, 
especially alpha-tocopherol is unknown. Possibly, the combination of pulmonary 
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rehabilitation and nutritional therapy (i.e. alpha-tocopherol) may attenuate exercise-induced 
lipid-peroxidation in these patients. However, this remains to be investigated.  
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SUMMARY AND CONCLUSIONS 
Skeletal muscle dysfunction frequently occurs in patients with severe COPD. Free radicals 
(oxygen and nitrogen centered) are generated in inactive skeletal muscle and generation is 
enhanced by contractile activity. Though free radicals are necessary for optimal contractile 
activity of skeletal muscles, overproduction is associated with muscle dysfunction. The 
diaphragm in COPD patients faces an elevated load due to increased airway resistance and 
hyperinflation, resulting in a disadvantage position of the diaphragm on the length tension 
curve. This may enhance generation of free radicals, contributing to muscle dysfunction.  
Nitric oxide (NO) is one of the nitrogen-centered free radicals generated in skeletal 
muscle. Many possible targets for NO have been identified in skeletal muscle. The 
sarcoplasmic calcium release channel, or ryanodine receptor calcium release channel (RyR) 
contains hyper reactive thiols, which have been shown to be regulators of the open probability 
of this channel. Indeed, it has been shown that the open probability of the RyR channel can be 
reversibly modulated by NO. These previous studies either used RyR channels in a lipid 
bilayer, or isolated sarcoplasmic vesicles containing RyR. We have studied the effect of the 
NO donor DEA-NO on RyR channel activity in intact cells (chapter 3).  Mouse C2C12 
skeletal myotubes were loaded with the Ca2+ indicator fluo-3, using confocal laser 
microscopy. Myotubes were activated using acetylcholine or the RyR agonist caffeine. Pre 
exposure to DEA-NO reduced the amplitude of acetylcholine and caffeine-induced 
intracellular Ca2+ responses in a dose dependent manner. The effects were partly reversible 
after exposure to the reducing agent DTT. To verify that these effects were mediated via NO, 
and not the parent compound, additional experiments were performed with the chemically 
distinct NO donor SNAP. Indeed, SNAP also reduced the amplitude of caffeine-induced 
intracellular Ca2+ responses. The effects of SNAP were reversible after exposure to DTT. We 
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concluded that NO impairs RyR channel Ca2+ release, via modification or reactive thiol 
groups present on this receptor.  
To investigate the effects of NO on cross-bridge recruitment and cross-bridge cycling, 
we exposed permeabilized single skeletal muscle fibers to the NO donor spermine-NO. 
(chapter 4). After 10 min of exposure to spermine-NO, fibers were activated using 
incremental Ca2+ concentrations. The effects of NO were determined on maximal and 
submaximal force generating capacity, on the fraction of cross-bridges in the force generating 
state and on cross-bridge cycling kinetics. Spermine-NO significantly reduced submaximal 
force and to a lesser extent maximal force. This indicates a reduced sensitivity of the muscle 
fibers to Ca2+. Subsequent experiments showed that spermine-NO reduced the fraction of 
cross-bridges in the force generating state, both during maximal and submaximal activation of 
the fibers. Cross-bridge cycling however, was only impaired at submaximal activation. Thus, 
these data indicate a NO-induced reduction in the Ca2+-sensitivity of cross-bridge recruitment. 
The effect of NO on cross-bridge cycling kinetics is limited to submaximal activation. The 
reduced Ca2+ sensitivity of cross-bridge recruitment could result from altered Ca2+ binding to 
troponin C, via modification of thiols on troponin T and I by NO. However, further studies are 
needed to confirm such a mechanism.  
Recent evidence indicates that hypoxia enhances generation of oxidants. Little is 
known about the role of free radicals in contractility of the rat diaphragm during hypoxia. 
Xanthine oxidase is a potential source for free radicals during hypoxia. We hypothesized that 
antioxidants improve contractility of the hypoxic rat diaphragm and that xanthine oxidase is 
an important source for free radicals in the hypoxic diaphragm. We performed experiments 
(chapter 5) to test the effects of different antioxidants (N-acetylcysteine and Tiron) on in vitro 
contractility of the rat diaphragm under hypoxic and hyperoxic conditions. Furthermore, the 
effect of xanthine oxidase inhibitor allopurinol was studied on contractility of the diaphragm 
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during hypoxia and hyperoxia. This study showed that both NAC and Tiron decreased 
maximal force generation, slowed shortening velocity and decreased power output of the 
diaphragm under hypoxic conditions. The fatigue rate was decreased in the presence of either 
NAC or Tiron. Xanthine oxidase inhibition did not alter contractility or fatigability of the 
diaphragm. During hyperoxia, neither NAC nor allopurinol affected contractility or 
fatigability of the diaphragm. We concluded that free radicals play a significant role in 
diaphragm contractility during hypoxia. Whether antioxidants exert a beneficial or harmful 
effect on muscle performance depends on the contraction pattern of the muscle. Free radicals 
generated by XO do not play a role in diaphragm contractility during either hypoxia or 
hyperoxia.  
Increased loading of skeletal muscles is associated with elevated generation of free 
radicals. The diaphragm in patients with COPD faces an elevated load due to increased airway 
resistance and pulmonary hyperinflation. In an animal model for pulmonary emphysema 
(‘emphysematous hamster’) we measured reduced and oxidized glutathione as a marker for 
free radical generation (chapter 6). Exercise training has been shown to up regulate 
antioxidant enzymes. In this study, we also investigated the effect of endurance training on 
diaphragm in vitro contractility and glutathione content. Emphysema was induced by 
intratracheal instillation of elastase, and it resembles morphological and functional alterations 
found in COPD patients. Six months after elastase instillation half of the hamsters participated 
in a 12-week lasting treadmill exercise-training program. The other groups of hamsters 
remained sedentary for 12 weeks. Subsequently the diaphragm was excised and used for 
measuring in vitro contractile properties and glutathione content. Pulmonary emphysema 
significantly reduced maximal twitch force and maximal tetanic force of the diaphragm 
compared to control hamsters. These detrimental effects of emphysema on maximal force 
generating capacity of the diaphragm could be reversed with exercise training. Before 
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training, the ratio of GSSG to GSH was significantly higher in the emphysematous diaphragm 
compared to the normal hamster diaphragm. Moreover, a significant inverse correlation exists 
between maximal twitch force and the ratio of GSSG to GSH. This indicates that elevated 
generation of free radicals is associated with impaired submaximal force generation in the 
(emphysematous) hamster diaphragm. Training did not affect GSSG or GSH concentration in 
the normal or emphysematous hamster diaphragm.  
In healthy subjects and in patients with COPD, strenuous exercise is associated with 
enhanced generation of free radicals as indicated by elevated blood glutathione oxidation. In 
addition, free radicals are involved in the development of fatigue in skeletal muscle of healthy 
subjects. Generally, it is assumed that the mitochondrial electron transport chain is the most 
prominent source for free radicals during exercise. In the present study (chapter 7), we 
investigated if exercise-induced free radical generation in COPD is associated with tissue 
damage. In addition, we studied the role of xanthine oxidase in exercise-induced free radical 
generation in these patients. Patients with severe COPD performed incremental cycle 
ergometry until maximal load. Half of this group of patients was pretreated with the xanthine 
oxidase inhibitor allopurinol. Arterial blood was withdrawn before and after exercise and 
analyzed for reduced and oxidized glutathione to confirm elevated generation of free radicals 
after exercise. Plasma lipid-peroxidation was measured before and after exercise as a marker 
for free radical mediated tissue damage. Though exercise was exhaustive for these patients, 
the absolute workload was low (~75 W). In control COPD patients, blood GSSG/GSH ratio 
and plasma-lipid-peroxides were significantly elevated after exercise. However, in allopurinol 
treated patients exercise was not associated with elevated blood glutathione oxidation or lipid-
peroxidation. This study shows that strenuous exercise, but low absolute workload, results in 
elevated generation of free radicals and tissue damage. Xanthine oxidase inhibition prevents 
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exercise-induced blood glutathione oxidation and plasma lipid-peroxidation, indicating that 
xanthine oxidase plays a key role in exercise-induced free radical generation in COPD.  
To follow-up on these data, we performed additional experiments in a larger group of 
COPD patients (chapter 8). The previous study (chapter 7) showed that xanthine oxidase 
plays a key role in generation of free radicals during exercise. We hypothesized that the 
degree of exercise-induced oxidative stress depends on the degree of tissue metabolic stress, 
since hypoxanthine, a marker for metabolic stress, is one of the primary substrates of xanthine 
oxidase. COPD patients performed incremental cycle ergometry until maximal load. Arterial 
blood was obtained before and after cycle ergometry and was analyzed for markers of free 
radical generation (reduced and oxidized glutathione and lipid-peroxides) and markers for 
tissue metabolic stress (pH, lactate, hypoxanthine). This study showed that blood GSSG at 
maximal workload significantly correlated with the markers for tissue metabolic stress. 
However, no significant correlation was found between GSSG and maximal oxygen 
consumption rate, neither between GSSG and lung function parameters. These data support 
the hypothesis that the degree of metabolic stress, but not mitochondrial oxygen consumption 
rate determines the degree of exercise-induced oxidative stress.  
In chapter 9, we studied the effects of pulmonary rehabilitation on exercise-induced 
oxidative stress in patients with severe COPD. Previous studies in both animal models and 
healthy subjects have shown that endurance training up regulates skeletal muscle oxidative 
and antioxidant enzyme activity. We have shown that pulmonary rehabilitation attenuates 
exercise-induced oxidative stress. This could be due to attenuation of free radical generation 
during exercise, or more likely, improvement in the antioxidant screen. However, pulmonary 
rehabilitation did not prevent exercise-induced lipid-peroxidation, indicating continued free 
radical mediated tissue damage. This discrepancy is probably due to the different underlying 
mechanisms of lipid-peroxidation and glutathione oxidation. Lipid-peroxidation can be 
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initiated by a single free radical and is self propagating (‘chain reaction’). In stead, each mol 
of GSH is assumed to reduce one mol of H2O2 (or other peroxide).  
In conclusion, free radicals play a prominent role in skeletal muscle (dys)-function. 
Specific intracellular targets for free radicals are located on the RyR Ca2+ release channel and 
on the contractile apparatus. Modulation of redox balance affects contractility of the rodent 
hypoxic diaphragm. The effect depends on the contraction pattern (fatiguing vs. non-fatiguing 
contractions). In the emphysematous hamster diaphragm a significant correlation exists 
between the degree of glutathione oxidation and in vitro contractility, also supporting the 
hypothesis that the redox balance plays a prominent role in muscle function. Free radicals 
generated by xanthine oxidase do not affect rat diaphragm contractility under either hypoxic 
or hyperoxic conditions. Alternatively, allopurinol appeared to be very effective in preventing 
exercise-induced oxidative stress en lipid-peroxidation in patients with COPD, indicating that 
xanthine oxidase plays a prominent role in free radical generation during exercise in these 
patients. Pulmonary rehabilitation is an effective strategy to attenuate exercise-induced 
oxidative stress, but does not affect free radical mediated tissue damage.  
 
Future directions 
The role of free radicals in skeletal muscle function and the potential relevance in skeletal 
muscle dysfunction is an exciting field for both basic and clinical research. Though the 
number of papers in this field has increased extraordinarily over the last years, the clinical 
significance of these findings in patients with COPD remains to be investigated. This will be a 
major challenge for future studies. Specifically, we need to know whether impaired force 
generation in peripheral and respiratory muscle is due to atrophy, change in fiber type 
distribution, fiber damage or to impaired excitation-contraction coupling. The role of free 
radicals in these processes needs to be investigated.  
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 Studies in this thesis show that strenuous exercise in COPD results in enhances 
generation of free radicals as indicated by elevated blood glutathione oxidation and lipid-
peroxides. Contracting skeletal muscles are the most likely source. However, this needs to be 
confirmed in biopsy studies. In addition, it should be evaluated if xanthine oxidase inhibition 
prevents exercise-induced muscle damage. If so, the long-term effects of xanthine oxidase 
inhibition on skeletal muscle function need to be determined in placebo controlled clinical 
studies. 
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SAMENVATTING EN CONCLUSIES 
Disfunctie van dwarsgestreeptespieren komt frequent voor bij patiënten met ernstig chronisch 
obstructief longlijden (COPD). Over de oorzaak van deze skeletspier disfunctie is weinig 
bekend. In de studies gepresenteerd in dit proefschrift wordt de rol van vrije radicalen bij 
skeletspier (dis)-functie onderzocht. Niet contraherende skeletspieren genereren vrije 
radicalen en deze productie neemt toe tijdens spieractiviteit. Vrije radicalen zijn essentieel 
voor optimale contractiliteit, maar overproductie van vrije radicalen heeft een negatief effect 
op spierfunctie. Ademhalingsspieren bij patiënten met COPD worden extra belast onder meer 
als gevolg van 1. verhoogde weerstand in luchtwegen en 2. de hyperinflatie stand van het 
diafragma, waardoor een nadelige positie van het diafragma op de lengte–tensie curve. Of de 
toegenomen belasting van het diafragma resulteert in verhoogde productie van vrije radicalen 
is niet bekend.  
 Stikstofmonoxide (NO) is een van de vrije radicalen die in spieren geproduceerd 
worden. Er zijn verschillende intracellulaire aangrijpingspunten voor NO. Het Ca2+ kanaal 
van het sarcoplasmatisch reticulum, ofwel de ryanodine receptor Ca2+ kanaal (RyR), heeft een 
aantal hyperreactieve thiolen die een rol spelen in de opening van dit kanaal. Moleculaire 
studies hebben aangetoond dat de doorgankelijkheid van dit kanaal, op een reversibele 
manier, gemoduleerd kan worden door NO. In de studie beschreven in hoofdstuk 3, is het 
effect van NO donors op de gestimuleerde doorgankelijkheid van het RyR-kanaal bestudeerd 
in intacte spiercellen. Intracellulaire Ca2+ metingen werden verricht middels confocale laser 
microscopie in C2C12 spiertubuli die geladen waren met de Ca2+ indicator fluo-3. Spiertubuli 
werden geactiveerd met acetylcholine of de RyR-kanaal agonist cafeïne. De amplitude van de 
Ca2+ response was significant lager wanneer spiertubuli waren blootgesteld aan de NO donor 
diethylamine NONO-ate (DEA-NO). Het effect van DEA-NO was deels reversibel na wassen 
van de cellen met de reducerende stof dithiotreitol (DTT). Om met zekerheid vast te stellen 
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dat de geobserveerde effecten gemedieerd waren via NO, werden experimenten ook 
uitgevoerd met een chemisch ander type NO donor, namelijk S-nitroso-N-acetylpenicillamine 
(SNAP). Dit leverde analoge resultaten op. Geconcludeerd werd dat NO, Ca2+ flow door het 
RyR-kanaal (na activatie van het kanaal) vermindert, via modificatie van reactive thiolen op 
deze receptor.   
 In een vervolgstudie werden de effecten van de NO donor spermine-NO (Sp-NO) op 
‘crossbridge recruitment’ en ‘crossbridge cycling’ bestudeerd in geïsoleerde 
gepermeabiliseerde m. psoas vezels van het konijn (hoofdstuk 4). Na expositie aan deze NO 
donor werden vezels geactiveerd door middel van Ca2+ in de perfusie vloeistof. Het effect van 
de NO donor werd bepaald op submaximale en maximale kracht generatie, fractie van de 
‘crossbridges in de kracht-genererende staat’ en op ‘crossbridge cycling’. Het negatieve effect 
van Sp-NO was groter tijdens submaximale in vergelijking met maximale activatie. Dit pleit 
ervoor dat NO de gevoeligheid van de spiervezels voor Ca2+ vermindert. Aanvullende 
experimenten toonden dat Sp-NO de fractie van ‘crossbridges’ in de kracht-genererende staat 
verminderde zowel tijdens submaximale als tijdens maximale activatie. Sp-NO had alleen 
tijdens submaximale activatie een negatief effect op ‘crossbridge cycling’. Deze studie toont 
dus aan dat NO de gevoeligheid van skeletspieren voor Ca2+-geïnduceerde ‘crossbridge 
recruitment’ vermindert. Deze verminderde gevoeligheid voor Ca2+ kan het gevolg zijn van 
veranderde Ca2+ binding aan troponine C, door middel van modulatie van thiolen op 
troponine T en I. Aanvullende studies zijn nodig om dit te bewijzen.  
 Recente studies tonen aan dat hypoxie productie van vrije radicalen stimuleert. De rol 
van vrije radicalen geproduceerd onder hypoxische omstandigheden op contractiliteit van het 
diafragma is niet bekend. Xanthine oxidase is een mogelijke bron voor vorming van vrije 
radicalen tijdens hypoxie. De hypotheses van de studies in hoofdstuk 5 zijn dat scavengers 
van vrije radicalen de contractiliteit van het diafragma verbeteren tijdens hypoxie en dat 
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xanthine oxidase een belangrijke bron is voor de vorming van vrije radicalen in het 
hypoxische diafragma. Het effect van de scavengers N-acetylcysteine (NAC) en Tiron op in 
vitro contractiliteit van het rat diafragma onder hypoxische en hyperoxische condities werd 
gemeten. Identieke experimenten werden uitgevoerd in aanwezigheid van de xanthine oxidase 
remmer allopurinol. Beide scavengers verminderden maximale kracht generatie, snelheid van 
contractie en power output van het diafragma tijdens hypoxie. Echter zowel NAC als Tiron 
vertraagde de vermoeibaarheid van het diafragma. Remming van xanthine oxidase had geen 
effect op kracht ontwikkeling of snelheid van contractie van het diafragma tijdens hypoxie. 
Onder hyperoxische omstandigheden had noch NAC noch allopurinol effect op de 
contractiliteit van het diafragma. Wij concluderen dat vrije radicalen een belangrijke rol 
spelen bij contractiliteit van het diafragma tijdens hypoxie. Of dit positieve of negatieve 
effecten zijn, hangt onder andere af van het contractie patroon. Vrije radicalen geproduceerd 
door xanthine oxidase spelen geen belangrijke rol bij contractiliteit van het rat diafragma in 
vitro.  
 Zoals besproken is de belasting van het diafragma bij patiënten met COPD verhoogd, 
hetgeen generatie van vrije radicalen in deze spieren zou kunnen doen toenemen. In het 
diafragma van een diermodel voor emfyseem, de emfysemateuze hamster, werd gereduceerd 
(GSH) en geoxideerd glutathione (GSSG) gemeten, als marker voor de generatie van vrije 
radicalen (hoofdstuk 6). Inspanningstraining verhoogt activiteit van antioxidatieve enzymen 
in perifere skeletspieren. In de studie in hoofdstuk 6 werd het effect van training op 
contractiele eigenschappen en glutathione concentratie van het hamster diafragma bestudeerd. 
Emfyseem werd geïnduceerd door intratracheale toediening van elastase. Zes maanden later 
werd een groep hamsters dagelijks getraind op een tredmolen gedurende 12 weken. Een 
controle groep werd niet getraind. Na 12 weken werd het diafragma geëxcideerd voor 
bepaling van in vitro contractiele eigenschappen en voor bepaling van GSSG en GSH. 
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Maximale twitch kracht en tetanische kracht waren significant lager in het emfysemateuze 
hamster diafragma. Echter, bij getrainde emfysemateuze hamsters was de kracht ontwikkeling 
van het diafragma gelijk aan die van het normale hamster diafragma. Bij ongetrainde hamsters 
was de ratio GSSG / GSH significant hoger in het emfysemateuze hamster diafragma. 
Aanvullende analyses toonde een significante inverse correlatie tussen GSSG / GSH en 
maximale twitch kracht. Dit suggereert dat toegenomen generatie van vrije radicalen in het 
diafragma geassocieerd is met verminderde kracht-productie.  
 Bij gezonde proefpersonen en bij patiënten met COPD is zware lichamelijke 
inspanning geassocieerd met toegenomen generatie van vrije radicalen, gezien de toegenomen 
glutathione oxidatie in bloed bij maximale inspanning. In vivo studies hebben aangetoond dat 
vrij radicalen een rol spelen bij het ontstaan van vermoeidheid in skeletspieren van gezonde 
personen. In het algemeen wordt aangenomen dat de mitochondriële ademhalingsketen de 
belangrijkste bron is voor vrije radicalen tijdens inspanning. In de studies beschreven in 
hoofdstuk 7 werd onderzocht of inspannings-geïnduceerde oxidatieve stress resulteert in 
weefselschade bij patiënten met ernstig COPD. Tevens werd de rol van xanthine oxidase bij 
de vorming van vrije radicalen tijdens inspanning bestudeerd. Patiënten met ernstig COPD 
ondergingen een maximale, symptoom-gelimiteerde fietsergometrisch onderzoek. De 
belasting werd elke minuut met eenzelfde waarde verhoogd. De helft van de patiënten kreeg 
24 uur en 1 uur voor het fietsergometrisch onderzoek 300 mg allopurinol. Voor en na 
inspanning werd arterieel bloed afgenomen voor bepaling van GSSG en GSH. Plasma lipide-
peroxides werden voor en na inspanning bepaald als marker voor vrije radicaal gemedieerde 
weefselschade. Hoewel deze patiënten een maximale inspanning verrichtten, was de absolute 
belastbaarheid laag (~75 W). In controle COPD patiënten was de ratio GSSG/GSH en plasma 
concentratie van lipide-peroxides significant verhoogd na inspanning. Echter in de COPD 
patiënten die waren voorbehandeld met allopurinol, resulteerde inspanning niet in toename 
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van GSSG/GSH ratio of van lipide-peroxides. Deze studie toont dus aan dat maximale 
inspanning, zelfs als de absolute externe belasting laag is, resulteert in vrije radicaal 
gemedieerde weefselschade. Remming van xanthine oxidase voorkomt zowel inspannings-
geïnduceerde glutathione oxidatie als lipide-peroxidatie. Dit suggereert dat xanthine oxidase 
een belangrijke rol speelt bij de vorming van vrije radicalen tijdens inspanning bij COPD 
patienten.  
 Hypoxanthine, een metaboliet bij de degradatie van ATP, is een van de substraten van 
xanthine oxidase. De hypothese van de studie beschreven in hoofdstuk 8 is dat de mate van 
inspannings-geïnduceerde oxidatieve stress afhankelijk is van de mate van metabole stress. 
Ook in deze studie verrichtten patiënten een maximale fietsergometrie test. Arterieel bloed 
werd voor en na inspanning afgenomen en geanalyseerd op markers voor vrije radicaal 
productie (GSH, GSSG en lipide peroxides) en markers voor metabole stress (pH, lactaat en 
hypoxanthine). Deze studie toonde dat er inderdaad en significante correlatie was tussen 
GSSG bij maximale inspanning en de markers voor metabole stress. Er was geen significante 
correlatie tussen GSSG en O2 consumptie bij maximale inspanning en ook niet tussen GSSG 
en longfunctie parameters. Deze resultaten ondersteunen de hypothese dat de mate van 
metabole stress en niet mitochondriële O2 consumptie de mate van inspanningsgeïnduceerde 
oxidatieve stress bepaald.  
 In hoofdstuk 9 werd het effect van 12 weken longrevalidatie op inspannings-
geinduceerde oxidatieve stress bij patiënten met COPD bestudeerd. Studies bij proefdieren en 
gezonde personen hebben aangetoond dat inspanningstraining resulteert in een toename van 
oxidatieve en antioxidatieve enzym activiteit.  De resultaten van deze studie lieten zien  dat 
longrevalidatie inderdaad oxidatieve stress ten gevolge van zware inspanning vermindert. Dit 
kan het gevolg zijn van verminderde vorming van vrije radicalen tijdens inspanning, of van 
een toename van activiteit van antioxidanten (enzymatisch of non-enzymatisch). Long 
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revalidatie had echter geen effect op vrije radicaal gemedieerde weefselschade. Deze 
discrepantie is mogelijk het gevolg van de verschillende biochemische mechanismen die ten 
grondslag liggen aan glutathion-oxidatie enerzijds en lipide-peroxidatie anderzijds. Lipide-
peroxidatie kan geïnitieerd worden door een enkel radicaal, hetgeen vervolgens resulteert in 
een cascade van reakties. Anderzijds, elke mol GSH kan een mol H2O2 (of ander peroxide) 
reduceren.  
 Concluderend spelen vrije radicalen een belangrijke rol bij skeletspier (dis)-functie. 
Specifieke intracellulaire targets voor vrije radicalen zijn ondermeer thiolen op RyR-kanalen 
en thiolen van contractiele eiwitten. Modulatie van de redox status van het hypoxische rat 
diafragma beïnvloedt contractiliteit. De richting van het effect is ondermeer afhankelijk van 
het contractie patroon (bijvoorbeeld vermoeiende vs. niet-vermoeiende contracties). In het 
diafragma van de emfysemateuze hamster werd een significante correlatie tussen de mate van 
glutathione oxidatie en in vitro contractiliteit gevonden. Dit ondersteunt de hypothese dat de 
redox status van een spier een belangrijke rol speelt bij de functie van die spier. Vrije 
radicalen gegenereerd door xanthine oxidase spelen geen prominente rol bij in vitro 
contractiliteit van het rat diafragma onder hyperoxische of hypoxische condities. In vivo 
echter, leidt remming van xanthine oxidase tot een afname in inspannings-geïnduceerde 
oxidatieve stress en vrije radicaal-gemedieerde weefselschade bij patiënten met COPD. 
Longrevalidatie vermindert inspannings-geïnduceerde oxidatieve stress, maar heeft geen 
effect op vrije radicaal gemedieerde weefselschade na inspanning.  
 
Toekomstig onderzoek 
De rol van vrije radicalen in skeletspierfunctie en met name ook skeletspier-disfunctie is een 
buitengewoon interessant gebied voor basaal en klinisch  onderzoek. Het aantal gepubliceerde 
studies met betrekking tot dit gebied is de laatste jaren enorm toegenomen. Echter de 
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pathofysiologische / klinische relevantie van deze bevindingen in het algemeen en bij 
patiënten met COPD in het bijzonder is vooralsnog onzeker. Dit zal een belangrijke uitdaging 
moeten zijn voor verder onderzoek. Met name de onderliggende oorzaken van perifere 
skeletspier- en ademhalingsspier-disfunctie bij patiënten met COPD dienen verder 
geanalyseerd te worden. Atrofie, verandering in vezeltype samenstelling, spiervezelschade en 
gestoorde excitatie-contractie koppeling kunnen een rol spelen. Welke rol vrije radicalen 
hierbij spelen, is niet bekend.  
 De klinische studies in dit proefschrift tonen dat inspanning bij patiënten met COPD 
geassocieerd is met toegenomen productie van vrije radicalen hetgeen zich uit in glutathione 
oxidatie en lipide-peroxidatie. Actieve skeletspieren zijn een waarschijnlijke bron van deze 
vrije radicalen. Aanvullende studies waarbij gebruik gemaakt wordt van spier-biopten voor en 
na inspanning moeten dit bevestigen. Deze studies kunnen ook antwoord geven op de vraag of 
remming van xanthine oxidase inspannings-geïnduceerde spierschade vermindert. In dat geval 
dient het effect van langdurige xanthine oxidase remming op skeletspier functie te worden 
geëvalueerd.  
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De schrijver van dit proefschrift werd op 15 Augustus 1969 geboren te Utrecht. In 1989 werd 
het VWO-B diploma behaald aan het Liemers College te Zevenaar. Nadien werd gestart met 
de studie geneeskunde aan de Katholieke Universiteit Nijmegen. Het doctoraal examen werd 
gehaald in 1993, het arts examen in 1996. De wetenschappelijke stage, getiteld ‘De excretie 
van glycosaminoglycanen in de urine van patiënten met een exacerbatie longemfyseem’ werd 
verricht in 1995 op de afdeling Longziekten van het Academische Ziekenhuis Nijmegen 
(Hoofd Prof. Dr. C.L.A. van Herwaarden). Van april 1996 tot april 2000 was hij als AIO 
werkzaam op de afdeling Longziekten van het Universitair Medisch Centrum St. Radboud 
Nijmegen, het geen resulteerde in dit proefschrift. In het kader van dit onderzoek was de 
auteur als research fellow werkzaam op de afdeling Anesthesia Research van de Mayo Clinic 
& Foundation, Rochester, MN (Head: Prof. Dr. G.C. Sieck) van april tot en met september 
1998. Vanaf 1 juli 2000 is hij werkzaam als assistent geneeskundige in opleiding (AGIO) in 
het Jeroen Bosch Ziekenhuis (Opleider: Dr. P. Netten) in het kader van de vooropleiding voor 
longarts.  
De auteur van dit proefschrift is samenwonend met Mariëlle van Loosbroek. Samen hebben 
zij een zoon, Niels.  
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